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SUMMARY
This study was concerned with two principal aspects of T -ce ll  
neoplasia in the ca t .  F i r s t ,  the role that T -ce ll  growth factor  
(TCGF) had to play in the p ro l i fe ra t io n  of neoplastic T -c e l ls  in 
v itro  and secondly, the properties of the viruses associated with  
the fe l in e  thymic lymphosarcomas in th is  series .
The f i r s t  part of the work (Chapter Two) concerned the 
production of lymphocyte conditioned medium (Ly-CM) which provided 
a source of TCGF, or IL -2 ,  as i t  is be tte r  known. This enabled the 
long-term culture  of normal activated fe l in e  T -ce l ls  which were 
used in routine blastogenesis assays to determine the level o f  IL-2  
in Ly-CM.
The next chapter (Chapter Three) involved the establishment of 
neoplastic fe l in e  T -ce ll l ines  in v i t r o . The c e l ls  were derived  
from thymic lymphosarcomas and were cultured both with and without 
Ly-CM. Most of these primary cultures required th is  source o f IL -2  
for p ro l i fe ra t io n  with two noticeable exceptions (designated T3 and 
T17) which were extensively studied in the following chapter.
The experiments in Chapter Four were designed to determine the 
role of IL -2  in T -ce ll  neoplasia. The evidence generated suggests 
that at leas t some neoplastic T -cell l ines have an a lte red  
requirement fo r ,  or response to ,  I L - 2 ' in v i t r o . Recent data from 
the study of human T-ce ll  neoplasia suggests tha t  enhanced IL -2  
receptor expression may be fundamental to the a l te ra t io n  in  the  
requirement for IL -2  observed with some of these c e l ls .  The 
strategy for the fu r th e r  characterisation of the growth 
requirements of neoplastic T -ce l ls  is discussed.
In Chapter Five the nature of the viruses associated with the 
thymic lymphosarcomas and the resultant ce ll  l ines was determined. 
The frequent presence of a novel FeLV which has recombined with a 
c e l lu la r  oncogene (c-myc) was reported and the in v i t r o
transmission of these recombinant viruses (FeLV/myc) was 
demonstrated. The association of additional FeLV subgroups other 
than A with thymic lymphosarcoma in the series was also observed. 
The generation of these subgroups and th e i r  possible ro le  in the 
development of neoplasia is discussed.
F in a l ly ,  in Chapter Six, the in vivo passage of the 
recombinant FeLV/myc virus from the T3 and F422 ce ll  l ines  was
described. These viruses, which originated from c e lls  from thymic 
lymphosarcomas, rap id ly  produced the same tumours in susceptible  
animals. Furthermore, the ce lls  isolated from these tumours 
read ily  established in culture without an exogenous source of
IL -2 .  These ce lls  continued to grow under the same conditions as
do the parental T3 and F422 ce ll l in e s .
The re la tionsh ip  between the enhanced expression of the myc 
oncogene and independence from an exogenous source of IL -2  fo r  
growth, is  discussed in the l ig h t  of recent evidence, and future  
experimental approaches are suggested.
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ABBREVIATIONS
ALV Avian leukosis v iru s .
ATL Adult T -cell leukaemia.
BSA Bovine serum albumin.
Con-A Concanaval in -A .
c-onc Oncogene present in c e l lu la r  sequences.
CsCL Caesium ch loride.
pCT4 3 ‘ Feline v-myc clone.
CTL Cytotoxic T-lymphocyte.
10% DMEM nulbecco's minimum essential medium, containing
L-Glutamine, Penic illin -Streptom ycin and 10% foetal  
bovine serum.
DNA Deoxyribonucleic acid.
EOF Epidermal growth fa c to r .
FEA Feline embryo c e l ls  of the FEA s t ra in .
F422 Suspension c e l ls  derived from a fe l in e  thymic
lymphosarcoma. They release FeLV-A.
FL74 Suspension ce l ls  derived from a fe l in e  lymphoid
tumour. They release FeLV-ABC/KT.
FeLV Feline leukaemia v irus .
xv
FBS Foetal bovine serum.
FFU T i t re  of virus expressed as focus-forming un its /m l.
FOCMA Feline oncornavirus-associated cell membrane a n t i g e n . ^
HTLV Human T -ce l l  leukaemia v irus .
IFN-'S Gamma in te rfe ro n .
IL1 In te r le u k in -1 .
IL 2 ' In te r le u k in -2 .
ppIL2 P a r t ia l ly  purif ied  human IL -2 .
0.25% Isc .  Iscove's modified Dulbecco's medium containing
pen ic i11 in-s treptom ycin , 2-Me and 0.25% BSAe
L/M Liebovitz L-l 5 and McCoy's 5A media in equal volumes
supplemented with L-glutamine, p e n ic i l1 in-streptomycin  
and 10% FBS.
LTR Long terminal repeat.
Ly-CM Lymphocyte conditioned medium.
2-Me 2-mercaptoethanol.
50:50 Medium composed of equal volumes of RPMI 20% + Me and
medium Ly-CM.
MuLV Murine leukaemia v irus .
PBS Phosphate buffered sa line .
PHA Phytohaemagglutinin.
PDGF P la te le t-der ived  growth fa c to r .
xvi
RNA , Ribonucleic acid.
ROOW Reverse osmosis d is t i l le d  water.
RPMI 20% RPMI 1640 medium containing L-glutamine, p e n ic i l l
+ Me streptomycin, 2-Me and 2 0 % FBS.
RPMI 0.25% RPMI 1640 medium containing L-glutamine, p e n ic i l l in -  
+Me streptomycin, 2-Me and and 0.25% BSA.
SPF Specific pathogen fre e .
Tac-ag IL-2 receptor designated Tac-antigen.
TCGF T-cell growth fa c to r .
TGF Transforming growth fa c to r .
v-onc Oncogene incorporated into a v ira l genome.
NOTES ON NOMENCLATURE
Throughout the th es is ,  the terms TCGF and IL -2  are used 
interchangeably and re fe r  to the same fa c to r .  Ly-CM refers to 
crude lymphocyte conditioned medium which is a source o f IL -2  but 
has not been p urif ied  in any way and therefore  re ta in s ,  in 
add it ion , mitogen and other growth fac to rs . The terms Ly-CM and 
TCGF/IL-2 are not therefore used interchangeably but re fe r  
s p e c if ic a l ly  to crude or purif ied  factor respective ly .  
Furthermore, in experimental protocols described in the following  
chapters the p urif ied  factor used is human (provided by Dr. R.C. 
Gallo, NCI, USA) and is designated ppIL-2 which stands for  
p a r t ia l ly  p u r if ied  IL -2  and always refers to th is  source of human 
fa c to r .
GENERAL INTRODUCTION
Pathogenesis of T -ce ll  neoplasia
A number of mechanisms have been proposed to explain the 
induction of T -ce ll neoplasia. More than one mechanism may operate 
in the development of even an individual tumour, as i t  would appear 
that m ultip le  steps are required for a ce ll to become f u l ly  
malignant (Peto, 1977).
Two groups of viruses have been shown to be the in i t ia t in g
agents of T -cell neoplasia. A herpesvirus of chickens is known to  
be the aetio log ica l agent of the economically important 
lym phoproliferative and lymphomatous condition, Marek's Disease 
(For Review see Powell, 1984). Most a tte n tio n , however, has been 
directed at the only known oncogenic RNA virus group, the 
re trov iruses. Viruses of. th is  group have been shown to be the 
aetio log ica l agents of T -cell neoplasia in mice (Moloney, 1960 and 
Gross, 1957), cats (J a r re t t  et a l . ,  1964) and gibbons (Kawakami et 
a l . ,  197?). The demonstration of these oncogenic viruses in animal 
populations stimulated a search for a s im ilar  v iru s . in  human T -ce ll  
neoplasia. In 1980 the search proved successful with the iso la tio n  
of the T -ce ll  leukaemia virus of man designated HTLV-I (Poiesz et 
a l . ,  1980a). The study of animal retroviruses has had a second 
important impact on cancer research in that i t  has revealed a set 
of c e l lu la r  genes, known as oncogenes, which have now been 
implicated in the development of a wide range of v ira l  and 
non-viral cancers.
Retroviruses have a r e la t iv e ly  simple structure and pattern of 
rep lica tion  (Varmus and Swanstrom, 1982) (F ig . 1 ) .  The genome is  
in the form of ribonucleic acid (RNA) and is enclosed by a protein  
core. This is surrounded by an envelope derived from modified
plasma membrane from which v ira l  glycoprotein spikes p ro jec t;  
these spikes, known as gp70, can bind to receptors on ta rg e t  c e l ls  
to i n i t i a t e  an in fe c t io n .  Whether or not a ce ll  has a surface 
receptor for a specific  v ira l  gp70 determines i f  tha t c e l l  is
susceptible to in fection  by that p a rt ic u la r  v irus . A ce l l  which 
displays a receptor for the virus is said to be a permissive ce ll
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fo r in fection  by tha t virus (host c e l l ) .  On in fecting  a host c e l l ,  
the virus uncoats to l ib e ra te  the nucleic acid which is transcribed  
in to  deoxyribonucleic acid (DNA) by a virus encoded enzyme called  
reverse transcriptase (RT). This property is unique to r e t ro ­
viruses and enables the stable integration  of a ONA copy of the 
v ira l  genome (provirus) into the c e l lu la r  DNA where i t  behaves, 
e s s e n t ia l ly ,  l ik e  a normal c e l lu la r  gene. The provirus contains 
three genes: the gag gene codes for the in ternal proteins of the 
v iru s ;  the pol gene codes for the reverse transcrip tase (RT); and
the env gene codes for the envelope glycoprotein of the spikes and
an envelope-associated protein known as pl5E. The provirus is  
flanked at both ends by long terminal repeats (LTRs) which are
non-coding but are essential in that they contain both promoter and 
enhancer sequences for transcrip tion  of the proviral genes. V iral  
glycoproteins are inserted into the ce ll  membrane and new virus  
part ic les  assemble beneath th is  and bud from the c e l l  in a 
non-cytopathic process.
Oncogenes
Oncogenic retroviruses can generally be c la s s if ie d  as strongly  
or weakly transforming. Weakly transforming viruses have long 
la te n t  periods before tumour formation and do not usually transform  
e ith e r  haemopoietic c e l ls  or f ib rob las ts  in v i t r o . Strongly  
transforming viruses have short la te n t  periods of a few weeks and 
often transform fib rob las ts  and, on occasions, haemopoietic c e l ls  
in v i t r o . Strongly transforming viruses usually contain spec if ic  
oncogenes (v -onc) which are derived from c e l lu la r  genes (Friend  
leukaemia virus is  one exception). These c e l lu la r  genes (c -onc) 
are incorporated into the v ira l  genome by recombination and are 
responsible for the transforming function (F ig . 2 ) .  Two principal  
differences between the v-onc genes and th e i r  c e l lu la r  homologues 
have been detected. F i r s t ly ,  many c -onc genes, l ik e  other  
eukaryotic genes, are divided into exon (coding) and in tron  
(non-coding) regions. The introns are missing in the v-onc gene 
structure ind icating  that the recombination process probably 
involves the reverse transcrip tion  of a v ira l  /c-onc hybrid mRNA
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s im ila r  to the model proposed by Swanstrom et al (1983) fo r  the
generation of Rous sarcoma v irus . Secondly, in the Harvey and
Kirsten strains of ra t  sarcoma v irus , a single point mutation has 
occurred at position 12 of the v-onc gene compared to i ts  c e l lu la r  
equivalent (Tabin et a l . ,  1982). The amino acid substitu tion  is
such that the t e r t i a r y  structure of the protein at th a t  region
would be "stiffened" which could completely change the c a ta ly t ic
function of the p ro te in . This suggests th a t ,  at leas t  in some 
cases, the c-onc gene may require a mutation to convert i t  to a
form which encodes a transforming prote in . This example of an
altered : gene is supportive of the hypothesis th a t  acutely
transforming viruses may exert th e ir  oncogenic e f fe c t  by
transm itting th is  altered gene to other ce lls  where i t  may be 
inappropria te ly , continuously, expressed through the enhancing and 
promoting a c t iv i ty  of the v ira l  LTR. Another hypothesis to explain  
the oncogenic potential of acutely transforming viruses is that  
they induce excessive amounts of the oncogene coded pro te in . This 
gene-dosage model is supported by evidence both from examination of 
Rous sarcoma virus (RSV) transformed ce lls  which contain a 100-fold  
increase in the oncogene ( src ) coded protein kinase over normal 
c e l lu la r  levels  (C o l le t t  et a l . ,  1978), and by experiments in which 
a normal c-onc gene attached to a re tro v ira l  LTR has been 
transfected into f ib rob las ts  causing transformation (Chang et a l . ,  
1982).
Models involving inappropriate or enhanced expression of a 
c e l lu la r  transforming gene could also apply to non-viral induced 
cancers i f  regulatory sequences con tro lling  c-onc expression were 
mutated by rad iation  or other known chemical carcinogens or i f  
c-onc sequences were moved to sites where th e ir  expression was 
placed under a ltered and active transcrip tiona l control by such 
events as chromosomal trans location . Support for th is  model arises  
from the observations that certa in  c e l lu la r  oncogenes c lu s te r  in 
chromosomal regions which are involved in specific  rearrangements 
in leukaemias and lymphomas (K le in , 1981). Sim ilar models have 
been applied to explain the oncogenic potential of non-acutely  
(weakly) transforming leukaemia viruses l ik e  fe l in e  leukaemia virus
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(FeLV) and avian leukosis virus (ALV) which do not carry a trans­
forming gene and induce tumours only a f te r  a long la te n t  period. 
Avian leukosis virus in avian B-cell tumours has been shown to 
in tegrate  next to a c e l lu la r  oncogene, designated c -myc, and 
enhance i t s  level of transcrip tion  many fold over the normal 
expression rate by in i t ia t io n  or enhancement of transcrip tion  from 
the v ira l  LTR through the adjacent (c -myc) c e l lu la r  sequences (Neel 
et a l . ,  1981). This mechanism of insertional mutagenesis (F ig .  3) 
is  not res tr ic ted  to the avian system or to B-cell tumours since 
recently in the ca t ,  FeLV provirus has been found to in tegrate  
close to the c-myc locus in a proportion of T -cell tumours (Neil et_ 
a K ,  1984).
A ra d ic a l ly  d i f fe re n t  model for the role of retroviruses in 
T-ce ll  neoplasia has been proposed by McGrath and Weissman (1979).  
In murine T -cell tumours caused by recombinant murine leukaemia 
viruses (MuLV), they have suggested that an auto-stim ulation model 
may operate. This model proposes that neoplastic growth can be 
in i t ia te d  through a continuous mitogenic signal resu lting  from 
repeated presentation of v ira l  antigens to an tigen -spec if ic  
receptors on the surface of ce lls  infected with recombinant MuLV. 
To date, the receptor responsible for virus binding by leukaemic 
blast ce lls  has not been c le a r ly  id e n t i f ie d ,  neither has i t s  
potential for recognition of virus as a mitogenic signal been 
assessed, which w il l  be essential to establish th is  theory. 
F in a l ly ,  some neoplastic T -cell l ines have been shown to have 
altered production o f ,  and response to ,  certa in  growth fators  which 
control the growth and d i f fe re n t ia t io n  of normal T -c e l ls  
(Gootenberg et a l . ,  1981).
Growth factors
Growth factors were f i r s t  implicated in transformation by 
DeLarco and Todaro (1978) who, when investigating  the properties of  
murine sarcoma c e l ls ,  found that they produced a fa c to r ,  designated 
transforming growth factor (TGF) which, when plated onto normal 
c e l ls ,  caused morphological transformation. T -ce ll  growth factor
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(TCGF) or In te r le u k in -2 ,  ( IL -2 )  as i t  is  also known, plays a 
fundamental role in the regulation and in te rac tion  of normal 
T -c e l ls ,  and i t  has been proposed that a loss of control in th is  
system could lead to the continuous p ro life ra t io n  of T -ce lls  and 
f in a l ly  neoplasia (G i l l  is  et a l . ,  1981; Mier and G allo , 1981). The 
regulation of T -cell growth has been extensively investigated and 
an understanding of the TCGF interactions involved in the normal 
system has f a c i l i t a te d  the study of the role that growth factors  
may play in tumorigenesis.
Regulation of normal T -ce ll  growth
T-ce ll ac tiva tion  and p ro l i fe ra t io n  is controlled by a complex 
series of in teractions between d is t in c t  subsets of T -c e l ls ,  antigen 
or mitogen and two in te r leu k in s , namely, the macrophage derived 
factor In te rleuk in -1  ( IL -1 )  (Oppenheim and Gery, 1982) and the 
T-cell derived T -ce ll  growth fa c to r ,  In te r leu k in -2  ( IL -2 )  (F ig .  
4 ).  The most usual mitogens used in T -cell ac tiva tion  studies are 
plant le c t in s ,  normally phytohaemagglutinin (PHA) or Concanavalin A 
(Con-A) which can substitute  for antigen in the accessory cell  
signal. Accessory ce l ls  (macrophages) which are antigen pulsed 
provide two d is t in c t  signals for T -ce lls  inducing them to release  
IL -2 ; f i r s t l y  antigen, presented in the context of proteins of the 
major h is tocom patib il ity  complex (MHC) and secondly IL-1  (Smith, 
198D). The helper T -ce ll  subset is the major source of IL -2  
although a l l  subclasses of T -ce lls  can be induced to produce th is  
factor (Pfizenmaier et a l . ,  1984). IL-2 w i l l  bind to any responder 
T-cell which has been activated (by antigen and possibly one or 
more in te rleuk ins ) to express. IL -2  receptors, regardless of i ts  
subclass or antigenic s p e c if ic i ty  (Schreier et a l . ,  198(1). The 
binding of IL-2  to a receptor bearing T -ce ll  in th is  manner induces 
the p ro l i fe ra t io n  of th is  ce ll by causing the ce ll  to progress from 
the la te  G1 phase of the ce ll  cycle into the S phase (Klaus and 
Hawrylowicz, 1984) with a concomitant induction of receptors for  
tra n s fe r r in  (Neckers and Cossman, 1983). The level and duration of 
the response to IL -2  is dependent on the concentration of IL-2  
present, the number of IL-2  receptors per ce ll and the continued
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expression of the receptors on the ce ll surface. I t  now seems 
c le a r ,  from various lines of evidence, that the induction and 
down-regulation of the high a f f in i t y  IL-2 receptor mediates the 
physiological role of IL -2  in T -cell p ro l i fe ra t io n  and is central 
in contro lling  the extent of the c e l lu la r  response (See Robb, 1984 
for review).
Other a c t iv i t ie s  of IL -2  in immune responses
The crucial role of IL -2  as a growth factor for activated  
T -ce lls  is undisputed but recent evidence suggests tha t th is  is  not 
i ts  only role and that i ts  a c t iv i t y  extends to non-T-cell immune 
responses (F ig . 5 ) .  Farrar et a l . (1982) demonstrated the a b i l i t y  
of IL -2  to induce secretion of ^ - in te r fe ro n  (IFNX) by T c e l ls .  IFN 
has many e ffec ts  on immune functions including tha t on natural 
k i l l e r  (NK) ce ll a c t i v i t y ,  modulation of the expression of h is to ­
com patib ility  antigens, macrophage activation  and the generation of 
cytotoxic T -c e l ls .  Other studies have shown that IL -2  can also 
play a d irec t role in stimulating non-T-cell immune responses by 
causing an increase in NK ce ll and lymphocyte activated k i l l e r  ce ll  
(LAK) a c t iv i ty  beyond that a t tr ib u ta b le  to induction of IFN 
(Henney et a l . ,  1981). In add it ion , T -cell l ines have recently  
been induced to produce B-cell growth factor (RCGF-1) when 
stimulated with p u rif ied  IL -2 .  This B-cell growth factor induces 
B-cells to both grow and d i f fe r e n t ia te  to antibody secretion and 
evidence suggests that the same high a f f i n i t y  IL -2 -rece p to r-  
ligand in teraction  is responsible, at least in part ,  fo r  both the 
IL -2  induced ce ll cycle trans itions  and lymphokine secretion  
(Howard et a l . ,  1983).
Production and p u r if ic a t io n  of IL -2
Morgan et a l . (1976) f i r s t  demonstrated the presence of a 
T-ce ll derived growth factor in crude PHA stimulated lymphocyte 
conditioned medium (Ly-CM) and i ts  a b i l i t y  to maintain normal human 
le c t in -a c t iv a te d  T -ce lls  in continuous p ro l i fe ra t iv e  c u ltu re .  
Since then IL-2  has been extensively purif ied  to homogeneity to
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enable biochemical and biological characterisation to take place 
( G i l l i s  et a l . ,  1 982). Purif ica tion  schemes vary in de ta il  but are 
bas ica lly  as follows: the crude Ly-CM is f i r s t  f i l t e r e d  to remove
gross debris ,- then concentrated by ammonium sulphate
p re c ip ita t io n .  A f f in i ty  chromatography can be used to remove 
contaminating le c t in  (Fagnani and Braatz, 1980) a f te r  which various 
methods of chromatography and electrophoresis can be applied to 
remove the m ajority  of remaining contaminating proteins (Mochizuki 
et a l . ,  1981). These p u r if ic a t io n  procedures are extensive and 
require large amounts of s tarting  material in order to recover 
s u f f ic ie n t  p urif ied  material for analysis . To th is  end, 
spontaneous lymphoma lines from murine, human and primate sources, 
have been established which c o n s titu tive ly  produce IL -2 ,  when 
stimulated with mitogen or antigen (Smith et a l . ,  1980). To
maximise the y ie ld  of IL-2 from tumour producer lymphoma l in e s ,  
several investigators have fused high y ie ld ing  producer lymphoma 
l ines  with a llo -an tigen  activated T -ce lls  (S tu ll  and G i l l i s ,  
1981). These stable hybridoma lines can be stimulated repeatedly  
with subtoxic concentrations of lec t ins  to secrete th e i r  
b io lo g ic a lly  active  IL -2  in r e la t iv e ly  large amounts. Furthermore, 
T-cell hybridomas release a res tr ic ted  set of lymphokines, mitogen- 
f re e ,  therefore reducing contaminating molecules, an advantage
previously displayed by spontaneous producer tumour l ines  in 
cu ltu re . Recently, Altman et al . (1982) have shown that hybridoma 
l ines can be successfully grown in vivo and re ta in  th e i r  a b i l i t y  to 
produce IL-2  in v i t r o . Another approach to the production o f IL -2  
has been the use of Xenopus oocytes to tran s la te  lymphocyte mRNA 
into b io lo g ic a lly  active  IL -2  (Bleackley et a l . ,  1981). Like the 
use of producer tumour ce ll l ines th is  provides IL-2  f re e  from
le c t in  and other major contaminants but generally in very small 
amounts, about 1% o f that from the orig inal l in e .  These problems 
of quantity and p u r if ic a t io n  have now been overcome by the  
successful cloning of the human IL-2 gene by Taniguchi et a l . 
(1983) and s im ilar  clones are also now ava ilab le  for generating  
large amounts of pure IL -2  su itab le  for character!*sation at the 
molecular l e v e l .
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The IL-2  molecule
Characterisation data reveals that human, gibbon ape and rat  
IL -2  are single polypeptide chains with molecular weights (m ol.wt.)  
of 19-22000 on g e l - f i l t r a t io n  chromatography and 15-17000 mol.wt. 
on SDS-PAGE (Mier and Gallo, 1981; Robb and Smith, 1981). Murine 
IL -2  appeared at f i r s t  to d i f f e r ,  being a molecule of 30-40000 
mol.wt. on gel f i l t r a t i o n  but th is  has now been a t tr ib u te d  to 
non-covalent dimerization of a 15-17000 mol.wt. sub-un it. IL-2  
from each of the species is hydrophobic and a l l  have almost 
equivalent specific  a c t iv i t i e s .  Furthermore, evidence from 
cro ss -re a c tiv ity  studies using monoclonal antibodies to the various 
IL -2 s showed that the molecules displayed specific  s tructural  
features, c le a r ly  demonstrating the homology of IL -2  between these 
species (Paetkau et a l . ,  1984). IL -2  is  heterogeneous with respect 
to size and charge which is due to pos t-trans la tional glycosylation  
with a variable  s ia l ic  acid content. This seems to have l i t t l e  
consequence fo r in v i t ro  a c t iv i ty  although i t  may play a role in in 
vivo clearance of the molecule (Robb and Smith, 1981). Human IL -2  
has been most extensively characterised and i t  is now known to be a 
polypeptide consisting of 133 amino acids with a 20 amino acid 
signal sequence which is removed prior to secretion (Taniguchi et 
a l . ,  1983; Robb and Smith, 1981). The polypeptide contains a 
single intra-m olecular disulphide bridge, connecting the cysteines 
in positions 58 and 105, which is essential fo r the active  
configuration of the molecule (Robb, 1984). The human gene for  
IL-2 is  present in single copy per haploid human genome and is  
located on chromosome 4q. The cat gene for IL -2  is  also present in 
single copy per haploid genome and is isolated on chromosome B1 
(Seigal et a l . ,  1984). The IL -2  gene is interrupted by 3 introns  
and the promoter sequences in the 5' region of the gene contain a 
prototype "TATA" box. Two points of p a rt ic u la r  note are: that
sequences upstream from th is  point show remarkable homology to the 
enhancer region of the IFN-^  gene, (Paetkau et a l . ,  1984) whose 
expression is under s im ilar  con tro l,  and also tha t  sequences tha t  
closely resemble the core sequences for v ira l  enhancer elements 
(Olabuenaga et a l . ,  1983) have been found in the second intron
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(F u j i ta  et a l . ,  1983). Although the mechanism of gene expression 
in the suggested "cascade" in teractions of the lymphokines remains 
to be e lucidated, (Yamamoto et a l . ,  1982) these observations 
suggest that the common sequences detected may be associated with 
t issue specific  t ranscrip tion  of lymphokine genes by T -ce l ls  on 
stimulation with antigen or mitogen.
The ro le  of IL -2  in T -ce ll neoplasia
The possible involvement of IL -2  in T-cell neoplasia of the  
cat is  the subject of Chapter Four. Similar studies on human 
leukaemias and lymphomas have recently proven rewarding. IL -2  and 
i t s  in te rac tion  with i ts  membrane receptor, is  central to the  
regulation of normal T -ce ll p ro l i fe ra t io n  (Robb, 1984) there fore  
the aberrant or inappropriate expression of IL -2  in T -c e l ls  could 
th e o re t ic a l ly  contribute to th e i r  progression in to ,  or maintenance 
o f ,  the transformed s ta te .  Gallo and Wong-Staal (1982) proposed 
that the HTLV provirus present in adult T -cell leukaemias (ATLs) 
could ac tiva te  c e l lu la r  IL -2  genes resulting in the continuous 
auto-stim ulation of membrane IL -2  receptors and hence uncontrolled  
p ro l ife ra t io n  of the c e l ls .  This hypothesis i n i t i a l l y  seemed 
l i k e ly  since T -ce lls  from patients with HTLV-positive leukaemias 
and lymphomas were reported to bind, and in some cases re lease , 
IL -2  in culture (Poiesz et a l . ,  1980b; Gootenberg et a l . ,  1981).  
However, fu rthe r  binding studies revealed that the modulation of 
the IL -2  receptor (designated Tac) by the anti-Tac monoclonal 
antibody, observed with normal activated human T -c e l ls  (Tsudo et 
al . ,  1982) did not occur with ATL c e l ls  (Tsudo et a l . ,  1983). This
led d ire c t ly  to the proposal that i t  was the co n s titu t iv e
expression of the Tac receptor on ATL ce lls  and not th e i r  
hyperproduction of IL -2 ,  tha t was prim arily  responsible fo r the 
uncontrolled growth of these c e l ls  (Yodoi et a l . ,  1983; Gallo £ t  
a l . ,  1983). The human IL -2  receptor has recently been molecularly  
cloned (Nikaido et a l . ,  1984; Leonard et a l . ,  1984) and th is  should
help to e lucidate the mechanism of leukaemogenesis, at leas t  of
human ATL.
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The search for a T -ce ll  leukaemia virus of man was a d irec t  
consequence of the study of oncogenic retroviruses in neoplastic  
conditions of animals. In th is  respect the fe l in e  model has been 
extremely important in the study of haematological neoplasia 
because of the association of fe l in e  leukaemia virus (FeLV) with  
th is  disease. The fe l in e  system represents a natural as well as an 
experimental disease model and enables the assessment of the degree 
to which the var ie ty  of molecular mechanisms id e n t i f ie d  in 
experimental systems are involved in spontaneous tumours in a 
randomly outbred species.
Transmission and epidemiology of FeLV
FeLV was o r ig in a l ly  isolated from cats with lymphosarcoma 
(J a r re t t  et a l . ,  1964) but is ,  in fa c t ,  associated with a whole 
spectrum of both neoplastic and non-neoplastic diseases of the 
domestic ca t.  In nature, the non-neoplastic conditions resu lting  
from virus in fe c t io n ,  such as reproductive fa i lu r e  and 
immunosuppression, are more commonly encountered than are those of 
the leukaemogenic e ffec ts  of the v irus . Transmission of virus  
occurs both h o r izo n ta lly ,  p r in c ip a lly  through sa liva  and 
congenita lly , across the placenta (Hardy et a l . ,  1973; J a r re t t  et_ 
a l . ,  1 973). The epidemiology of FeLV in the cat population reveals  
two d is t in c t  patterns dependent on whether the cats are maintained 
in closed m ultip le  cat households (MCH) or are free  range. In a 
closed MCH, into  which FeLV is introduced, the incidence of  
persistent in fection  is high (about 40%), probably due to the  
increased incidence of exposure to r e la t iv e ly  high doses o f virus  
at an early  age. These circumstances are those under which most 
FeLV related diseases occur (Hardy et a l . ,  1973; J a r re t t  et a l . ,  
1978). The prognosis fo r pers is ten tly  infected cats is  poor; 
approximately 90% die within f iv e  years of in fec tion  compared to  
15% o f virus-negative cats in the same environment (McClelland et 
a l . ,  1980). The m ajority of the cats in these closed households, 
however, become tra n s ie n t ly  in fec ted , tha t is ,  they appear to 
recover from the in fection  and about two-th irds of these produce 
virus neutra lis ing  antibodies which are believed to render the cats
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res is tan t to re in fec tion  (Hardy et a l . ,  1976; Russell and J a r r e t t ,  
1978a). In contrast, free-range cats show a much lower incidence 
of persistent in fection  (less than 1%) and only a small proportion  
have neu tra lis ing  antibodies which appear only to develop following  
a reasonable degree of virus growth in the ca t .  Consequently 
free-range cats manifest fewer FeLV related diseases. The 
d ifference observed in the outcome of exposure to virus in these 
two s ituations can be explained by the fac t  that cats become more 
res is tan t to virus in fection  with age, the c u t -o f f  being about six 
months a f te r  which time the cat is res is tant to in fec tion  unless a 
predisposing immunosuppression occurs concomitantly. Free-range 
cats are probably exposed to virus when they are older than cats 
exposed in m ulticat households, therefore they w il l  be more 
res is tan t to in fection  by FeLV at that time. Furthermore, in 
m ulticat households contact between cats is intim ate and constant 
so tha t fa r  la rger doses of virus w il l  be transmitted between cats 
in closed households than in the free-range s itu a t io n .  I t  has 
recently been reported (Rojko et a l . ,  1982; Madewell and J a r r e t t ,  
1983) tha t  FeLV has the a b i l i t y  to form a la te n t  in fec tion  even in 
the presence of a virus neu tra lis ing  antibody response. Treatment 
with immunosuppressive agents induces the expression of these 
la te n t  viruses causing viraemia and the release of in fectious virus  
p art ic les  in the saliva of cats. Latently infected cats may 
represent an important reservoir of in fectious virus in the 
population and, up until  recently , would have appeared to be 
virus-negative using standard diagnostic assays.
Subgroups o f FeLV
FeLV isolates can be c la s s if ie d  on the basis of in te rfe rence  
subgroup. The basis of th is  is that ce lls  previously infected with  
a virus of one subgroup are res is tant to superinfection with a 
virus of the same subgroup. Sarma and Log (1973) demonstrated 
three subgroups of FeLV, designated A, B and C, using the 
in terference system. Interference subgroup is  determined by the  
v ira l  envelope (env) gene product and re f le c ts  the ce l l  surface 
receptors u t i l iz e d  by FeLV to  in fec t a host c e l l .  Although each
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subgroup can be separated as non-defective components, in nature, 
subgroups B and C are always found in association with subgroup A 
(Sarma and Log, 1973; J a r r e t t ,  1980). Experimental studies have 
shown that the e f f ic ie n t  rep lica tion  of subgroups B and C in v ivo , 
and the transmission of subgroup B, are dependent on the 
concomitant presence of the subgroup A of FeLV (J a rre t t  and 
Russell, 1978a). The possible association of FeLV subgroup with 
disease is discussed fu rthe r  in Chapter Five.
T -cell lymphosarcoma of the cat
The most common neoplastic disease associated with FeLV is  
T-cell lymphosarcoma. Most tumours of th is  type are v iru s -p o s it ive  
unlike the B-cell alimentary lymphosarcoma which are equally common 
but are v irus-negative . Two common forms of T -ce ll  lymphosarcoma 
are seen; thymic lymphosarcoma, where the tumour mass is
predominantly at a . single s i te ;  that of the thymus, and
m ulticentr ic  lymphosarcoma in which m ultip le  lymph nodes are 
involved.
Certain strains of FeLV, notably Rickard (Rickard et a l . ,  
1969) have been shown to produce thymic T-cell lymphosarcoma in 
vivo a f te r  a short period of time, usually 3-4 months (Rojko et
a l . ,  1979). The mechanism of transformation by Rickard and re lated
viruses is not understood but several mechanisms of induction of 
neoplasia, previously discussed in th is  Introduction, l ik e  v ira l  
induction of a growth factor or oncogene a c t iv a t io n ,  are possible.
The present study
The experiments described in the following chapters were designed 
to determine the ro le  of growth factor and oncogenes in the 
pathogenesis of FeLV induced thymic T -ce ll  lymphosarcoma, both in 
an experimental system and in tumours occurring spontaneously in 
the cat population. The growth properties of the ce l l  cultures  
obtained from the tumours were examined for a lte ra t io n s  in the 
requirement fo r ,  or response to ,  exogenous IL-2 to determine i f  an
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auto-stim ulation type of model re la ting  to growth factor could be 
involved in the generation or maintenance of neoplasia in these 
cats (Chapters Three and Four). The properties of the viruses 
associated with the tumours and also c ircu la tin g  in the plasma of 
the cats were assessed with respect to the subgroup of virus  
present, in that i t  has previously been observed than an additional 
subgroup other than A is more often present in diseased cats than 
in th e ir  normal healthy counterparts ( J a r r e t t ,  198D). The 
association of subgroup with tumours in th is  series is  discussed 
fu rther in Chapter Five.,
F in a l ly ,  in collaboration with Dr. J. N e il ,  the involvement of 
oncogenes in thymic lymphosarcoma has been investigated . Tumour 
DNA was examined to determine i f  the c -myc locus was re-arranged by 
FeLV ( in d ica tive  of insertional mutagenesis). In order to determine 
i f  the in fecting  FeLV was in tegrating  at a preferrea s i t e ,  the 
flanking sequences of host DNA adjacent to each provirus must be 
determined. Since the task of preparing lam bda;lib raries  of each 
integrated provirus is enormous, a tumour was selected (designated 
84793) which had a low copy number of integrated proviruses (in  
th is  case 3 ) .  Two of the three proviruses were successfully cloned 
by Dr. J. Neil and the flanking sequences of these were analysed 
i n i t i a l l y  by screening with known oncogenes. I t  was hoped tha t  one 
or more of these probes may have proven positive but a lack of 
detectable hybrid ization would not have ruled out the model of 
insertional mutagenesis as the sequences involved may have been of 
a novel oncogene. Surpris ingly , however, one of the proviruses 
(pCT4) appeared not to be inserted within or close to a c e l lu la r  
oncogene but in fact to be a defective recombinant virus containing  
myc sequences within the proviral genome (Neil et a l . ,  1984). This 
began the search in other tumour DNAs for s im ila r  recombinant 
viruses and also revealed upstream in tegration  of FeLV adjacent to 
c-myc in some cases. The in v i t ro  properties of these novel fe l in e  
leukaemia viruses and th e i r  oncogeneic potential in vivo are the 
subjects of Chapters Five and Six respective ly .
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The elucidation of the pathogenesis of T -ce ll neoplasia in the 
cat w il l  be of considerable value in two main respects. F i r s t ly ,  
i t  w i l l  contribute s ig n if ic a n t ly  to the understanding of the 
complex process of neoplasia in general and secondly, as the 
discovery of retroviruses in animals d ire c t ly  led to the detection  
of those of man, so may the determination of the role tha t FeLV may 
play in the generation of T -cell tumours of the ca t ,  d ire c t  the 
investigation  of the role that HTLV may play in the generation of 
T -ce ll  tumours of man.
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Figure 2 shows the 3 possible structures of the provira l genome. 
The structure of Rous sarcoma virus is unusual in th a t  i t  
has acquired a v-onc gene without concomitant loss of  
v ira l  inform ation. This transforming virus is  unique in 
th is  respect and is said to be 'non-defective ' (does not 
require helper virus fo r re p l ic a t io n . )
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Figure 3 depicts a possible model for insertional mutagenesis.
Here the virus has integrated adjacent to the cel 1u la r -onc 
gene and in the same transcrip tiona l o r ie n ta t io n .  In th is  
orien tation  i t  is  possible to generate a hybrid  
t ra n s c r ip t ,  in i t ia t in g  in the 3 ‘ v ira l  LTR and carrying on 
into the c -onc coding sequence. This process w i l l  be 
under the transcrip tiona l control of the v ira l  LTR and may 
resu lt  in the enhanced or inappropriate expression o f the  
c-onc pro te in .
FIGURE 4
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growth factor inducing cytotoxic T-cell p ro l i fe ra t io n
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FIGURE 5.
Involvement of IL -2  in non-T-cell immune responses
T -ac t ,  activated T -c e l l ;  T-resp, IL -2  responsive T c e l l ;  NK 
natural k i l l e r  c e l l ;  LAK, lymphocyte activated k i l l e r  cell  
B-act, activated B c e l l ;  # -IFN, immune (gamma) in terferon  
BCGF, B c e l l  growth fac to r;  BCDF, B ce ll  d i f fe re n t ia t io n  factor  
Ag, antigen.
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CHAPTER ONE
GENERAL MATERIALS AND METHODS
1 6
The materials and methods detailed  below are used repeatedly  
throughout the experiments in the following chapters. Any method 
s p e c if ic a l ly  re la ting  to work in an individual chapter is  detailed  
in the materials and methods section of that chapter.
Culture of monolayer ce lls
Cells
Feline leukaemia virus is routine ly  grown in fe l in e  embryonic 
f ib ro b las ts .  Feline embryo (FE) ce lls  of the FEA s tra in  (J a r re t t  
et a l . ,  1973), uninfected or infected with FeLV (FEA + FeLV), were 
used between passages 13 and 40.
Clone 81 (c81) ce lls  derived from the Crandell f e l in e  kidney 
cell l in e  (CCC) contain the genome of Moloney MSV and were used in 
the FEA/c81 virus detection assay (Fischinger et a l . ,  1974).
Media
The monolayer ce lls  FEA and c81 were maintained in Dulbecco's 
Minimum Essential Medium (Gibco Biocult Ltd) supplemented with 2mM 
L-glutamine, 400 units/ml pen ic ill in -s treptom ycin  and 10% foetal
bovine serum (FBS) (Gibco Biocult Ltd) and the complete medium is  
referred to as 10% DMEM.
Cell Culture
Stock monolayer ce lls  were passaged in 250 ml glass bottles
with 15 ml of medium or in 2.5 l i t r e  ro ta ting  bott les  with 100 ml
of medium. Cells were routinely  subcultured 1:4 twice weekly when 
they were confluent. The c e l ls  were removed from the glass by
rinsing with versene followed by 0.01% trypsin  in 0.02% EOTA 
obtained from the In s t i tu te  o f Virology, University o f Glasgow. 
Resuspended ce lls  were transferred to fresh bottles  and gassed with  
5% carbon dioxide in a i r .
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For virus detection by the FEA/c81 assay and for determination 
of virus subgroup by in te rference, c e l ls  were grown in 5 cm 
diameter plates (Nunclon) with 4 ml of medium.
Culture of suspension ce lls
Cells
Two fe l in e  tumour T -ce ll  l ines  were a v a ila b le .  They grow as 
suspension c e l ls ,  the f i r s t  of which, the FL74 ce ll l in e ,  
orig inated from a lymphoid tumour in the kidney of a k it te n  
infected with FeLV (Theilen et a l . ,  1969) and continuously release  
FeLV-ABC/KT.
F422 c e l ls  were established by Rickard (1969) from a thymic 
lymphosarcoma of a k itten  inoculated with cell free thymic tumour 
homogenate. These ce lls  continuously release a subgroup A v iru s .
Media
The suspension ce ll l ines FL74 and F422 were maintained in 
medium consisting of equal volumes o f Liebovitz L-15 and McCoy's 5A 
media (Gibco Biocult L td .)  supplemented with 2mM L-glutamine, 400 
units/ml pen ic ill in -s treptom ycin  and 10% FBS. The complete medium 
is  referred to as L/M.
Cell Culture
Suspension ce lls  were grown' in stationary cultures at  
densities of 5 x 1 o5 -  3 x 10^ per ml. . They were subcultured twice  
weekly by removing 3/4 o f the suspension and replacing with an 
equal volume of fresh L/M.
The culture of both normal T -ce lls  and other tumour derived  
T -ce lls  is described in deta il  in materials and methods in Chapters 
Two and Three respective ly .
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Virus p u r if ica t io n
Virus was purif ied  and concentrated to high t i t r e  fo r  use in 
some in vivo infections discussed la te r  and also for preparation of 
v ira l  RNA for molecular ana lys is .
C la r i f ic a t io n
Culture supernatants were collected and centrifuged at 10,000 
x g for 10 minutes. They were then f i l t e r e d  through a 0.45 ym 
Nalgene s te r i le  f i l t e r  and, i f  necessary, stored at th is  stage at 
-70°C.
Concentration
Two methods of virus concentration were used.
( i )  U l t r a f i l t r a t io n  (Amicon Hollow f ib re  concentrator Model CH4). 
The c la r i f ie d  supernatants were concentrated up to 50 -fo ld  by 
passage through a hollow f ib re  cartr idge (Amicon D iaflo  hollow 
f ib re  cartr idge , nominal molecular weight c u t -o f f  1 ,000 ,00 0 ).  In 
some instance the concentrated virus was then fu rthe r  p u r if ie d  by 
density gradient cen tr ifugation  and p e lle ted .
( i i )  Ammonium Sulphate P rec ip ita tion
Equal volumes of c la r i f ie d  supernatant and saturated ammonium 
sulphate (pH 7.4) were mixed and incubated at 4°C fo r  30 minutes. 
The mixture was then centrifuged at 10,000 x g for 10 minutes and 
the p rec ip ita te  resuspended in 1 /1 Oth orig ina l volume of TS buffer  
(0.1 M NaCl , 0.1 M Tris-H C l, 0.001 M EDTA, pH 7 .4 ) .
Density gradient cen trifugation
The concentrated virus was then fu rther  p u r if ie d  by 
ultracen tr ifuga tio n  in discontinuous sucrose gradients. Gradients 
were made up in Beckman SW41 rotor tubes by overlaying 0 .5  ml of
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50% sucrose in TS buffer with 2 ml of 30% sucrose in TS b u ffe r .  
The tubes were f i l l e d  with concentrated virus and centrifuged at
40,000 rpm for 45 minutes a f te r  which time the virus had banded at 
the in te rface  of the two solutions. The bands were collected by 
puncturing a hole in the bottom of the tubes and co llec t ing  the 
fractions by v isua liz ing  the l ig h t -s c a t te r in g  virus band with a 
strong l ig h t  sourc-e.
Pel 1eting
The purif ied  virus collected was d ilu ted  in TS bu ffe r  and 
centrifuged at 35,000 rpm for 30 minutes in a Beckman SW41 ro to r .  
The virus p e l le t  was e ith e r  resuspended for fu r th e r  analysis or 
stored at -70°C un ti l  required.
Assay o f FeLV
FeLV was assayed by focus formation in c81 c e l ls  (Fischinger  
et a l . ,  1974). The assay used was a modification of th is  (J a r re t t  
et a l . ,  1982) and was carried out as follows: 3 x 10^ FEA c e lls
and 3 x 104 c81 ce lls  were seeded onto 5 cm plates in 4 ml of 10% 
nMEM. The next day the virus in 1 ml of medium containing 4 yg/ml 
polybrene was adsorbed for 2 hours at 37°C. The virus was then 
removed and replaced by 4 ml of fresh medium. That medium was 
changed three days la te r  and foci of transformed c e l ls  were counted 
under the microscope 7 days a f te r  in fe c t io n .  The t i t r e  of the 
virus obtained by th is  method was expressed as focus forming units  
(FFU) per m l.
Preparation of RNA from virus
RNA was prepared from purif ied  virus as follows: to in h ib i t
nuclease damage to the RNA, pelleted virus was disrupted in a 
modified 4M guanidinium isothiocyanate buffer described by Chirgwin 
(1979). The buffer used consists o f: 4.2M guanidinium
isothiocyanate, 17mM Na-N-lauroyl sarcosine, 25mM sodium c i t r a t e  
(pH 7 .0 ) ,  100 mM p-mercaptoethanol and 0.33% anti-foam A. C arr ie r
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yeast t-RNA (40 yg-100 yg) was added and the RNA layered over 1-2 
ml of 56% caesium chloride (CsCl) in TS b u ffe r ,  in Beckman SW41 
rotor tubes. The RNA was pelleted by u ltracen tr ifu g a tio n  at 35,000 
rpm for 20-24 hours, a f te r  which time the p e l le t  was resuspended in 
200 A -  500 A of a solution containing: lOmM Tris-HCl (pH 7 .4 ) ,  5mM 
EDTA (pH 8 .0 ) ,  and 1% SDS. The RNA was then extracted once with a 
4:1 mixture of chloroform and 1-butanol and the aqueous phase 
transferred to a fresh tube. The organic phase was re-extracted  
with an equal volume of the Tris-HCl buffer (pH 7 .4 ) .  The two 
aqueous phases were then combined and 0.1 volumes of 3M sodium 
acetate (pH 5.2) and 2.2 volumes of ethanol added. This was stored 
at -20°C for a minimum of two hours to p rec ip ita te  the RNA which 
was then recovered by centr ifugation  at 10,000 rpm for 10 minutes. 
The p e l le t  obtained was dissolved in 1 ml of reverse osmosis 
d is t i l le d  water (RODW) and reprec ip ita ted  with ethanol. The RNA 
was stored in 70% ethanol at -70°C until  required.
Iso la tion  of RNA from tumour material
Tumour tissue taken for analysis of RNA was flash frozen in 
l iq u id  nitrogen. To prepare RNA from material stored in th is  way, 
the frozen tissue was placed d ire c t ly  into the 4M guanidinium 
isothiocyanate buffer and minced using scalpels . I t  was then 
homogenised b r ie f ly  and c la r i f ie d  by centr ifugation  at 10,000 rpm 
for 10 minutes. The supernatant was layered onto discontinuous 
CsCl gradients, consisting of 2 ml of 51% CsCl on top of 2 ml of 
56% CsCl, and ultracentrifuged a t 35,000 rpm for 20-24 hours. The 
p e l le t  was recovered, extracted and stored according to the  
protocol for iso la tion  of RNA from v iru s , previously described 
(Maniatis et a l . ,  1982).
Iso lation  of DNA from infected and uninfected FEAs
FEA c e lls  (1 x 10^ c e l ls )  were removed from 2.5 l i t r e  glass 
bottles  by standard procedure and washed once in phosphate buffered  
saline (PBS). The ce l ls  were then resuspended in TNE (10 mM 
Tris-HCl pH 8 .0 ,  100 mM NaCl, and 10 mM EDTA) which contained 0.5%
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SDS and 250 yg/ml proteinase K (Boehringer). This was incubated at 
37°C for a minimum of three hours a f te r  which time the DNA was
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extracted by gentle mixing for 10 minutes with an equal volume of 
phenol pH 8 .0 .  The aqueous phase was then removed to a fresh tube 
and re-extracted once more with an equal volume of phenol a f te r  
which the aqueous phase was extracted twice with an equal volume of 
chloroform then dialysed against TE (10 mM Tris-HCl pH 7 .9  and 1 mM 
EDTA) at 4°C with 2-3 changes of b u ffe r .  Ribonuclease A, at a 
concentration of 100 yg/ml was then added to the DNA and incubated 
at 37°C for a minimum of three hours. The DNA was then extracted  
exactly as before and dialysed extensively against TE buffer at  
4°C, and stored at 4°C until  required.
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CHAPTER TWO
THE PRODUCTION AND ASSAY OF T-CELL GROWTH FACTOR (11-2)
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Introduction
A source of fe l in e  in te r le u k in -2  ( IL -2 )  was considered 
essential for three p r inc ip le  reasons: ( i )  to develop a system for
establishing ce ll cultures from tumours enabling the study of the 
properties of the viruses associated with them, ( i i )  to determine 
i f  these cultured neoplastic T -ce l ls  had altered requirements fo r ,  
or response to IL -2 ,  in v i t ro  and ( i i i )  to maintain normal T -c e l ls  
in culture as targets fo r p o te n t ia l ly  leukaemogenic v iruses.
IL-2 is  predominantly produced by mature helper T -c e l ls  which 
have been activated by antigen or mitogen and in te r le u k in -1  
( IL - 1 ) .  Since IL-1 is  ,a mitogenic product of macrophages 
(Rosenstreich and M ize l, 1978) a good source of both mature 
T-lymphocytes and macrophages was required fo r  optimal IL -2  
production. In these experiments mononuclear c e l ls  were iso lated  
from the spleens of cats and mesenteric lymph node ce l ls  were added 
to make up the f in a l  ce ll  number required.
IL -2  has been produced from several sources. Human peripheral 
blood lymphocytes (PBL) optimally produce IL -2  when stimulated by 
1% PHA with lower a c t iv i t y  obtained using Con-A. (A1 varez et a l . ,  
1 979) which is the reverse of the s ituation  with murine PBLs 
( G i l l i s  et a l . ,  1978). These differences presumably r e f le c t  the 
d is t in c t iv e  mitogenic response to PHA and Con-A which are higher
with PHA on human c e l ls  (Arala Charles et al . ,  1978) and Con-A on
rodent c e l ls ,  (Stobo, 1972). I t  was, there fo re , important to 
establish which mitogen was optimal fo r IL -2  production in the cat 
and th is  was one of the parameters determined in the f i r s t  set of 
experiments. Cell densities used fo r IL -2  production vary between
1-5 x 106 c e l ls /m l .  In the human system, the maximal IL -2
production/cell in the culture is  obtained using Ix  106 c e l ls /m l .  
However i f  no p u r if ic a t io n  is performed on the crude lymphocyte 
conditioned medium (Ly-CM) produced then the use of high ce l l
numbers i . e .  5 x lO^/ml is  most e f fe c t iv e  fo r removing 
contaminating mitogen from the medium. In high density cultures  
peak IL-2 levels  in the medium occur 18-24 hours a f te r  mitogen
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stim ulation , but for low density cultures i t  is between 48-60 
hours. The optimum duration of culture for two d i f fe re n t  ce ll  
densities was studied and a blastogenesis assay, f i r s t  described by 
G ill  is  et al . (1978) to determine the a c t iv i t y  of the T -cell growth 
fac tor obtained, was optimised for use in the fe l in e  system.
The IL-2 produced was used for the cu lture  of normal 
mitogen-activated T -ce l ls  which were derived from the thymus of 
spec if ic  pathogen free  cats. The T -ce lls  were characterised by 
th e i r  absolute dependence on T -cell growth factor for th e i r  
continued p ro l i fe ra t io n  in culture and by E-rosetting with guinea- 
pig red blood ce ll s.
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MATERIALS AND METHODS
Cells
Spleen and mesenteric lymph node c e l ls ,  fo r  production of 
Ly-CM, were obtained from specific  pathogen free (SPF) cats .  
Spleen ce lls  provide a good source of macrophages fo r IL-1  
production, therefore the to ta l  spleen c e l ls  ava ilab le  were passed 
through Ficoll-Paque (Pharmacia L td .)  to iso la te  the mononuclear 
ce lls  and these were combined with mesenteric lymph node c e l ls  to a 
to ta l number of 2.5 x 106 cells /m l for Ly-CM production.
Normal activated T -ce l ls  were derived from the thymuses of SPF 
cats and were cultured for a minimum o f 4 weeks as deta iled  la te r  
in th is  section. These ce lls  were used to assay the a c t iv i t y  of 
IL -2  in routinely  produced Ly-CM. The rep lica tion  of normal 
activated T -c e l ls ,  which have been in culture fo r a period 
exceeding 4 weeks, is absolutely dependent on an exogenous source 
of IL -2 .
The cell l ines FL74 and F422, previously described in Chapter 
One, were used to optimise the blastogenesis assay for use in th is  
system.
Media
RPMI 1640 medium (Gibco Biocult L td .)  supplemented with 2mM 
L-glutamine, 400 units/ml pen ic i l l in -s trep to m yc in , 5 x 10“^M.
2-mercaptoethanol (2-Me) and 20% FBS was used in equal volume with  
Ly-CM to maintain normal T -c e l ls .  The complete medium is referred  
to as 50:50 medium.
Iscove's modified Dulbecco's medium (Gibco Biocult L td .)  
supplemented with 400 units/ml p e n ic i l l  in -streptom ycin, 5 x 10‘ 5M
2-Me and 0.25% bovine serum albumin (BSA) was used fo r production 
of Ly-CM and the complete medium is referred to as 0.25% Isc .  
Concanavalin-A (Con-A) (Miles S c ie n t i f ic )  was the T -ce ll  mitogen
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used both in Ly-CM production and for ac tiva tion  of normal 
T -c e l ls .  I t  was made up to a stock solution of 1 mg/ml in RPMI 
1640 medium supplemented with 400 units/ml pen ic ill in -s trep tom ycin  
and stored in aliquots a t -20°C. The PHA used to determine the 
most potent mitogen ava ilab le  for IL -2  production was supplied by
Gibco Biocult Ltd. and was made up to a stock solution in d is t i l le d
water and used at a f ina l concentration of 1%.
The production of Ly-CM (Figure 6)
Ly-CM was routinely  produced by the following procedure: The
spleen and mesenteric lymph nodes of an SPF cat were removed 
asceptica lly  into 0.25% Isc containing 1% preservative free  heparin 
(Paines and Byrne L td .)  and rinsed twice in 0.25% Isc . The tissues  
were transferred independently into 9 ml petri dishes (Nunc!on) 
and diced with scalpels in 0.25% Isc. The s lu rr ies  were put into  
s t e r i l e  p las tic  stomaching bags (Seward Surgical) and pulped in a 
Stomacher machine. The single ce ll spleen suspensions were then 
layered onto Ficoll-Paque and centrifuged at 2,000 rpm for 10 
minutes a f te r  which time the mononuclear leucocytes had banded at 
the in te r fa c e .  These were washed with medium, counted, and made up 
to a to ta l  of 2.5 x 106 cells /m l using lymph node c e l ls  in 0.25% 
Isc . Con-A was added at a concentration of 7.5 yg/ml and the 
complete culture was incubated at 37°C for 24 hours, a f te r  which 
time the Ly-CM was harvested and c la r i f ie d  by cen tr ifugation  at
10,000 rpm for 15 minutes, s te r i le  f i l t e r e d  through 0.22 ym 
M il l ip o re  membranes and stored in a liquots at -70°C.
The culture of normal fe l in e  T -ce l ls
Normal T -ce lls  were cultured from the thymus of SPF cats tha t  
were less than one year o ld . They were collected asc ep tica lly  into  
RPMI 1640 medium, diced with scalpels then stomached once, b r i e f l y .  
The single ce ll suspension was washed in fresh medium and 
resuspended in RPMI 20% +Me at a concentration of 1 x 10® c e l ls /m l .  
7.5 yg/ml Con-A was added to ac tiva te  the T -ce l ls  and the cu lture  
was incubated for 18 hours. The following day the the c e l ls  were
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washed free of Con-A and resuspended in medium composed of equal 
volumes of RPMI 20% +Me and Ly-CM (re ferred  to as 50:50 medium). 
The ce l ls  were maintained by sub-culturing twice weekly into fresh  
medium at a concentration of 5 x 1ofyml.
The determination of the optimum la b e l l in g  conditions fo r the 
blastogenesis assay
This assay was f i r s t  developed by G i l l i s  et al . (1978) and was 
described as a specific  and quantita tive  microassay for T -cell  
growth fac to r .  I t  is based on the p ro l i fe ra t io n ,  as measured by 
[^H]-thymidine (Tdr) incorporation of a TCGF-dependent T -cell  
l in e .  The assay was used to determine IL -2  a c t iv i t y  in the Ly-CM 
by t i t r a t in g  the conditioned medium against normal T -ce l ls  grown in 
culture  for a minimum of 4 weeks prior to use in the assay. The 
assay was also used to determine the i n i t i a l  response of tumour 
c e lls  to TCGF (Chapter Three) and to determine the response of 
TCGF-independent ce ll l ines to other regulatory factors (Chapter 
Four). The assay was optimised using FL74 and F422 c e l l  l ines  
which are TCGF independent. Two parameters were studied: ( i )
concentration of radioactive label used to pulse label the c e l ls  
and ( i i )  duration of pulse label applied to the c e l ls .  The c e l ls  
were washed and resuspended in fresh L/M at 5 x 105 c e l ls /m l .  100 
pi of ce lls  were plated per m ic ro t itre  well and the four conditions  
of label were applied for both four hours and overnight (standard­
ised to 18 hours) on each of three consecutive days a f te r  which 
time the ce lls  were harvested and counted.
Radio-active la b e l l in g
[6 “3H]-thymidine (Tdr) was obtained from Amersham at a 
specific  a c t iv i t y  of 2 Ci/mM and was d ilu ted  e ith e r  in RPMI-1640 
medium or in cold thymidine made up to a stock concentration of
1 mg/ml in RPMI-1640 medium and d ilu ted  in the same medium. The 
four conditions of label applied were: ( i )  ?Ci/mM spec if ic
a c t iv i t y ;  0.5 yCi per w e ll ,  ( i i ] 0 -98 Ci/mMspecific a c t iv i t y ;  2yCi/  
w e ll ,  ( i i i )0.56 Ci/mM specific  a c t iv i t y ;  0.8 yCi/well and ( iv )  0.32  
Ci/mM specific  a c t iv i t y ;  1 .6 y C i/w e ll .
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Harvesting the ce lls
The ce lls  were harvested from the m ic ro t itre  plates onto glass 
f ib re  f i l t e r  papers using a T ite rtek  ce ll harvester. The ce lls  
were flushed onto the f i l t e r s  using a 20 second pulse of deionised 
water followed by a 20 second pulse of a i r  to p a r t ia l ly  dry the 
f i l t e r .  The f i l t e r s  were completely dried for 30 minutes in a 37°C 
hot room then the individual wells on the f i l t e r s  were transferred  
to s c in t i l la t io n  v ia ls .
S c in t i l la t io n  Counting
The s c in t i l la t io n  f lu id  used was Aqua-Luma which is  toluene  
based and the samples were counted on a Packard Tri-Carb 300C 
l iq u id  s c in t i l la t io n  counter.
The determination of the optimum conditions for the production o f  
IL -2  in Ly-CM
IL -2  a c t iv i ty  obtained from Ly-CM was optimised with respect 
to three parameters: ( i )  Mitogen type and mitogen concentration;
which were 1% PHA, 1 yg/ml Con-A, 5 yg/ml Con-A and 7.5 yg/ml 
Con-A. ( i i )  Cell density; c e l ls  were seeded at e i th e r  2.5 x 106/ml 
or 5 x 1nfyml. ( i i i ) Duration of cu ltu re ;  cultures were incubated 
at 37°C for e ith er  24 hours, 48 hours or 72 hours. The cultures  
were set up in 24 well Costar plates and harvested on the 
appropriate day. IL-2 a c t iv i t y  in the supernatants was determined 
using the standard blastogenesis assay with TCGF-dependent cultured  
normal T -ce lls  as the ta rget population.
The determination of IL -2  a c t iv i t y  in Ly-CM by blastogenesis assay
The level of IL -2  a c t iv i t y  present in each batch of 
lymphocyte-conditioned medium was assayed by incubating normal 
cultured fe l in e  T -ce lls  with seria l d ilu t ions  of Ly-CM. Normal 
T-ce lls  were used at confluence and were spun down at 2,000 rpm for  
5 minutes then resuspended in RPMI 20% + Me at 5 x 105 ml. 100 yl
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100 yl of th is  suspension was plated in each well of a U bottom 
m ic ro ti tre  plate (Nunclon) and an equal volume of Ly-CM, s e r ia l ly  
dilu ted  in RPMI 20% + Me, was added and the plate incubated at 37°C 
overnight (16-18 hours). The next day 0.5 yCi of [^Hl-Tdr at a 
specif ic  a c t iv i ty  of 2 Ci/mM was added per m ic ro t itre  well and the  
plate was incubated at 37°C for a fu rther 16-18 hours. After th is  
incubation the p late  was harvested and the level of [ 3H]-Tdr 
incorporation was determined by s c in t i l la t io n  counting as described 
on the previous page. A positive control value was obtained by 
plating the normal T -ce lls  with a previously assayed, ac tive  Ly-CM 
and a negative control value was determined by p lating the c e l ls  
into conventional tissue culture medium alone (RPMI 20% + ME).
An E-rosette te s t  on normal cultured fe l in e  T -ce lls
The guinea pig erythrocyte (GPE) rosette te s t  is considered 
to be a specific  marker for T -ce lls  (Mackey et a l . ,  1975;
Cockerall et a l . ,  1976). This te s t  was carried out on normal
cultured T -ce lls  in the following manner. Guinea pig erythrocytes  
were washed and resuspended to 1 % in phosphate buffered saline
(PBS). 200 yl of th is  suspension was added to 200 yl of normal 
cultured fe l in e  T -c e l ls ,  at a concentration of 2 x 10fi c e l ls /m l ,  in 
a V bottom tube ( S t e r i l i n ) .  The mixture of ce l ls  was centrifuged  
at 1 ,000 rpm for 5 minutes then l e f t  at room temperature fo r 30
minutes. At the end of th is  time 100 yl of supernatant was removed
and replaced with an equal volume ( 1 0 0  y l ) of 1% crystal v io le t .
The ce lls  were very gently disturbed from the p e l le t  and an a liquot
was removed onto a haemocytometer for rosette counting. A rosette  
was defined as one T -ce ll  in contact with 3 or more guinea pig
erythrocytes and a minimum o f 200 T -ce lls  were counted. The number
of rosette positive T -ce l ls  compared to rosette negative T -c e l ls  
was expressed as a percentage.
The Geimsa staining of cytocentrifuge preparations of T -c e l ls
Normal cultured fe l in e  T -ce lls  were resuspended to a f in a l  
concentration of 1 x 105 cells /m l in RPMI 20% + Me. 500 yl of th is
suspension was used per cytocentrifuge s l id e .  The slides were 
f ixed in methanol for 1 0  minutes at room temperature, stained with 
20% May Grunwald Geimsa for 4 minutes then stained twice with 10% 
Geimsa before washing in phosphate buffered saline (PBS) pH 6 . 8 . 
(The Geimsa stains were also made up in PBS pH 6 . 8 ) .  The slides  
were dried at room temperature then visualized and photographed, 
using o il  immersion l ig h t  microscopy.
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RESULTS
The optimum la b e l l in g  conditions for the blastogenesis assay
Figures 7 and 8  show the response of ce ll  l ines FL74 and F422 
respectively to the 4 la b e l l in g  conditions l is te d  in the legends to 
the f igures . The optimum radioactive label for both ce ll l ines  was 
0.5 yCi/well of [ 3 H]-Tdr at a specific  a c t iv i ty  of 2 Ci/mM.
Maximum incorporation of label occurred overnight at day 2-3 with  
acceptable incorporation overnight at day 1-2 . A 4-hour label 
applied on any of the 3 consecutive days resulted in suboptimal 
la b e l l in g  of the c e l ls .
The optimum conditions fo r the production o f IL -2  in Ly-CM
Figures ,9 and 10 graphically  represent the results  of a
blastogenesis assay of normal T -ce ll growth in response to IL -2
present in Ly-CM produced under the varying conditions of cu lture
shown. Figure 9 represents a ce ll culture concentration of 2.5 x
106 cells /m l which shows optimum IL -2  production 24 hours a f te r  
stimulation by 7.5 yg/ml Con-A. S im ilar ly  5 x 10fi ce lls /m l cu lture  
(Figure 10) optimally produces IL -2  under the same conditions but 
the y ie ld  o f IL -2  is s ig n if ic a n t ly  less.
The demonstration of IL -2  a c t iv i t y  in Ly-CM
IL -2  a c t iv i t y  was routinely  monitored in Ly-CM batches by 
blastogenesis assay of growth of normal cultured fe l in e  T -c e l ls .
Serial 2 -fo ld  d ilu tions  of the Ly-CM results in a growth response
curve for normal T -c e l ls ,  an example of which is shown in Figure 
11.
An E-rosette te s t  on normal cultured fe l in e  T -ce lls
An E-rosette te s t  was carried out in quadruplicate as de ta iled  
in Materials and Methods on normal fe l in e  T -ce lls  cultured fo r  a 
minimum of 4 weeks. The experiment gave a mean resu lt  o f  31.01% 
E-rosette positive (see Table 1 ) .
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The Geimsa staining of cytocentrifuge preparations of T -ce l ls
A typ ical stained preparation of normal cultured fe l in e  
T -ce lls  is shown in Figure 12. The mononuclear morphology of the 
ce lls  is  c le a r ly  demonstrated.
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DISCUSSION
The concentration of radioactive label to be used in the 
blastogenesis assays was optimised to ensure tha t maximum counts 
per minute (cpm) would be detected fo r s ta t is t ic a l  analysis without 
loss of ce ll  v i a b i l i t y  due to radio-nucleotide damage. From the 
results  presented in Figures 7 and 8 i t  was determined tha t  0.5  
pCi/well of undiluted label (spec if ic  a c t iv i ty  2 Ci/mM) ensured 
high cpm in a range suitab le  for analysis without loss of ce ll  
v iab il  i ty .  ; -■ - - . • .
. This was, there fo re , the concentration of rad io-label used 
for ce l ls  in a l l  the blastogenesis assays performed. From the same 
figures i t  is obvious tha t most label is  incorporated overnight 
between days 2 and 3 of the assay. The explanation for th is  is  
probably due to the fact tha t the FL74 and F422 c e l ls  used have 
mean doubling times o f  30 hours and 21 hours respective ly  (Toth,
1980), and are confluent, i . e .  in s ta t ic  cu ltu re , on day 0 o f  the 
assay. They are fed with fresh medium (L/M) p rior to p lating  in 
the m ic ro t itre  wells and the observed increase in incorporation of 
[^H]-Tdr with time is possibly a re f lec t io n  of a r is in g  number of  
c e lls  capable of d iv id in g . The 4 hour labels were not successful 
compared to the overnight labels again probably due to the
re la t iv e ly  few ce lls  undergoing d iv is ion in th is  period. From the 
results i t  was decided to standardise the la b e l l in g  of the c e l ls  to 
overnight between days 1 and 2 as th is  gives in te rp re tab le  cpm and 
reduces the overall duration of the assay by 24 hours.
Preliminary results from Onions et al . (1980) suggested that  
Con-A was a more potent mitogen than PHA for inducing the
production of IL -2  from fe l in e  mononuclear c e l ls .  This was
confirmed and the optimum Con-A concentration for production of 
IL-2 was found to be 7.5 yg/m l. Two f a i r l y  high ce ll densities  
were tested for optimum production (2 .5  x 106 and 5 x 106 c e l l s /  
m l).  No fu rther  p u r if ic a t io n  of the IL -2  was planned and high 
ce ll  densities are more e f f ic ie n t  for removing contaminating
mitogen from the medium than low ce ll densities as they adsorb more 
Con-A onto the surface. For both ce ll densities maximum IL -2  was
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released a f te r  24 hours in cu ltu re . A cu lture  of 2.5 x 10^ ce ll/m l  
gave a better y ie ld  of IL -2  than did 5 x 10fi c e l ls /m l .  This may be 
due to the self-adsorption of IL-2 by the activated ce l ls  in the 
culture ( R i l l i s  et a l . ,  1978) which is also why, even with the 
lower ce ll number, the level of IL-2 produced declines over the 
three days. A good y ie ld  of IL -2 ,  determined by IL -2  dependent 
normal T -cell blastogenesis, seems to be dependent on a high 
percentage of spleen c e l ls  in the cu ltu re . Spleen c e l ls  are the 
best source of macrophages and hence IL -1 ,  the second mitogenic 
signal required for IL -2  production by mature T -c e l ls .  Rased on 
these resu lts , IL-2 was routinely  produced by incubating 2.5 x 106 
cells/m l fo r 24 hours, using the to ta l mononuclear spleen cell  
population a va ilab le ,  and stimulating with 7.5 yg/ml Con-A.
The blastogenesis assay shown of the determination of IL-2  
a c t iv i ty  in these cultures of Ly-CM, was typical of the response of 
normal cultured fe l in e  T -ce lls  to conditioned medium produced in 
th is  way. However, residual Con-A in the medium can occasionally  
show s lig h t in h ib it io n  of T -cell response at high concentration. 
Equal volumes of Ly-CM and RPMI 20% + Me (50:50 medium) proved to 
be most sa t is fac to ry  for the routine maintenance of T -ce l ls  in 
cu ltu re . Even using reasonably high cell density to produce IL -2 ,  
the crude Ly-CM used reta ins in add ition , IL -1 ,  in te rfe ron  and 
other growth factors (Garland, 1982). Ruscetti and Gallo (1981) 
have indicated that because of th is ,  the use of crude Ly-CM creates  
d i f f i c u l t i e s  in assessing c e l lu la r  response to IL -2 .  From the data 
presented i t  seems certa in  that the crude fe l in e  Ly-CM d e f in i te ly  
supports the growth of a mature T -ce ll population. The source of 
normal fe l in e  T -ce lls  used for culture is the thymus, the 
overwhelming mononuclear ce ll population of which i s ,  by 
d e f in it io n ,  T - c e l l .  E-rosette testing  with guinea-pig erythrocytes  
has been used as a specific  marker for T -ce l ls  and the resu lts  of 
GPE-rosettes with normal cultured fe l in e  T -c e l ls ,  presented in 
Table 1, show an average value of 30% E-rosette p o s it iv e .  This 
percentage of T -ce lls  which were E-rosette positive was expected 
since the T -ce ll  population tested was not synchronised and 
E-rosette formation is known to be c e l l -c y c le  dependent (Cockerell
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et a l . ,  1976). Furthermore, the Geimsa stained cytocentrifuge  
preparation of the same c e l ls ,  shown in Figure 12, c le a r ly  
demonstrates the mononuclear appearance of these c e l ls .
In conclusion, a re l ia b le  blastogenesis assay has been 
developed to enable routine screening for IL-2 present in fe l in e  
lymphocyte conditioned medium. The IL-2  produced has been used 
both to support the growth of normal IL -2  dependent fe l in e  T -c e l ls ,  
and also to establish neoplastic fe l in e  T -c e l ls ,  in v i t r o , which 
w ill  be discussed, in d e t a i l ,  in the following chapter.
TABLE 1
E-rosette te s t  on normal cultured fe l in e  T -c e l ls .
T -ce ll sample Rosette +ve Rosette -ve % Rosette +ve
1 68 173 28.21%
2 73 142 33.95%
3 74 162 31 .35%
4 69 157 30.53%
Mean = 31.01%
Standard deviation = 2.36
FIGURE 6.
The production and assay of Ly-CM
Spleen cells + node c e lls ] Iscoves +0*25%  BSA 
to final 2 -5 x 1 0 s/m l J 7*5 ug ml CO N-A
*• 18 -  2 4h  3 7 ° C
Harvest supernatant 
Plate 1 0 0 X  dilutions
jgS' v^§o£/ K!S5S.nOOn' roPOQ,
100  A RPMI 10% FCS 
+ 5  x 10 4 T -ce lls
2 4 h  3 7  C
20 A 3H Thymidine
18h 3 7 °C
Harvest cells. Count.
FIGURE 7
Determination of the, optimum lab e ll in g  
conditions for ce ll  l in e  FL74
FL74 ce lls  were labelled  w i th .4 concentrations o f [^H]-Tdr denoted 
as follows:
Symbol Specific A c tiv ity  yCi/we!1
( i )  Q  2 Ci/mM 0.5 gCi
( i i )  H  : 0.98 Ci/mM 2.0 gCi
(1 i 1) : 0.56 Ci/mM 0.8 gCi
( iv )  ^  ! 0.32 Ci/mM 1 .6 gCi
cpm
 
x 
10
FIGURE 7.
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FIGURE 8
Determination of the optimum lab e ll in g  
conditions for ce ll  l in e  F422
F422 c e l ls  were labe lled  with 4 concentrations o f  [3H]-Tdr denoted 
as follows:
Symbol Specific A c tiv ity  yCi/wel1
( D □ 2 Ci/mM 0.5 yCi
( i i ) m 0.98 Ci/mM 2.0 yCi
( 1 1 1 ) n | 0.56 Ci/mM 0 . 8  yCi
( iv ) ■ i 0.32 Ci/mM 1 . 6  yCi
FIGURE 8.
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FIGURE 9
Determination of the optimum conditions for  
IL -2  production using 2.5 x 1 0  ^ ce lls /m l culture
Mononuclear ce lls  were seeded at a density of 2.5 x 10^/ml in 
0.25% Isc and the supernatants were harvested on the days shown. 
The mitogen and mitogen concentrations added are denoted as 
follows:
Symbol Mitogen concentration
7.5 yg/ml Con-A 
5 yg/ml Con-A 
1 yg/ml Con-A 
1% PHA
Fig. 9. cpm without Ly-CM = 450 cpm.
FIGURE 10
Determination of the optimum conditions for  
IL-2 production using 5 x 10^ cells /m l culture
Mononuclear ce lls  were seeded at a density of 5 x 10fi/ml in 0.25% 
Isc and the supernatants were harvested on the days shown. The 
mitogen and mitogen concentrations added are denoted as above.
F ig . 10. cpm without Ly-CM = 7 8 2  cpm.
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FIGURE 11
Normal cultured T -ce ll  response curve
The graph shows a typical response curve of normal cultured fe l in e  
T -ce lls  to the IL -2  present in Ly-CM. The Ly-CM was produced from 
an SPF cat using 2.5 x 10^ cells /m l culture stimulated with 7.5 
yg/ml Con-A fo r  24 hours.
FIGURE 12
Geimsa stained normal cultured T-ce lls
The photograph shows geimsa stained mononuclear ce l ls  prepared 
cytocentrifugation of cultured T -c e l ls .
CHAPTER THREE
THE ESTABLISHMENT OF NEOPLASTIC FELINE T-CELLS IN VITRO
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INTRODUCTION
Normal activated T -ce lls  can be grown in continuous 
p ro l i fe ra t iv e  culture only i f  they are f i r s t  activated by antigen 
or mitogen and IL-1 to express receptors for IL -2 .  Their growth 
can then be sustained for a long period of time by repeatedly  
supplementing the medium with IL-2  (Ruscetti et a l . ,  1977). In 
contrast to th is ,  T -ce lls  obtained from T-cell malignancies can 
frequently be cultured d ire c t ly  with IL -2  without p rior ac tiva t ion  
suggesting that they already display the IL -2  receptor (Poiesz et_ 
a l . ,  1980b). Before the discovery of IL -2 ,  r e la t iv e ly  few
neoplastic T -cell l ines were successfully established in culture  
since the neoplastic tissue was plated d ire c t ly  into conventional 
tissue culture medium. Human neoplastic T-cell l ines derived from 
patients with acute lymphoblastic leukaemia (T-ALL) were cultured  
in th is  manner and only one could be induced to produce free  IL - 2  
in the medium. Both th is  l in e  (designated JURKAT) and another nine 
did not display receptors for IL -2  nor did they respond to i t  
(Smith, 1982). Where data was ava ilab le  on these cell l in e s ,  Smith 
reports that most of the ce lls  which were i n i t i a l l y  placed in 
culture died and the l ines  which eventually became established  
arose from a small number of c e l ls  (perhaps even a single c e l l )  in 
the orig ina l inoculum. All of the ce ll l ines which established in 
culture were in i t ia te d  a f te r  the patients had received chemotherapy 
which is a potential source of mutagenesis so these l ines  may not 
be representative of the orig ina l neoplastic T -ce l ls  in v iv o .
Now that IL -2  is ava ilab le  there has been considerably more 
success in establishing neoplastic T -ce ll lines in cu ltu re .  Poiesz 
et al . (198Db) have established six out of six human cutaneous 
T-ce ll lymphoma cell l ines (CTCL) by p lating the neoplastic tissue  
d ire c t ly  into tissue culture medium supplemented with human 
p a r t ia l ly  p u r i f ie d ,  le c t in - f r e e ,  IL -2 .  Four of these l ines  have 
subsequently become independent of exogenous IL -2  for th e i r  
continued p ro l i fe ra t io n  in cu ltu re , a phenomenon never observed 
with any normal T -cell l in e .  I t  has subsequently been demonstrated 
that these cell l ines both produce and respond to IL -2 ,  suggesting
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th a t  at least some malignant T -cell l ines  may be capable of of 
autonomous growth by v ir tue  of th is  property (Gootenberg et a l . ,  
1981). These .IL-2 independent T -cell l ines  produce no detectable  
IL -2  a c t iv i t y  free in the supernatant of the cultures but i t  can be 
demonstrated by acid-glycine treatment resulting  in the release of 
IL -2  from the cell membrane. In marked contrast to th is  a 
gibbon-ape T -ce ll l in e  established from a gibbon ape with 
spontaneous lymphosarcoma (Kawakami et al . ,  1 972) c o n s ti tu t iv e ly  
released detectable IL-2 in the culture supernatant which was 
capable of supporting the growth of human, primate and murine IL-2  
dependent T -ce lls  in v i t ro  (Rabin et a l . ,  1981). This ce ll l in e  
was established d ire c t ly  into conventional tissue cu lture medium 
and i t  has only recently been demonstrated that i t  can also both 
produce and respond to IL -2  (Smith, 1982) supporting a hypothetical 
autonomous growth system s im ila r  to th a t  proposed for the IL -2  
independent human CTCL ce ll l in e s .
Very few neoplastic fe l in e  T-cell l ines have been successfully  
established in long-term cu ltu re . The FL74 ce l l  l in e  (Theilen et
a l . ,  1969) and the F422 ce ll l in e  (Rickard et al_., 1969) were
established by plating the neoplastic tissue into  conventional 
t issue culture medium but nothing was known of th e i r  response to or 
production of IL -2 .  Since a source of fe l in e  IL -2  was ava ilab le  
(described in , th e  previous chapter), the neoplastic T -ce lls  from 
the spontaneous lymphosarcomas in the present experiments were 
plated both into conventional tissue culture medium (RPMI 20% + Me) 
and the same tissue culture medium + Ly-CM (50:50 medium) in an 
attempt to establish these T -ce ll s in v i t r o . Blastogenesis assays 
of neoplastic T -ce ll response to Ly-CM on the day tha t the c e l ls  
were isolated from the lymphosarcoma were carried out in order to 
determine i f  th is  i n i t i a l  response was ind ica t ive  of which c e l ls  
would p ro l i fe ra te  in cu ltu re . C e llu la r  growth was also compared, 
by blastogenesis assay, using p a r t ia l ly  p u r i f ie d ,  l e c t in - f r e e ,  
human IL -2  (provided by Or. R.C. Gallo) and crude fe l in e  Ly-CM, to 
determine i f  the ce lls  responded in a s im ila r  manner to both 
sources of fac to r .  This would ind icate whether or not i t  was 
re a l ly  the IL -2  in the crude fe l in e  Ly-CM tha t  was supporting the
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growth of these ce lls  or i f  they were simply responding to residual 
mitogen (ConA) in the preparation. (Poiesz et a l . ,  1980b).,
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MATERIALS AND METHODS
Cel 1 s
Normal fe l in e  T -c e l ls ,  used for the comparison of the e f fe c t  
of p a r t ia l ly  purif ied  human IL -2 (pp IL -2 ) and crude fe l in e  Ly-CM 
on the growth of c e l ls ,  were isolated and cultured as deta iled  in 
Chapter Two.
FL74 and F422 ce l ls  used in a s im ila r  study were cultured as 
described in Chapter One.
Media
RPMI-1640 medium, (Gibco Biocult L td .)  supplemented with 400 
units/ml p e n ic i l1 in-streptomycin and 2% FBS was used for iso la t in g  
tumour material and stomaching these c e l ls .  This medium is  
referred to as RPMI 2%.
Ly-CM was produced as described in Chapter Two and i t s  
a c t iv i t y  tested on normal cultured fe l in e  T -ce l ls  p r io r  to use.
The preparation and establishment of ce ll  cultures from tumours
Fourteen thymic lymphosarcomas isolated from f ie ld  cases were 
in i t ia te d  in culture in the following manner. The tumours were 
removed asceptica lly  into RPMI 2% and washed twice in th is  medium. 
They were then diced in petri dishes (Nunclon) with scalpels to a 
f ine  suspension and stomached once, as described in Chapter One. 
The single ce ll suspension was centrifuged at 2000 rpm for 5 
minutes and the ce ll p e l le t  resuspended to 1 x 1 0 6 ce lls /m l e i th e r  
in RPMI 20% + Me or in an equal volume of RPMI 20% + Me and Ly-CM 
(50:50 medium). I f  many dead c e l ls  were present (determined by 
trypan blue exclusion te s t )  the c e l ls  were passed through 
Ficoll-paque for 10 minutes at 2 0 0 0  rpm and the l iv e  ce l ls  iso lated  
from the in te r fa c e .  These were washed once in RPMI-20% and 
resuspended as above. Cultures were maintained by sub-culturing
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the ce lls  twice weekly, and resuspending them back to 5 x 10^/ml in 
fresh medium.
The i n i t i a l  response o f primary tumour c e l ls  to Ly-CM
Blastogenesis assays were performed on primary tumour ce l ls  on 
the day of iso la tion  from the cat. The ce lls  were prepared as for  
culturing above but were resuspended to 5 x 10^ cells /m l in RPMI 
20% + Me then 100 yl seeded into m ic ro t itre  wells giving a f ina l  
concentration of 5 x 104 c e l ls /w e l l .  Ly-CM was added in 2 -fo ld  
seria l d ilu t ions  in RPMI 20% + Me and the assay was la b e l le d ,  
harvested and counted as described in Chapter One.
The response of normal and cultured tumour c e l ls  to Ly-CM and pp 
IL-2
A comparison was made of the e f fe c t  of crude fe l in e  Ly-CM and 
human pp IL-2 on the growth of normal fe l in e  T -ce l ls  and tumour 
c e l ls  ( T i l )  established in cu ltu re . Blastogenesis assays were used 
in the usual way previously described (Chapter One). Both cell  
l ines were grown to confluence before use and were dependent on 
Ly-CM for growth.
RESULTS
The establishment of tumour c e l ls  in culture
Of 14 thymic lymphosarcomas in i t ia te d  in cu lture  (Figure 13) 
only one, T17, grew when plated d ire c t ly  in to  RPMI 20% + Me without 
added Ly-CM. T17 has now been in culture for more than 6 months. 
Four of the res t;  T1 0 , 1 1 , T14 and T16 formed IL -2  dependent 
longterm cultures ( th e ir  continued growth was absolutely dependent 
on the medium being supplemented with 50% Ly-CM). These c e l ls  were 
rou tine ly  sub-cultured into RPMI 20% + Me only but they never grew 
in the absence of Ly-CM. Another ce ll l in e  which established in 
cu ltu re ,  T3, i n i t i a l l y  required exogenous IL -2 ,  as the c e l ls  which 
were seeded d ire c t ly  into  RPMI 20% + Me only, died immediately.
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However, w ithin one week the ce lls  which were o r ig in a l ly  seeded 
in to  50:50 medium, survived and grew when they were subcultured 
into RPMI 20% + Me alone. This ce ll l in e  has now been in culture  
fo r  2 years and w il l  be discussed extensively in the following  
chapters.
The i n i t i a l  response of primary tumour ce l ls  to Ly-CM
Figure 14 represents the results of blastogenesis assays 
performed on freshly  isolated tumour ce lls  to determine i f  th e ir  
i n i t i a l  response to growth factor was a re l ia b le  ind ication  of 
whether or not they would establish in cu ltu re . The response to 
growth factor was expressed as a m ultip le  of the negative control 
value, which was obtained by seeding the ce l ls  into RPMI 20% + Me 
with no Ly-CM. A ty p ic a l  normal cultured fe l in e  T -ce ll response is  
shown for comparison. Two v iru s -p o s it ive  tumours, T7 and T10 
showed a low level response while the others showed v i r tu a l ly  no 
response at a l l  (represented by the area between the dotted 
l in e s ) .  The la te s t  two tumours, T16 and T17 are not included in 
these results as th is  assay was not done on these c e l ls  (see 
di scussion).
The response of normal and cultured tumour ce l ls  to Ly-CM and 
PP.IL-2
Figure 15 demonstrates v i r tu a l ly  p a ra lle l  responses of normal 
and tumour T -ce l ls  to crude fe l in e  Ly-CM and pp human IL -2 .  T i l ,  a 
long-term cultured, IL -2  dependent ce ll l in e ,  represents the 
response of tumour ce lls  to these fac tors . Both sources of growth 
factor are s l ig h t ly  in h ib ito ry  at a d i lu t io n  of 1:2  in 0.25% Isc on 
both ce ll types. The response to crude fe l in e  Ly-CM is g rea te r ,  in 
both cases, than the response to pp human IL -2 ,  which is probably a 
function of species s p e c if ic i ty .  The response index is again 
expressed as a m ultip le  of the negative control value, which was 
obtained by p lating both ce ll lines into RPMI 20% + Me, without 
additional growth fa c to r .
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DISCUSSION
Cells were isolated from the thymic lymphosarcomas of 14 cats 
in order to attempt to establish them in culture as neoplastic  
fe l in e  T -ce ll  l in e s .  Feline IL -2 ,  present in Ly-CM produced from 
SPF cats, was used to i n i t i a t e  these ce l ls  in culture as th is  
approach has been more successful in other systems than the use of 
conventional tissue culture medium alone (Poiesz et al . ,  1980b). 
As a control the ce lls  were also plated into conventional tissue  
culture medium without Ly-CM. Figure 13 summarises the results  
obtained using these two methods of cu ltu re . Of the 14 tumours in 
the series , 12 were FeLV-positive and two were FeLV-negative, 
determined by virus iso la tio n  from the plasma of these cats.  
Tumour ce l ls  cultured from cats that had infectious virus present 
in the plasma were also tested fo r virus release from the ce l ls  
in to  the culture supernatant. All of the neoplastic c e l ls  tha t  
established in cu lture  were FeLV-positive both in the plasma and 
from the cultured c e l ls  with the noticeable exception of T17 which 
had no in fectious FeLV c ircu la t in g  in the plasma but was releasing  
low levels  of FeLV from the cultured tumour c e l ls .  The release of 
virus from the ce lls  and c ircu la tin g  in the plasma of these cats
f  ■.. .....
w il l  bej discussed fu rther in Chapter Five.
The f iv e  ce ll l ines  which i n i t i a l l y  established in Ly-CM 
supplemented medium remained t o ta l ly  dependent on th is  source of 
IL -2  for continued growth with the exception of T3 which rap id ly  
became independent of an exogenous source of IL-2 (w ith in  one week 
of c u l tu re ) .  Possibly these ce l ls  consisted of both IL -2  dependent 
and IL-2 independent c e l ls ,  the l a t t e r  being a very small 
percentage of the to ta l  population. In th is  event there may have 
been too few ce lls  capable of autonomous growth in the c u ltu re ,  
when plated d ire c t ly  into tissue culture medium alone, to enable 
them to establish into a ce ll l in e  (cloning of single v iable  c e l ls  
was not attempted). A lte rn a t iv e ly ,  the ce l ls  may have required a 
mitogenic signal present in the crude lymphocyte conditioned media 
before they became capable of growth independent of exogenous 
IL -2 .  In te re s t in g ly ,  the T3 ce l l  l in e  has always been absolutely
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dependent on the presence of mercaptoethanol in the tissue culture  
medium for continued p r o l i fe ra t io n .  S im ila r ly ,  T17, which did 
establish in v i t ro  in the absence of a source of exogenous IL -2 ,  
has also always been dependent on the presence o f  2-Me in cu ltu re .
; 2-Me provides an I L - l - l i k e  mitogenic signal to ce lls  in culture
(Chen and Hirsch, 1972) which would support a hypothesis that these
; two tumour cell l ines may be independent of exogenous IL-2 by
| v ir tue  of th e i r  capacity to both produce and respond to th is
fa c to r ,  in a se lf -s t im u la to ry  type of mechanism. This p o s s ib i l i ty  
j  was investigated and the evidence for and against th is  theory is
the subject of the next chapter.
Figure 14 demonstrates that the i n i t i a l  response of these 
ce lls  to Ly-CM on the day of iso la tion  from the tumour (Day 0) gave 
no indication of whether or not they were going to form ce ll l ines
in cu ltu re . T1 0 did respond on Day 0 but.very l i t t l e ,  in comparison
to the response of normal cultured T -ce lls  to the same conditioned 
medium. I t  was hoped tha t th is  i n i t i a l  response assay would
provide a fast screen of tumour ce lls  to determine which ones were 
l ik e ly  to grow, and whether or not they required an exogenous 
source of IL -2  in cu ltu re . As th is  assay did not provide any 
information on subsequent tumour ce ll growth i t  was not used a f te r  
tumour T15. The f i r s t  day.of iso la tion  of these c e l ls  from tumour 
material was possibly not the best time to carry out th is  type of 
assay as they had jus t  been traumatised by tra n s fe rr in g  them from 
an in vivo to an in v i t ro  environment and usually l i t t l e  c e l lu la r  
growth in tissue culture was observed over the f i r s t  few days. The 
IL-2 dependent ce ll l in e s ,  once established in c u ltu re ,  responded 
to IL -2  in a manner s im ila r  to normal T -ce l ls  (exemplified by T i l ,  
Fig. 15). These ce lls  were un like ly  to be a normal population  
based on the evidence of the nature of the virus associated with 
them, which w il l  be discussed la te r  (Chapter S ix ) .
Figure 15 also demonstrates the comparison of the e f fe c t  of 
crude fe l in e  Ly-CM and p a r t ia l ly  purif ied  human IL -2  on both a 
normal and a neoplastic ( T i l )  ce ll  l in e .  The para lle l  response of 
the ce l ls  to the two sources of factor strongly supports the 
assumption that i t  is the IL -2  in the crude fe l in e  Ly-CM th a t  the
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ce lls  are responding to and not some other growth or mitogenic 
fa c to r .  P a r t ia l ly  p urif ied  human IL -2  was provided by Dr. R. Gallo 
and has been extensively treated to remove contaminating le c t in  and 
other growth factors (Mier and Gallo, 1982). The reduced response 
observed to the human factor compared to the fe l in e  fac tor is 
probably due to cross-species re s tr ic t io n  but the noticeable  
d ifference in a c t iv i t y  between the 1:2 and 1:4 d i lu t io n  is  
unexpected and more d i f f i c u l t  to in te rp re t .  An increase in 
a c t iv i ty  occasionally does occur at a 1:4 d i lu t io n  of crude fe l in e  
Ly-CM compared to the 1:2 value. Residual le c t in  in crude 
conditioned medium often creates th is  result (Ruscetti and G allo ,
1981) by in h ib it in g  c e l lu la r  growth at high concentrations. This 
e f fe c t ,  however, can also be seen here with the pp human IL -2  which 
is le c t in - f re e  and therefore was not expected to produce th is  
e f fe c t .  I t  has been stated that continued stimulation with mitogen 
is equally toxic  to cultured transformed T-ce lls  as i t  is to normal 
cultured T -ce lls  which is why p a r t ia l ly  purif ied  preparations can 
sustain the growth of malignant T -ce lls  in culture longer than can 
crude preparations ( Poiesz et a l . ,  1980b). The IL -2  dependent ce ll  
l ines presented here were maintained in culture for at leas t four 
months and could be grown in numbers s u f f ic ie n t  for the preparation  
of c e l lu la r  DNA and RNA for ana lys is .
The successful establishment of these cell l ines fa c i l i t a te d  
further investigation of the properties of these ce lls  and of the 
viruses associated with them. The role that growth factors may or 
may not play in neoplasia is controversial and the experiments 
described in the following chapter were undertaken to t ry  to  
elucidate the involvement of IL-2 in the T -ce ll  neoplasias 
described here, and in the classic fe l in e  neoplastic T -ce ll l ines  
FL74 and F422.
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Figure 13: Twelve fe l in e  leukaemia v irus -pos it ive  and two fe l in e
leukaemia virus-negative tumours were in i t ia te d  in 
culture by seeding them both into RPMI 20% + Me alone 
and th is  medium supplemented with 50% Ly-CM.
FIGURE 13
The establishment of tumour T -ce l ls  in culture
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FtGURE 14
The i n i t i a l  response of tumour ce lls  to Ly-CM
The area between the dotted lines on the graph represents the 
response of T l ,  T3, T4, T5, T6, T8, T i l ,  T12 and T15 to Ly-CM. 
Each point on the graph represents the mean o f 6 rep lica tes  {% 
S.E. < 9 . 5 % ) .
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FIGURE 15
The response of normal and IL -2  dependent 
tumour ce l ls  to Ly-CM and ppIL-2
The solid l in e  in the graph represents the response of the c e l ls  to  
crude fe l in e  Ly-CM and the dashed l in e  represents the response of 
the ce lls  to pp human IL -2 .  Each point on the graph represents the  
mean of 6 replicates (% S .E .^! 8.7%).
CHAPTER FOUR
INVESTIGATION OF THE ROLE OF IL -2 IN T-CELL NEOPLASIA
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INTRODUCTION
The exact nature of the involvement of growth factors in 
tumourigenesis is s t i l l  unknown but several mechanisms have been 
proposed to explain how they may operate in in i t i a t in g  or 
maintaining the transformed s ta te .  Fundamental to the under­
standing of the role tha t growth factors may play in neoplasia is  
the method by which they p art ic ip a te  in the regulation of normal 
c e l lu la r  p ro ! ife ra t io n  as depicted in Figure 16. A growth factor  
can be considered to be a mitogenic signal to a ce ll  which induces 
c e l lu la r  p ro l i fe ra t io n  by binding to a specific  receptor on the 
cell surface and in i t i a t in g  a sequence of c e l lu la r  events to 
transmit th is  message to the nucleus, culminating in ce ll  
d iv is io n . Therefore i t  can be envisaged that an a l te ra t io n  at any 
level of action of the growth fa c to r ,  e i th e r  at the level of the  
molecule i t s e l f ,  the c e l lu la r  receptor, or within the in t r a c e l lu la r  
messenger system, could resu lt in loss of regulation of ce ll  
growth.
Since de Larco and Todaro (1978) f i r s t  demonstrated the 
involvement of a growth fac tor in the neoplastic state  
(transforming growth factor (TGF) in the murine system) many more 
examples which should help to e lucidate th is  re la tionsh ip  have come 
to l ig h t .  Both from these i n i t i a l  studies by de Larco and Todaro 
and from subsequent investigations i t  has been determined tha t  
ce lls  infected by Moloney murine sarcoma virus (MuSV) produce an 
endogenous growth factor called TGF which blocks the receptors fo r  
epidermal growth factor (EGF) on the surface of these c e l ls .  
Furthermore the transforming a c t iv i ty  released by MuSV transformed 
ce lls  is  probably due to the combined action of two fac to rs ;  one 
EGF-like (TGF-oC) and one th a t ,  in combination with EGF or TGF-^<, 
induces phenotypic transformation but has no mitogenic a c t iv i t y  in 
i t s e l f  (TGF-p) (Anzano et a l . ,  1983). Production of TGFs is not 
res tr ic ted  to MuSV transformed c e lls  but is  a property o f several 
transformed ce ll l ines (Kaplan and Ozane, 1982; Todaro et a l . ,  1980 
and Twardzik et a l . ,  1983) and has also been found in normal 
t issues (Roberts et a l . ,  1981). The use of tem perature-sensitive
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mutants of Moloney and Kirsten MuSVs has c le a r ly  demonstrated the 
re la tionsh ip  between transformation and TGF production (Todaro et 
a l . ,  1979; Kaplan et_ al_., 1982). The transformed sta te  was
absolutely dependent on TGF production implying tha t the respective  
v ira l  oncogene products p37mos and p21^“ras d i r e c t ly  or in d ire c t ly  
regulate TGF synthesis at the transcrip tiona l or tran s la tio n a l  
le v e l .  Evidence on the re la tionsh ip  of certa in  growth factors to 
known oncogenes is rap id ly  emerging and is providing data l in k in g  
d i f fe re n t  oncogenes to the d i f fe re n t  levels  of action of growth 
fac to rs . The example of TGF demonstrates how a v ira l  oncogene can 
induce the production of a c e l lu la r  growth fac tor which can bind to 
the c e l l 's  EGF receptor and induce transformation at th is  level of  
the s igna lling  system.
Examples also ex is t  of oncogene products which mimic the 
growth factor molecule. The oncogene v-s i s , which is carr ied  by 
simian sarcoma virus (SSV) has close amino acid sequence homology 
to p ia te le t-d e r iv e d  growth factor (PDGF) which is  one of the 
mitogenic signals involved in c e l lu la r  d iv is ion (W aterfie ld  et a l . ,  
1983; H o o l i t t le  et a l . ,  1983). Another re tro v iru s ,  Parodi-Irgens  
fe l in e  sarcoma virus (FeSV) carries a s im ila r  oncogene with 
homology to c -s is  although i ts  exact re la tionsh ip  to the PDGF gene 
remains to be established (Besmer et a l . ,  1983a). I t  has been 
proposed th a t  in these cases the v ira l  gene product functions as a 
growth fac to r  (PDGF) agonist by in te rac ting  with the PDGF receptor 
and stim ulating ce ll  r e p l ic a t io n .
A s tructura l re la tionsh ip  between a growth fac to r  receptor and 
a v ira l  oncogene product has also been demonstrated by the strong 
amino acid homology between the EGF receptor and the transforming  
protein of avian erythroblastosis  virus (AEV), gp65e r^-B. AEV 
appears to have acquired the part of the EGF receptor gene tha t  
codes for the internal domain and transmembrane region of the 
receptor but not the external domain containing the EGF binding 
region. The lack of a regulatory EGF binding domain may then be 
accompanied by a con s titu tive  ac tiva tion  of the e f fe c to r  domain
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(Downward et a l . ,  1984). A functional homology also ex is ts  in tha t  
several growth factor receptors and transforming proteins have 
tyrosine kinase a c t iv i t y ,  including the PDGF receptor (Heldin et_ 
a l . ,  1983), the EGF receptor (Cohen et a l . ,  1982) and many
re tro v ira l  oncogene products ( fo r  review see Heldin and Westermark, 
1984).
Of p a rt ic u la r  in te re s t  with respect to the results  in the 
following chapters is the re la tionsh ip  of oncogenes to growth 
factors at the level of the in t r a c e l1ular messenger system which 
relays the signal from the stimulated receptor to the nucleus. 
Evidence has emerged which shows that two hours a f te r  mitogenic 
stimulation by PDGF of stationary Balb/C 3T3 c e l l s ,  s ig n if ic a n t  
increase in the expression of mRNA of a proto-oncogene, c -myc, is  
detected. This also occurs when mouse lymphocytes are stimulated  
with mitogen (K elly  et a l . ,  1983). The myc product is  a nuclear 
binding protein (Abrams et a l . ,  1982; Donner et a l . ,  1982) and is 
transduced by several retroviruses causing transformation of a 
spectrum of ta rget ce lls  of d i f fe re n t  histogenetic orig ins (Graf 
and Beug, 1978). Other proteins whose level of synthesis is 
increased a f te r  c e l lu la r  exposure to mitogen have been detected but 
th e ir  re la tionsh ip  to known oncogenes has not yet been determined 
(Pledger et a l . ,  1981). S im ila r ly ,  proteins tha t  s p e c if ic a l ly  
undergo phosphorylation on stimulation of in tac t  c e l ls  have been 
detected (Cooper et a l . ,  1982) and should eventually  enable
id e n t i f ic a t io n  of the target c e l lu la r  substrates for the 
receptor-associated kinases.
On the assumption that c-myc has a ro le  to play in the control 
of normal c e l lu la r  p r o l i f e r a t io n , i t  is easy to envisage tha t the 
aberrant expression of c-myc or the transduction of a v i ra l  v-myc 
could resu lt  in neoplastic transformation of a wide v a r ie ty  of 
cel Is .
Normal c e l lu la r  proto-oncogenes need not be transduced by 
viruses to become oncogenic. The aberrant expression o f these 
genes can also be achieved by chromosomal translocation  of the gene
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to a d i f fe re n t  location where i ts  expression is under a ltered  
con tro l,  such as happens to c -myc in B u rk it t 's  lymphoma (Dalla  
Favera et a l . ,  1982; Taub et a l . ,  1982). A lteration  of control of 
gene expression in any manner, even by conventional mechanisms of 
mutagenesis, could lead to abnormal production o f ,  or response to ,  
a growth factor with or without v ira l  involvement. In the T -cell  
tumour series presented here, the involvement of growth factor  
( IL -2 )  was investigated to determine i f  the neoplastic ce l ls  had an 
alte red  response to ,  or requirement fo r IL -2 .  When these 
experiments were i n i t i a l l y  undertaken there was no evidence for the 
involvement of an oncogene or oncogenic product in fe l in e  T -ce ll  
neoplasia. Since then the association of the oncogene myc with 
T-ce ll tumours has been established (Neil et a l . ,  1984) and the 
results w il l  be discussed in th is  l ig h t .
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MATERIALS AND METHODS
The adsorption of IL -2  by neoplastic T -ce lls
Tumour T -c e l ls ,  freshly isolated from fe l in e  thymic 
lymphosarcomas, were incubated at a concentration of I f )7 cells /m l 
in crude fe l in e  Ly-CM to determine i f  the ce lls  were expressing 
receptors for IL -2  and were ac t ive ly  adsorbing i t  from conditioned 
medium. Cells were resuspended at in 7 in 1 ml of both Ly-CM and
0.25% Isc , the l a t t e r  serving as a control to detect the possible
production of an endogenous growth factor from the tumour c e l ls .
The ce l ls  were incubated for one hour at 37°C in dup licate .  
Duplicate tubes were also set up containing each medium alone 
without ce l ls  as negative contro ls . After 1 hour each tube had 1 
ml of reciprocal medium added in order to standardise the Ly-CM 
concentration in each ( f in a l  concentration 1/4) (Table 2 ) .  All 
tubes were then centrifuged for 5 minutes at 2,000 rpm at 4°C to 
p e l le t  the c e l ls .  The control tubes of media alone were treated  
id e n t ic a l ly .  The supernatants were then removed in a liquots  and 
stored at -20°C until  assayed. The IL -2  remaining in the media was 
determined by blastogenesis assay (previously described) using
normal cultured fe l in e  T -c e l ls .
The spontaneous production of a growth factor by neoplastic T -ce ll  
1 ines
The cultured neoplastic T -ce ll  l ines FL74, F422 and T3 were 
studied to determine i f  they released detectable quan tit ies  of an 
endogenous growth factor into the cu lture supernatant. The 
supernatant of a l l  three cell lines was harvested 21 h r s . ,  48 hrs. 
and 72 hrs. a f te r  sub-culturing the c e l ls .  The c e l ls  were spun 
down at 2,000 rpm for 5 minutes at 4°C and the supernatants
removed. Virus was then pelleted at 40,000 rpm for 45 minutes at
4°C in case i t  in te rfered  with the growth of the normal T -ce l ls  to
be used in a blastogenesis assay. The supernatants were then 
s te r i l is e d  by f i l t r a t i o n  and growth factor a c t iv i t y  was assayed by 
blastogenesis assay using normal cultured fe l in e  T -c e l ls .  The
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ce lls  were confluent when used and were spun down at 2,000 rpm for  
5 minutes then resuspended to  5 x 10^ cells /m l in RPMI 20% + Me. 
The supernatants were added in equal volume i . e .  they were not 
t i t r a te d  out since i t  seemed un like ly  that growth factor would be 
present in a high enough quantity to be detected at any more than a 
1 :2 d i lu t io n .
The response of neoplastic T -ce ll l ines to crude fe l in e  Ly-CM and 
pp human IL-2
The cultured cell l ines used in th is  experiment were F422, T3, T17 
and FL74 which are a l l  independent of an exogenous source of IL-2  
for growth in v i t r o . The classic  ce ll l ines FL74 and F422 grow 
well in culture in 10% FBS supplemented medium (L/M) and do not 
require 2-Me. In contrast to t h is ,  the cell l ines T3 and T17, 
in i t ia te d  from th is  tumour series , prefer 20% FBS supplemented 
medium (RPMI 20% +Me) and are absolutely dependent on 2-Me for  
growth in v i t r o . These were the media used to resuspend the c e l ls  
for assay. Although these ce ll l ines do not require an added 
source of IL -2 ,  these experiments were designed in order to assess 
i f  they were capable of responding to exogenous IL -2 ,  perhaps by an 
enhanced growth ra te .  Since crude fe l in e  Ly-CM retains mitogen 
which may be in h ib ito ry  to these c e l ls ,  pp human IL -2  was also used 
for comparison. The ce l ls  were used at confluence and were spun 
down at 2,000 rpm fo r  5 minutes then resuspended in fresh medium at 
a concentration of 5 x 10^ c e l ls /m l .  Blastogenesis assays were 
performed as usual on each ce ll  l in e  t i t r a t i n g  out both crude
fe l in e  Ly-CM and pp human IL -2  in seria l d i lu t io n s .  A pos it ive
control value was obtained by p lating the c e l ls  in medium
supplemented with the optimum concentration of FBS and a negative
control value was provided by adding 0.25% Isc to the wells instead  
of Ly-CM or pp human IL -2 as th is  is  the medium used to generate 
conditioned medium.
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The response of T3 c e l ls  in l im it in g  serum conditions to pp human
IL-2
T3 c e l ls  were plated in 0.25% BSA and a blastogenesis assay 
was used to determine th e ir  response to serial d ilu t ions  of pp 
human IL -2 .  This serum level was used to t r y  to a rres t ce ll  growth 
and prevent the ce lls  from making an endogenous growth fac tor which 
would p o te n t ia l ly  block receptors for IL -2 .  T3 c e l ls  were spun
down and washed in RPMI 0.25% + Me resuspended to 5 x 10^/ml and 
100 1^ cel 1 s /m ic ro - t i t re  well were p lated. Serial d i lu t io n s  of pp 
human IL -2 ,  d ilu ted  in RPMI 0.25% + Me was added, 6 wells per
d i lu t io n .  RPMI 0.25% + Me was added to the c e l ls  to produce a
negative control value and RPMI 20% + Me was used to produce a
positive control value. The plates were incubated, la b e l le d ,  
harvested and counted as usual.
Dexamethasone in h ib it io n  of neoplastic T -ce ll  l ines
I t  has been reported tha t in the murine system the gluco­
cortico id  dexamethasone s p e c if ic a l ly  in h ib its  the production but 
not the u t i l is a t io n  of IL -2  by mature T -ce lls  ( G i l l i s  et a l . ,  
1979a; 1979b). I t  has subsequently been shown that glucocorticoids  
can in h ib i t  the p ro ! ife ra t io n  of some neoplastic T -ce l l  l ines  
(Norman and Thompson, 1977; Smith, 1982) and in the case of IL -2  
independent neoplastic T -ce ll  l in e s ,  such as those cultured in th is  
series of cats, the in h ib it io n  of growth by dexamethasone would 
indicate that these ce lls  may be producing and responding to an 
endogenous growth fa c to r .  The e f fe c t  of pharmacological levels  
( 1 0 - 6m _ lo-^fyf) dexamethasone on normal cultured fe l in e  T -ce l ls  
was assessed. These ce l ls  are dependent on an exogenous source of 
IL-2 fo r  p ro l i fe ra t io n  in v i t ro  and were therefore cultured in 
equal volumes of molar concentrations of dexamethasone and Ly-CM. 
G i l l i s  et a l . (1979a) observed a 30% reduction in p ro l i fe ra t io n  of 
cytotoxic T lymphocyte l ines  (CTLL) when they were cultured in th is  
manner. This indicates that glucocorticoids exert an in h ib ito ry  
e f fe c t  on T-lymphocytes by a dual mechanism; that i s ,  a d ire c t  
in h ib ito ry  e ffe c t  on T -ce ll  p ro l i fe ra t io n  as well as in h ib it io n  of
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IL-2 production.
The e f fe c t  of dexamethasone on the p ro l i fe ra t io n  of Ly-CM 
supplemented normal T -ce lls  was assayed in the following manner. 
Normal cultured T -ce l ls  at confluence were spun down at 2,000 rpm 
for 5 minutes and then resuspended to 5 x 10^ cells /m l in Ly-CM. A 
volume of 100 yl of th is  suspension was plated in each well of a 
Nunc 96 well p la te .  Dexamethasone was prepared and stored at 4°C in 
99% Analar ethanol at a concentration of 2 x lO-^M. A 100 yl 
aliquot of the solution was evaporated in a well of a 6-well 
microculture plate (Costar). After evaporation 10 ml of RPMI 20% 
+Me was added and the microculture plate was incubated a t 37°C for  
30 minutes. A fter incubation, th is  solution (2- x l 0 ” fiM) was 
d ilu ted  to give log concentrations ranging from 10~6M to 10“^ M  
dexamethasone. To serve as a positive control value in a l l  
experiments, 100 yl of 99% Analar ethanol without dexamethasone was 
evaporated and subsequently d ilu ted  in 10 ml of appropriate tissue  
culture medium (in th is  instance RPMI 20% +Me) and 100 yl was added 
to the ce lls  in the m ic ro t i tre  p la te .  The e ffe c t  of dexamathasone 
was assayed by adding 100 y l /d i lu t io n  to each of 6 m ic ro t i t re  wells  
containing 100 yl ce lls  in Ly-CM and measuring ^n-Tdr incorporat­
ion following the protocol for a standard blastogenesis assay.
The 4 IL-2 independent T -ce ll lines FL74, F422, T3 and T17 
were also assayed to determine the e f fe c t  of the same range of  
concentrations of dexamethasone (10“ M^ -  10“^ M ) on c e l lu la r
p ro l i fe ra t io n .  Each cell l in e  was spun down at 2,000 rpm fo r  5 
minutes then resuspended to 5 x 105 cells /m l in appropriate tissue  
culture medium. A volume of 100 yl of ce lls  were plated per micro­
t i t r e  well and to th is  100 yl of e ith e r  control medium (previously  
described) or 100 yl of dexamethasone was added to each of 6 wells  
and the ^H-Tdr incorporation measured by standard blastogenesis  
assay technique.
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The e f fe c t  of adding an exogenous souce of IL-2  to dexamethasone
suppressed ce lls
I t  has been shown (Smith, 1982) that the addition of an 
exogenous source of IL-2  to dexamethasone inh ib ited  MLA-144 gibbon 
ape T -ce lls  (Rabin et a l . ,  1981) ameliorates the g lucocortico id-  
mediated suppression of p ro l i fe ra t io n .  I f  the fe l in e  T -ce ll  l ines  
which were suppressed by the addition of dexamethasone were 
suppressed by the in h ib it io n  of production of an endogenous growth 
factor then the supplementation of the ce lls  with an exogenous 
source of IL -2  ( fe l in e  Ly-CM or pp human IL -2 ) should . rescue them. 
To determine i f  th is  was the case with the T3, T17 and F422
neoplastic T -ce lls  10"^M dexamethasone was added to 5 x 105 
cells/m l supplemented with a f in a l  concentration of 1:2 to 1:32 
crude fe l in e  Ly-CM or pp human IL -2 .  The ce lls  were spun down at 
2,000 rpm for 5 minutes and resuspended to 5 x 10^/ml in 10"^M 
dexamethasone resuspended in appropriate tissue cu lture  medium. 
A volume of 100 yl of th is  ce ll suspension was added to each well 
of a 96-well m ic ro t i tre  p la te . One hundred yl of each Ly-CM or pp 
IL-2 d i lu t io n  was added to each of six m ic ro t itre  w e lls .  ^H-Tdr 
incorporation was determined using the protocol for a standard 
blastogenesis assay.
RESULTS
The adsorption of IL -2  by neoplastic T -ce lls
The adsorption of growth factor by the fresh ly  isolated  
neoplastic T -ce lls  from conditioned medium is shown in Table 3. 
Normal activated T -ce ll  adsorption is shown as a co n tro l.  The 
adsorption figures are very d i f f i c u l t  to in te rp re t  since the 
percentage standard error is so high due to the samples only being 
run in dup licate . There is some indication that T3 may be
adsorbing factor but the rest of the ce lls  do not appear to be 
adsorbing factor to any great extent. This w il l  be discussed in 
the la s t  section of th is  chapter.
The spontaneous production of a growth factor by neoplastic T -ce ll  
lines
The results of the assays of the culture supernatants of the 
T3, F422 and FL74 ce ll l ines are shown in Table 4. Since a l l  three  
cell lines are capable of growth in v i t ro  without an exogenous 
source of IL -2  the cu lture  supernatants of the l ines  were assayed 
to determine i f  these ce l ls  were producing th e ir  own growth fac tor  
and releasing i t  into the culture f lu id .  C learly none of these 
cell lines are releasing growth factor in detectable amounts free  
in the supernatant. However, the following experiments were 
undertaken to determine i f  IL -2  was involved in the p ro l i fe ra t io n  
of these c e l ls .
The response of neoplastic T -ce ll  l ines to crude fe l in e  Ly-CM and 
pp human IL-2
Figures 17 and 18 are graphs representing the response of the  
neoplastic T -ce ll  l ines T3, F422 and T17 to both crude fe l in e  Ly-CM 
and pp human IL -2 respective ly . The ce ll l in e  FL74 was only tested  
using crude fe l in e  Ly-CM since th is  ce ll l in e ,  although growth 
factor independent, does not have a myc recombinant virus  
associated with i t  and has consequently been studied less intensely  
than T3, T17 and F422.
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Figure 17 shows that s ig n if ican t enhancement of growth occurs 
with a l l  4 ce ll  lines when they are supplemented with exogenous 
IL -2  at a 1 /8  d i lu t io n .  Student's t - te s ts  gave p values as 
follows: p > 0.001 for T3, p >  0.01 fo r T17, p >  0.02 for FL74 and 
p ^  0.01 for F422. The in h ib it io n  detected at the 1/2 d i lu t io n  is  
most probably due to residual ConA in the crude medium.
Figure 18 shows the response of the ce ll l ines  T3, F422 and 
T17 to pp human IL -2 .  This preparation (provided by Dr. R. Gallo) 
has been extensively p urif ied  and is reputedly free of
contaminating mitogen and other growth factors apart from IL -2 .  
The graph, however, shows both in h ib it io n  and enhancement of the T3
and T17 ce l l  l ines when supplemented with th is  source of IL -2 .  The
F422 ce ll l in e ,  however, is markedly inh ib ited  by th is  preparation  
and shows no enhancement of growth at a l l .  Student's t - t e s ts  
performed on the data at a 1/32 d i lu t io n  of pp IL -2  showed th a t  T3 
and T17 responded s ig n if ic a n t ly  to th is  level of fac to r  (p y  0.D01 
for both ce ll  l in e s )  and that F422 was s t i l l  s ig n i f ic a n t ly
inh ib ited  (p 0 .0 1 ) .  One possible reason for the in h ib it io n  of 
a l l  3 ce ll  l ines could be competition between a putative endogenous 
fac tor and the exogenous factor for ce ll  receptors. This was 
investigated in the following experiment.
The response of T3 ce l ls  in l im it in g  serum conditions to pp human 
IL-2
Figure 19 shows the response of the T3 ce ll  l in e  to pp human 
IL -2  under l im it in g  conditions for growth (0.25% BSA serum le v e l ) .  
Assuming tha t th is  renders the ce lls  incapable of producing a 
putative endogenous factor they now demonstrate s ig n if ic a n t  
response to the exogenous IL -2  (p 0.001 at 1/4 and 1/16 d i lu t io n  
p o in ts ).  At high pp IL -2  concentrations (1 /2 )  there was in h ib it io n  
below the negative control value which is commonly observed when pp 
IL -2  is plated onto both normal and neoplastic fe l in e  T -c e l ls  (see 
also Figures 18, 22 of th is  chapter and Figure 15 o f Chapter 
Three).
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Dexamethasone in h ib it io n  of neoplastic T -ce ll l ines
Figure 20 shows that the IL -2  independent T -ce ll  l ines  T3, T17 
and F422 are markedly inh ib ited  by 10“®M dexamethasone, whereas the 
IL-2 independent FL74 ce l l  l in e  p ro l i fe ra t io n  is only inh ib ited  by 
approximately 40% of the positive control value (growth in 10% 
L/M). Smith (1982) showed that for the gibbon ape T -ce ll  l in e
MLA-144 3H-Tdr incorporation was suppressed by only 20 -25% with 
10-7 m dexamethasone. This was subsequently determined to be due 
to the MLA-144 ce ll population being heterogeneous with respect to  
glucocorticoid s e n s it iv i ty  and TCGF production. The im plication of 
the results of the dexamethasone in h ib it io n  of the fe l in e
neoplastic T -ce ll l ines shown in Figure 20 w i l l  be discussed in
re la tio n  to these observations.
The e f fe c t  of adding an exogenous source of IL-2 to dexamethasone 
suppressed ce l ls
Figure 21 shows the response of dexamethasone inh ib ited  T3, 
F422 and T17 ce l ls  to IL -2  present in crude fe l in e  Ly-CM. A
positive control value was obtained by p lating c e l ls  without 
dexamethasone into conventional tissue culture medium and a 
negative control value was obtained by p lating c e l ls  into
conventional tissue culture medium plus 1 0 “7 M dexamethasone
without an exogenous source of IL -2 .  Recovery of the c e l ls  is  
expressed as a percentage of the positive control value. T3 and 
F422 show a maximum recovery of only 6.8% and 8.2% respective ly  but 
T17 is rescued to  43% of the positive control value with a 1/4  
d ilu t io n  of Ly-CM. The recovery at th is  level is greater than tha t  
with a concentration of 1/2 Ly-CM probably due to in h ib it io n  of the 
c e lls  by residual mitogen in the crude conditioned medium. 
Student's t - te s ts  were performed to demonstrate that the observed 
rescue was s t a t is t i c a l ly  s ig n if ic a n t .  For a l l  3 c e l l  l ines  
response at both 1/2 and 1 /4  d i lu t ions  of crude factor was shown to
be s ig n if ic a n t  (p 0.001) and the same p value was obtained fo r
the rescue of these inh ib ited  c e l ls  with pp IL -2 , shown in Figure 
22 (p 0.001 at 1/2 and 1 /4  d i lu t io n  po in ts ).  Positive and
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negative control values were obtained in an identical manner to 
that described for the rescue of inh ib ited  ce lls  by crude fe l in e
Ly-CM and the recovery was again represented as a percentage of the
positive con tro l.  T3 and F422 inh ib ited  ce l ls  recover to 11.6% and 
4 .2% of the positive control value respectively and is s im ila r  to 
the levels  of recovery detected with crude fe l in e  Ly-CM. The T17 
rescue by pp IL-2 however, is reminiscent of the response of 
uninhibited T17 ce l ls  to pp IL -2  (see Fig. 18) i . e .  there appears 
to be both in h ib ito ry  and enhancing e ffe c ts  operating 
concomitantly. Maximum rescue occurs with a 1/16 d i lu t io n  of pp 
IL -2  and is 27% of the positive con tro l.  Differences in recovery 
obtained with the two sources of IL -2  are most probably due to a 
combination of factors including d i f fe re n t  levels  of IL -2  a c t iv i t y  
in the two fac tors , residual mitogen in the crude Ly-CM and the 
problem of cross-species re a c t iv i ty  with the human pp IL -2 .
The negative control values were depressed to the same extent
in .F ig s .  20, 21 and 22 as follows:
Fig. 20 Fig. 21 F ig . 22
T3 95% 98% 98%
T17 85% 88% 88%
F422 98% 98% 99%
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DISCUSSION
The preceding experiments were designed in order to determine 
whether or not neoplastic T -ce l ls  had an altered requirement fo r ,  
or response to ,  IL -2 .
Figure 23 depicts two possible relationships tha t  may ex is t  
between IL -2  and growth of T -cell tumours. In th is  series of 
thymic lymphosarcoma T -ce ll  cultures there are two d is t in c t  ce ll  
types with respect to requirement for an exogenous source of IL-2  
fo r p r o l i f e r a t io n . In the case of the IL-2  dependent cultured  
T-cell l in e s ,  exemplified by T i l ,  c lea r ly  an exogenous source of  
IL -2  is  essential for continued p ro l i fe ra t io n  of these c e l ls  in 
cu ltu re . In those cell l ines that are independent of exogenous 
IL-2 fo r  growth (exemplified by T3), two principal p o s s ib i l i t ie s  
exis t to explain IL -2  involvement in the p ro l i fe ra t io n  of these 
c e l ls .  Either IL -2  plays no role in the growth of these ce l ls  
in v i t ro  i . e .  the c e l ls  have escaped the requirement for th is  
fa c to r ,  or the ce lls  may be producing and responding to IL -2  or an 
IL -2 - l ik e  endogenous growth fa c to r .  The cell l ines  T3 and T17 are 
dependent on the presence of 2-Me (an IL-1 l ik e  s ignal) in the 
culture medium for growth suggesting that th is  may serve as a 
mitogenic signal to these ce lls  to produce IL -2 ,  s im ila r  to the 
induction of IL -2  production by normal helper T -c e l ls .  The IL -2  
independent T -ce ll  l ines  FL74 and F422 however do not require 2-Me 
for growth suggesting that e i th e r  these ce l ls  do not produce th e i r  
own factor o r . th a t  they have los t  the requirement fo r  th is  s ig n a l.
The f i r s t  set of experiments performed on th is  series of 
thymic lymphosarcomas was carried out to determine i f  these 
neoplastic T -ce lls  were displaying receptors fo r IL -2  and were 
ac t ive ly  adsorbing i t  from lymphocyte conditioned medium. There 
were, however, several problems associated with the design of th is  
experiment since the m ajority  of these tumours did not estab lish  in 
long-term culture and i t  was impossible to determine in advance 
which ones would. I t  was therefore necessary, in order to 
standardise the assay, to use ce l ls  which were fresh ly  iso lated
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from tumour material and these ce lls  may not have been ac t iv e ly  
divid ing as w il l  be discussed la t e r .  The in te rp re ta t io n  of the 
results was also rendered d i f f i c u l t  because of the exceedingly high 
standard error of the re s u lts .  The standard errors were 
unacceptably high due to the necessity to compare only two sets of 
duplicate points (adsorption medium/control medium). In re t ro ­
spect, at least four more duplicates for each te s t  set should have 
been run to bring the standard error down to an acceptable level 
for analysis of the data. I t  would, however, appear from the 
results that there is some indication of adsorption o f IL -2  from 
Ly-CM by the T3 c e l ls .  T3 established in cu lture  as an IL -2  
independent T -cell l in e  a f te r  one week, during which time the c e l ls  
were dependent on IL -2  fo r  growth. Therefore the low level of 
adsorption of IL -2  may have been due to only a subset of the T3 
ce lls  being responsive to IL -2  or a l te rn a t iv e ly  tha t IL -2  receptors 
on the ce ll surface were already blocked. I f  the l a t t e r  were 
indeed the case then th is  would imply tha t  these ce l ls  are 
producing th e i r  own endogenous factor which can bind to surface 
IL-2 receptors and block them. This p o s s ib i l i ty  was investigated  
extensively in subsequent experiments. Of the other ce ll  l ines  
tested T il  established in culture as an IL -2  dependent ce ll l in e  
but these ce l ls  showed no IL -2  adsorption in th is  te s t  and none of 
the other tumours tested adsorbed IL -2  to the extent tha t  was 
expected. There are two principal explanations for th is :  f i r s t l y ,
the necessity to use freshly isolated tumour ce lls  meant th a t  any 
IL -2  receptors on the ce lls  may have already been blocked in vivo 
rendering them incapable of adsorbing detectable quantit ies  of IL -2  
from the conditioned medium in th is  t e s t .  Secondly, since these 
ce lls  had been isolated from the tumours immediately before use, 
they may i n i t i a l l y  have gone through a lag period, during which 
time IL -2  receptors may not be expressed, before recommencing ce ll  
d iv is io n . Consequently, the lack of detectable adsorption in th is  
assay may not be ind ica tive  of e ith e r  a lack of receptors fo r  IL -2  
or a lack of response to i t .
The p o s s ib i l i ty  that the IL -2  independent ce ll  l ines  may be 
producing an endogenous growth factor was investigated fu rth e r  by
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analysing the culture supernatants of the T3, F422 and FL74 c e l ls  
for IL -2 .  The results  o f IL -2  production over a 3-day te s t  period 
demonstrate tha t none of these ce lls  are spontaneously producing 
detectable IL -2  free in the culture medium. Mier and Gallo (1981) 
have demonstrated acid-g lycine buffer e lu tion  of IL-2  from the
surface of a human IL -2  independent neoplastic T -ce ll  l in e  
suggesting tha t  a s ig n if ic a n t  portion of IL-2  synthesised by the 
ce ll  is immobilized on the plasma membrane. Unfortunately, the 
acid e lu tion  protocol was unsuccessful in my hands. Furthermore, 
the neoplastic T -ce ll l in e  described by Mier and Gallo also 
ac t iv e ly  adsorbed IL -2  from conditioned medium in a manner s im ila r  
to normal activated T -c e l ls ,  which was not the case with T3.
Mier and Gallo (1981) have also reported that th is  p a r t ic u la r  
l in e ,  although independent of an exogenous source of IL-2 for
growth, can respond to added IL -2  by increased p ro l i fe ra t io n  in 
c u ltu re .  The FL74, F422, T3 and T17 IL-2  independent fe l in e  T -ce ll  
l ines were s im ila r ly  tested for IL -2  response by adding two 
d if fe re n t  sources of exogenous IL -2 ;  crude fe l in e  Ly-CM and pp
human IL -2 .  Figures 17 and 18 show the response of the ce ll  l ines  
to both factors with n u t r i t io n a l ly  optimum medium. All four ce ll  
l ines show a s lig h t increase in p ro l i fe ra t io n  over the positive  
control value when supplied with crude fe l in e  Ly-CM suggesting that  
they are capable of responding to some extent to exogenous IL -2 .  
The l im ited  magnitude of response could be explained i f  these ce l ls  
are indeed producing th e ir  own growth factor which is blocking the 
IL-2 receptor s ites  e i th e r  at the external or in ternal domain. In 
support of th is  theory, the T3, F422 and T17 ce ll  s.show in h ib it io n  
of positive control levels  of growth when supplemented with high 
concentrations of pp human IL -2 .  Since th is  source o f IL -2  is  
reputedly free of mitogen and other contaminating growth fac to rs ,  
i t  may be that th is  preparation is competing with the c e l ls  own
putative growth factor for ava ilab le  receptors. Since, however, 
Mier and Gallo found that the ce lls  responded maximally to an 
exogenous source of IL-2 when they were plated under n u t r i t io n a l ly  
sub-optimum conditions, the response of T3 ce lls  to pp human IL -2  
was determined under these conditions (Figure 19 ) .  Although the
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response obtained was 2-3 times that of the negative control value, 
i t  was only, at most, 10-12% of the positive con tro l.  Idea lly  
various concentrations of serum plus pp IL -2  would require to be 
assayed but the quantity of pp human IL -2  ava ilab le  to us at that  
time was l im i t in g .  I t  was concluded that these IL-2 independent 
T-cell l ines were capable of responding to an exogenous source of 
IL -2  but that further investigation  was required to determine i f  
the c e l ls  were producing an endogenous factor which could be 
blocking IL -2  receptors.
G ill  is  et a l . (1979a; 1979b) have shown in the murine system 
that the g lucocorticoid , dexamethasone, s p e c if ic a l ly  in h ib its  the 
production but not the u t i l is a t io n  of IL-2 by mature T -c e l ls .  
Figure 20 demonstrates that dexamethasone s im ila r ly  inh ib ited  the 
T3, T17 and F422 c e l l  l ines  by 90%. The FL74 c e l l  l in e  was 
inh ib ited  only by 40% maximum and th is  was possibly due to  
heterogeneity of the ce lls  with respect to glucocorticoid  
s e n s it iv i ty  previously reported by Smith (1982). These results  
strongly support the hypothesis that these iL-2 independent T -ce ll  
l ines are producing and responding to an endogenous growth fac tor  
and tha t  the in h ib it io n  of production of th is  factor terminates  
cell growth. Since T3, T17 and F422 were inh ib ited  to a greater  
extent by dexamethasone i t  is possible that these cell populations 
are f a i r l y  homogeneous with respect to glucocorticoid s e n s i t iv i t y .
These three cell l ines were further investigated to determine 
i f  the dexamethasone suppressive e f fe c t  could be ameliorated by the 
addition of an exogenous source o f IL -2  proving the s p e c if ic i ty  of 
the in h ib it io n .  The results of these experiments were inconclusive  
but as is shown in Figures 21 and 22 both crude fe l in e  Ly-CM and pp 
human IL -2  are capable of at least p a r t ia l ly  rescuing these c e l ls  
from dexamethasone in h ib i t io n .  Of p a rt ic u la r  note is the fac t  th a t  
T17 is  rescued fa r  be tte r  by crude fe l in e  Ly-CM than are T3 and 
F422, furthermore, high concentrations of pp human IL -2  are once 
again in h ib ito ry  to these ce lls  to the extent tha t maximum rescue 
occurs at a d ilu t io n  of 1/16 pp IL -2 .  The explanation fo r the  
incomplete rescue of these ce ll l ines is possibly d i f fe re n t  fo r  the
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two d i f fe re n t  sources of IL -2 .  F i r s t ly ,  the low level of rescue 
effected using crude fe l in e  Ly-CM may be a function of the low
level of a c t iv i t y  of IL-2 in th is  medium compared to that normally 
produced endogenously by the c e l ls .  I f  th is  were so then only a 
small proportion of the c e l lu la r  IL -2  receptors would be stimulated 
and the response would be minimal l ik e  that of T3 and F422. The 
discordance in the response of T17 could hypothetica lly  be 
explained by a lesser requirement for IL -2  by these c e l ls  for 
growth and they may consequently be expected to produce less 
endogenous factor than T3 or F422. Clearly actual c e l lu la r  levels  
of IL-2 w i l l  have to be determined to te s t  th is  hypothesis.
Secondly, although pp human IL -2  is highly active  i t  may have 
reduced a c t iv i t y  on fe l in e  ce lls  and may even be competitive at 
high concentrations as in h ib it io n  is detected at these le v e ls .  The 
comparison of the e f fe c t  of crude fe l in e  Ly-CM and. pp human IL -2  on 
normal fe l in e  T -ce lls  and on the IL -2  dependent T il neoplastic  
T-ce ll l in e  (F ig . 12, Chapter Three) suggests tha t although pp 
human IL -2  is highly active  (800 x concentrated) i t  has no greater  
a c t iv i t y  on fe l in e  ce lls  than does crude fe l in e  Ly-CM which is  
unconcentrated. Furthermore, there was in h ib it io n  at high 
concentration (1 :2  pp IL -2 ) of factor detectable in Fig. 22 which 
th e o re t ic a l ly  cannot be due to contaminating mitogen.
In conclusion, preliminary evidence from these results  
suggest- that the IL -2  independent ce ll l ines  T3, T17 and
F422 (and possibly FL74) may be capable of growth in v i t r o  in the
absence of an exogenous source of IL -2  by v ir tu e  of th e i r  capacity  
to produce and respond to an endogenous fa c to r .  The only 
d e f in i t iv e  way ( in  the absence of suitable  anti sera) o f determining 
IL -2  levels  in these ce ll  l ines  w il l  be to examine c e l lu la r  mRNA 
fo r IL -2  gene expression.. A human IL -2  probe has now been made 
ava ilab le  (courtesy of Hr. R. Gallo) which w il l  be tested to 
determine whether or not i t  w il l  detect fe l in e  IL -2  sequences and 
to determine i f  the IL -2  gene is rearranged in the tumours, perhaps 
as a secondary step in the transformation of these c e l ls .
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TABLE 2.
Adsorption te s t  protocol
Tube No. Cell 1 Hr. in 1 ml medium After 1 hr +
concentration 1 ml medium
1 107 Ly-CM 0.25% Isc .
la 10? Ly-CM 0.25% Isc.
2 •107 0.25% Isc . Ly-CM
2a 10? 0.25% Isc. Ly-CM
3 0 Ly-CM 0.25% Isc .
3a 0 Ly-CM 0.25% Isc .
4 0 0.25% Isc . Ly-CM
4a 0 0.25% Isc. Ly-CM
The tab le  shows the protocol used to detect the adsorption of IL -2  
from Ly-CM with control tubes to detect production of an endogenous 
factor and negative controls of media alone. All tubes were 
incubated at 37°C fo r  1 hour.
TABLE 3
The adsorption of IL -2  by neoplasticT_cei i s
Test Set x n % S.E. % Adsorption % S.E,
T 3A 107 c e l ls  Ly-CM 1072
B II It II
C No 1784
D it ii ii
T 4A 107 " 568
B II 1 II
C No 670
0 ii ii it
T 5A 1 o7 " 2531
B II II II
C No 3324
0 II II II
T 7A 107 " 6384
B II II It
C No 7802
D II II II
T 8A 107 “ 7604
B II II II
C No 9815
D II II II
T1 OA 107 " 11181
B II II II
C No 15689
D ii ii a
T il A 1 o7 " 16667
B II II II
C No 17193
0 it n ii \ l68 95  6
40.0
15.3
24.0
18.2
22.6
28.8
3.1
13.9
5.5
1 2 . 8
2.3
8.5
18.0
5.2
TABLE 3 (Cont'd).
Test Set X n % S.E. % Adsorption % S.E
T1 5A 1 07 1 1 23064 ( 23685 6 5.0
B " II 1 \ 22443 6 3.5 19.0 6.5
C No II II 28386 f27290 5 7.6
D II II {29482 6 6.1
N:TA1 10? ce lls  Ly-CM /3887 4 1 .7
B1 " II It 3962 41 01 4 3.3
A2 " II it 3808 4 3.6 30.0 3.0
B2 " II II ^4054 4 4.0
Cl No II II f  5650 4 1.9
m  " II II 5621 5816 4 6.2
C2 " II II 5561 4 2.2
02 " II II ^5459 4 3.3
T3-T1 5 are tumour cell l in e s .
N:T are normal cultured fe l in e  T -c e l ls .
TABLE 4
The spontaneous production o f a growth 
factor by neoplastic T -ce ll l ines
Sample set x (cpm) n S.E,
FL74 +ve Control 19841 6 350.0
-ve Control 67 6 5.7-
24 h r .  supernatant 113 6 13.0
48 hr. supernatant 101 6 13.4
72 hr. supernatant 102 6 14.3
F422 +ve Cotrol 19841 6 350.0
-ve Control 67 6 13.0
24 hr. supernatant 84 6 5.7
48 hr. supernatant 63 5 3.1
72 hr. supernatant 111 5 35.3
T3 +ve Control 741 3 5 541 .6
-ve Control 90 6 4.9
24 hr. supernatant 112 6 15.5
48 hr. supernatant 186 6 42.8
72 hr. supernatant 101 6 14.3
The +ve control value was obtained by p lating  the normal cultured  
T-ce lls  in RPMI 20% + Me with an equal volume of Ly-CM and the -ve 
control value was obtained by p lating the ce l ls  in RPMI 20% + Me 
alone.
FIGURE 16.
PROPOSED MECHANISM OF MITOGENESIS IN NORMAL CELLS
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Figure 16 depicts the mechanism of mitogenesis th a t  is thought to 
induce cell d iv is io n . One or more mitogenic signals may 
stimulate a cell membrane receptor to relay a series of 
in t r a -c e l lu la r  messages to the nucleus to in s tru c t  the  
ce ll  to d iv ide .
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FIGURE 17
The response of neoplastic T -cell l ines  to crude fe l in e  Ly-CM
Students t - te s ts  performed on the data at the 1/8 d i lu t io n  
point revealed s ig n if ican t  differences over positive control values 
for a l l  the cell l in e s .  (F422, p >  0.01; T17, p >  0.01; T3, p >  
0.001 and FL74, p > 0 .0 2 ) .  Each point on the graph represents the 
mean of 6 rep licates (% SE <  5%).
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FIGURE 18
The response o f neoplastic T -ce ll  lines to pp IL -2
Students t - te s ts  performed on the data at the 1/32 d i lu t io n  
point revealed s ig n if ican t  differences over pos itive  control 
values. The T3 and T17 ce l l  lines show enhancement and the F422 
cell l in e  shows in h ib it io n  (T3, p > 0.001; T17, p 0 . 0 0 1 ; F422 p^  
0 .0 1 ) .  Each point on the graph represents the mean of 6 rep lica tes  
(% SE <  a * ) .
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FIGURE 19
The response of T3 ce l ls  in l im it in g  serum conditions to pp IL-2
Students t - te s ts  performed on the data at the 1 /4  and 1/16 d i lu t io n  
points revealed s ig n if ic a n t  enhancement over negative control 
values (p 0 .001 ) .  Each point on the graph represents the mean of 
6 rep lica tes  (% SE 5.8%).
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FIGURE 20
Dexamethasone in h ib it io n  of neoplastic T -ce ll  l ines
This f igure shows the in h ib ito ry  e f fe c t  of the g lucocorticoid  
dexamethasone on 4 neoplastic T -ce ll  l ines and on normal cultured  
T -c e l ls .  Each point on the graph represents the mean o f 6 
rep lica tes  (% SE O o % ) .
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FIGURE 21
The p art ia l  rescue o f dexamethasone suppressed c e l ls  with Ly-CM
Students t - te s ts  performed on the data at the I / 2  and 1 /4  d i lu t io n  
points revealed s ig n if ic a n t  differences over negative control 
values for a l l  3 ce l l  l ines (p >  0 .0 0 1 ) .  Each point on the graph 
represents the mean of 6 re p l ic a te s .  (For T3, % S.E 4- 5.9%, T17, % 
S .E .C  6.6%; F422, % S . E . <  12.8%).
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FIGURE 22
The p art ia l  rescue of dexamethasone suppressed ce l ls  with pp IL -2
Students t - te s ts  performed on the data at the 1 /2  and 1 /4  d i lu t io n  
points revealed s ig n if ic a n t  d ifferences over negative control 
values for a l l  3 ce ll  l ines  (p >  0 .001 ) .  Each point on the graph 
represents the mean of 6 re p l ic a te s .  (For T3, % S.E 4  5.8%; T17, % 
S .E .4  9.7%; F422, % S.E. 4  9.5%).
FIGURE 23
The re la t io n  of growth fac tor to tumour ce ll growth
Figure 23 depicts two possible re lationships tha t  may exist  
between IL -2  and growth of T -ce ll  tumours. In th is  tumour series, 
two types of cell were cultured with respect to requirement for an 
exogenous source of IL -2  fo r  p r o l i fe r a t io n .  The f i r s t  ce ll  type 
is absolutely dependent on exogenous IL -2  for growth and is 
exemplified by T i l .  The other cell type which grows independently 
of an exogenous source of IL -2  and is exemplified by T3, may 
e ith e r  have los t  the requirement for th is  signal for cell  
p ro l ife ra t io n  or may be producing and responding to an endogenous 
fa c to r .
FIGURE 23.
The re la t io n  of growth fa c to r  to tumour cell-  growth
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CHAPTER FIVE
THE NATURE OF THE VIRUSES ASSOCIATED 
WITH FELINE T-CELL LYMPHOSARCOMAS
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INTRODUCTION
Oncogenic retroviruses are generally c lass if ied  as weakly or 
strongly transforming and several models (deta iled  in the General 
Introduction) have been proposed to explain the pathogenesis of 
each type. In b r ie f ,  strongly transforming viruses usually contain 
a specific  oncogene and are consequently defec tive , requiring a 
non-defective helper virus for re p l ic a t io n .  I t  is thought tha t the 
altered or inappropriate expression of the v ira l oncogene (v -onc) 
may be how the strongly transforming retroviruses exert th e ir  
oncogenic e f fe c t .  Models to explain the oncogenic potential of 
weakly transforming retroviruses include insertional mutagenesis 
which is implicated in the pathogenesis of avian B-cell tumours 
induced by ALV. In th is  process the virus is found integrated  
adjacent to the oncogene c-myc and enhances i t s  level of
transcrip tion  many fold over the normal expression rate (Neel et
a l . ,  1981). This model was investigated in the pathogenesis of the 
thymic lymphosarcomas associated with FeLV presented here. 
Surpris ingly , although in tegration  of FeLV close to the c-myc locus 
did occur in a proportion of the cats, causing a rearrangement of 
the c-myc gene, fa r  more frequently a novel fe l in e  leukaemia virus  
was isolated which had acquired a v-myc oncogene (Neil et a l . ,
1984).
In the following chapter these recombinant viruses were 
studied in three respects; ( i )  the v ira l  genomic RNA was analysed 
for myc sequences ( i i )  in v i t r o  experiments were carried out to 
determine i f  these recombinant viruses were in fectious for FEA
ce lls  and ( i i i )  the subgroup of the viruses both c irc u la t in g  in the 
plasma of these cats and released from the cultured tumour c e l ls  
was determined to establish whether or not a specific  subgroup of 
FeLV was associated with thymic lymphosarcoma of the c a t .
There are three subgroups of FeLV defined by in te rfe rence  
testing  which are designated A, B or C (Sarma and Log, 1973). The 
basis of the in terference te s t  is  that ce l ls  infected with a virus  
of one subgroup are res is tan t to superinfection with a virus of the
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same subgroup but can be super-infected with a virus of a d i f fe re n t  
subgroup. Although the viruses being tested are leukaemia viruses 
and are non-cytopathic to the FEA c e l ls ,  for challenge i t  is  
convenient, for detection, to use a sarcoma virus that is a 
pseudotype with a transforming genome and the envelope of a
leukaemia virus of a specif ic  subgroup. These pseudotype viruses 
produce a morphological a l te ra t io n  of the FEA c e lls  ind icating  that  
in fection  has occurred.
Two principal approaches have been used to establish  a 
corre la tion  between FeLV subgroup and disease. One has been to 
determine the subgroup of FeLV associated with spec if ic  types of 
disease in individual animals and the other has been to 
experimentally in fe c t  cats with viruses of known subgroup and
observe the outcome of in fe c t io n .
The subgroups FeLV-B and FeLV-C have never been iso lated  in 
natural conditions alone but always occur in the cat together with 
FeLV-A (Sarma and Log, 1971 , 1973; J a r re t t  et a l . ,  1 978). FeLV-A 
grows well in cats, 1 0 0 % of k ittens inoculated at b ir th  becoming 
p ers is ten tly  viraemic (Hoover et a l . ,  1 976; J a rre t t  et a l . ,  1984). 
However there is an age-related decline in the permissiveness for  
FeLV-A in fection  which is correlated with a decline in the a b i l i t y  
of macrophages to support FeLV rep lica tion  (Hoover et a l . ,  1981). 
FeLV subgroups B and C are also capable of producing a pers istent  
viraemia to a lesser or greater extent ( 2 0 % and 1 0 0 % respective ly )  
when inoculated into newborn k ittens  but resistance to in fec tio n  by 
these viruses develops almost immediately a f te r  b i r th .  In
experimental in vivo studies by J a r re t t  and Russell (1978) on the 
d i f fe r e n t ia l  growth and transmission of FeLV subgroups A and B,. i t  
was determined that virus was quickly recovered from the blood and 
oropharynx of most animals infected with subgroup A alone, whereas 
only 20% of cats infected with subgroup B alone developed a 
viraemia, and that a f te r  a long tim e. In cats in fected with a 
mixture of the two subgroups (FeLV-AB), the results  showed th a t
FeLV-A was recovered from the plasma f i r s t  in a high percentage of 
cats and FeLV-B appeared la te r  in a much lower percentage of cats .
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In th is  respect, there fo re , the viruses appeared to operate 
independently but evidence of in teraction  was also apparent in that  
the percentage of cats which were viraemic with FeLV-B was greater  
following FeLV-AB in fec tion  than a f te r in fe c t io n  with FeLV-B alone. 
In add it ion , FeLV-B was transmitted by contact from cats infected  
with, and excreting , FeLV-AB but not from cats infected with and 
excreting FeLV-B alone.
In s im ila r  studies on the in teraction  of FeLV subgroups A and 
C, results  show that cats over 8 weeks of age, which are normally 
not susceptible to FeLV-C, can become infected when subgroup C is  
introduced into the cat in a mixture with FeLV-A (FeLV-AC) (J a r re t t  
et a l . ,  1984). Again FeLV-A is detected in the plasma long before 
FeLV-C. Assuming tha t the hypothesis that many more c e l ls  in the  
cat are susceptible to subgroup A in fection  than are susceptible to 
subgroups B and C in fection  is correc t, then the observed 
enhancement in the growth of FeLV-B and FeLV-C by FeLV-A is  
probably atta ined by the generation of phenotypic mixtures when 
both viruses grow in the same c e l l .  This would give r ise  to 
viruses with subgroup B and C genomes and mosaic envelopes 
predominantly subgroup A, enabling the spread of subgroup B and C 
viruses into  ce l ls  normally permissive for in fection  by subgroup A 
only.
In nature FeLV-C is the only one of the three subgroups of 
FeLV associated with a specific  disease, although epidemiological 
observations suggest tha t an additional subgroup other than A, 
usually B, is more often associated with cats with lymphosarcoma 
than with th e i r  healthy viraemic counterparts ( J a r r e t t ,  1980). 
FeLV-C causes erythroid hypoplasia, a condition in cats which, is  
analagous to pure red ce ll  aplasia in humans (Hoover et a l . ,  1974; 
Mackey et_ al_., 1975). There are four individual iso lates of FeLV-C 
which were a l l  isolated from natura lly  occurring cases of severe 
anaemia and experimentally produce erythroid hypoplasia on 
inoculation into newborn k ittens  (Mackey et a l . ,  1975; Onions et 
a l . ,  1982). In add it ion , in the experiments of J a r re t t  et a l . 
(1984) on the in te rac tion  of subgroups A and C, i t  was found that
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the appearance of subgroup C in the plasma of the 8 week old 
kittens inoculated with FeLV-AC strongly correlated with the 
development of erythroid hypoplasia in a l l  these k i t te n s .  The 
generation of erythroid hypoplasia c le a r ly  demonstrates the 
s p e c if ic i ty  of th is  virus (FeLV-C) for the erythroid precursor 
c e l l ,  the BFU-E (Boyce et a l . ,  1981; Onions et a l . ,  1988). -
Evidence for the association of an additional subgroup of 
virus other than A with neoplastic disorders is  la rg e ly  based on 
epidemiological investigations . Mentioned e a r l i e r ,  was the 
observation by J a rre t t  (1980) tha t in closed MCHs there was a 
higher proportion of FeLV-AB in cats with lymphosarcoma than in the 
normal healthy viraemic cats. This may e ith e r  ind icate  th a t  FeLV-B 
has some, as yet undefined, role to play in the generation of 
lymphosarcoma or i t  may simply re f le c t  that the household has been 
endemic with FeLV for a long time, resu lting  in a greater 
opportunity for the development of lymphosarcoma which has a long 
la te n t  period in cats under natural conditions (J a r r e t t ,  1980). 
Further evidence suggesting that the association of subgroup B with 
lymphosarcoma is specific  comes from the results of the outcome of 
in fection  of k ittens with FeLV-B alone in the experiments of 
Jarre tt  and Russell (1978). In these experiments FeLV-B infected  
cats were followed longterm and 85% (2 /8 )  developed lymphosarcoma 
a f te r  a long la te n t period (1 -2  years) (J a r r e t t ,  1980) suggesting 
that the B subgroup may indeed be involved in the development of 
neoplasia. Strongest support for th is  hypothesis has emerged 
recently from experiments by Onions et a l . (pers. comm.) 
demonstrating the rapid induction of myeloid leukaemia by a novel 
FeLV containing both subgroups A and B, termed FeLV-AB/GMl, which 
was o r ig in a l ly  isolated from the spleen and bone marrow of a f ie ld  
case of erythroleukaemia. The development of leukaemia by th is  
virus correlated with the appearance of the subgroup B virus in the 
plasma. Following in fection  with the v iru s , a l l  the cats became 
viraemic with the subgroup A virus and la te n t ly  infected with the 
subgroup B v iru s . In those cats which remained haematologically  
normal, th is  d is tr ib u tio n  of subgroups was maintained, whereas in 
those cats which underwent the t ra n s it io n  from normal haematology
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to leukaemia, there was a concomitant change from subgroup A 
viraemia with subgroup B latency to subgroup AB v iraem ia.
In the tumour series presented here the subgroup of the virus  
associated with the tumour ce lls  and c ircu la tin g  in the plasma was 
determined to establish whether or not there was any co rre la t ion  
between subgroup and disease in these cats. The ra p id i ty  of the 
onset of leukaemia induced by the FeLV-GMl virus was unusual as 
most fe l in e  leukaemia viruses have long la te n t  periods in vivo 
before neoplasia develops. This suggests that these viruses may 
carry an oncogene as FeLV appears to be p a r t ic u la r ly  adept at 
recombining with c e l lu la r  proto-oncogenes (Besmer et a l . ,  1983b) 
and recombinant viruses containing the myc oncogene have been 
iso lated from four of the tumours presented here (Neil e t  a l . ,  
1984). Viral RNA was isolated from tumours known to contain 
recombinant myc viruses and the infectious nature of these viruses 
in v i t ro  is  demonstrated and discussed in th is  chapter.
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MATERIALS AND METHODS
Interference tes t
The basis of in terference testing  is deta iled  in the 
Introduction. Fischinger and O'Conner (1969) demonstrated that  
fe l in e  ce lls  infected with FeLV were res is tan t to superinfection  
with a FeLV pseudotype of a murine sarcoma virus (MuSV) of the same 
subgroup. The interference tes t  used here is  a modification of 
th is  orig ina l tes t  developed by Russell and J a rre t t  (1976) and was 
carried out as follows.
FEA c e lls  were seeded at a density of 3 x 10  ^ cel 1s in 4 ml of 
10%DMEM in 5 cm plates (Nunc!on) and incubated a t 37°C fo r  24 
hours. The medium was then removed and e ith e r  1 ml of plasma 
dilu ted  1:10 with 10% DMEM or 1 ml of a 1:1 ra t io  of 10% DMEM plus 
tumour cell culture supernatant (0 .45 ym f i l t e r e d  and taken when 
the tumour ce lls  were ac t ive ly  d iv id ing ) was added, with 4yg/ml 
polybrene and incubated at 37°C for a fu rthe r  2 hours. At the end 
of th is  adsorption period the medium was removed and 10% DMEM 
added. The infected FEA c e lls  were then routine ly  subcultured (as 
described in Chapter One) for a minimum o f 3 weeks to ensure spread 
of the virus throughout the cu ltu re .
The subgroup of the in fecting  FeLV was then determined by 
in terference testing  in the following manner. 5 x 10^ infected  
FEA c e l ls  were plated in 0.5 ml 10% DMEM with 4 yg/ml polybrene in 
each of 8 wells of a 24-well Costar p la te .  The plates were 
incubated at 37°C overnight then duplicates of one of the following  
were added, e ith er  ( i )  10% DMEM, ( i i )  sarcoma virus (SV) pseudotype 
A(SV-A), ( i i i )  SV pseudotype B (SV-B) or ( iv )  SV pseudotype C 
(SV-C). The plates were further incubated at 37°C overnight then 
the medium was replaced with 1 x 10 5 uninfected FEA c e lls  per well 
in 1 ml 10% DMEM which improves the detection of foci three days 
l a t e r .  The presence of foci is in d ica t ive  of transformation and 
was detected when the challenging sarcoma virus was of a d i f fe re n t  
subgroup from the in fecting  leukaemia v irus . Hence, i f  the
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subgroup of the in fecting  FeLV was A, foci would be detected on 
infected monolayers of FEA ce lls  which had been challenged with 
SV-B and SV-C but not in the wells challenged with SV-A.
The analysis of v ira l  genomic RNA for myc. sequences
( i ) Iso la tion  of virus for analysis
Virus released from ce ll cultures of FL74, F422 and T3 was 
prepared for Northern b lo tt in g  (Maniatis, 1982) and molecular 
analysis with a fe l in e  myc probe designated pCT4 3' to  determine 
i f  the tumour c e l ls  F422 and T3, which had previously been shown 
to contain recombinant FeLV/myc proviruses, (Neil et a l . ,  1984) 
were releasing these viruses in cu ltu re . Growing c e l ls  were 
spun down and resuspended in 500 ml fresh medium at a concentration  
of 2 x 10 6 /m l . The flasks were gassed and incubated at 37°C fo r  4 
hours a f te r  which time the ce lls  were spun down again and the 
supernatant collected for virus is o la t io n .
The supernatant was c la r i f i e d  by centr ifugation  at 10,000 x 
!g for 10 minutes at 4°C then any remaining c e l lu la r  debris was 
! removed by f i l t e r i n g  the c la r i f ie d  medium through a 0.45 ym Nalgene 
f i l t e r .  Throughout the procedure the virus was kept at 4°C as i t  
rapidly degrades at room temperature. (Vogt, 1965). The v i ra l  RNA 
was then prepared for running on an agarose gel by the procedure 
detailed in Chapter One (virus p u r i f ic a t io n ) .  Virus was 
concentrated using the second method, that of ammonium sulphate 
p re c ip ita t io n .  A fter concentration the virus was p u r if ied  by 
banding on discontinuous sucrose gradients then pelleted  at 35,000 
rpm for 30 minutes in a Beckman SW41 ro to r .
The RNA was prepared from p u r if ied  virus according to the 
protocol in Chapter One then electrophoresed through a 1.5% agarose 
gel as follows:
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( i i ) Electrophoresis of RNA through gels containing formaldehyde
For a 150 ml ge l,  2.25g of agarose (BRL) was boiled in 109.5 
ml of d is t i l le d  H^ O (d^O ) by placing in a microwave oven for 4 
minutes. The agarose was cooled to 60°C then 15 ml of 10 x MOPS 
buffer ( 0 . 2M morpholinopropanesulfonic acid (MOPS) pH 7 .0 ,  50 mM 
sodium acetate , and 1 mM EDTA pH 8.0) and 24.3 ml of 37% formalde­
hyde was added. The gel was the poured onto a f latbed horizontal 
plate and 1 x MOPS (gel running buffer)  was added when the gel had 
set.
( i i i ) Viral RNA sample preparation
The samples were prepared for loading onto the gel as
follows. The RNA was dissolved in 4.5 y1 of dH2 0  in a s te r i le
Eppendorf tube and mixed with 2 yl of 10 x MOPS, 3 . 5y1 of 37% 
formaldehyde and 10 y1 formamide and incubated at 55°C fo r  15 
minutes. Restriction fragments of radio labelled X  DNA were used as 
molecular weight markers and were treated and run exactly as the 
RNA samples (105 cpm/lane of marker was used). At the end of the 
incubation period the samples were cooled on ice and 2 y l / tu b e  of 
s te r i le  loading buffer (50% g ly c e ro l , 1 mM EOTA, 0.4% bromophenol 
blue, 0.4% xylene cyanol) was added. The samples were then loaded 
onto the gel and run at 100 mA f o r . approximately 3-4 hours un til  
the tracking dye had progressed at leas t  2/3 of the length of the 
g e l .
( iv )  Transfer of formaldehyde-denatured RNA onto Gene-screen
Gene-screen membrane (New England Nuclear) was used in the
following b lo tting  procedure to tran s fe r  the v ira l  RNA from the gel
onto a suitable f i l t e r  for hybridisation and molecular probing. 
After removing the gel from the electrophoresis tank i t  was rinsed 
in 1 x Gene-screen buffer (25 mMNaP04  pH 6 . 5 ) . This buffer was used 
throughout the procedure to presoak a l l  the f i l t e r  papers used and 
as the trans fe r  b u ffe r .  The gel was cut to size and the Gen-
screen f i l t e r  and two pieces o f  3 MM Whatman f i l t e r  paper were cut
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to the same size and a trans fe r  system depicted in Figure 24 was 
set up and l e f t  overnight. After the tran s fe r  was complete the 
Gene-screen f i l t e r  was removed and rinsed in 1 x buffer then placed 
between two sheets of Whatman 3 MM f i l t e r  paper and baked at 80°C 
for 2 hours.
(v) Nick trans la tion
Nick trans la tion  of the pCT4 3 ‘ myc probe was carried out 
using a nick trans la tion  k i t  (Amersham) as fo llows. 0.5 yg of DNA 
was added to 10 x buffer solution containing 100 ym dATP, 100 
yMdGTP and 100 yMdTTP in Tris/HCl pH 7 .8 ,  magnesium chloride and 
2 -mercaptoethanol in a polypropylene reaction tube in an icebath. 
32p_radiolabelled dCTP was added at 100 yC i/reaction  (3000 Ci/mMol) 
and f in a l ly  5 units of DNA polymerase 1 plus 100 pg DNase in a
buffer containing Tris/HCl pH 7 .5 ,  magnesium ch lo r ide , glycerol and 
BSA were added to the reaction and the tube was capped and inverted  
several times to mix the solutions. The tube was then placed in a 
constant temperature bath at 14°C for 2.5 hours a f te r  which time 
the reaction was stopped by adding 2 yl of 0.5M EDTA. The specif ic  
a c t iv i ty  obtained by th is  method was usually 1 x 1 0 ^  cpm/yg DNA.
The nick translated DNA probe was then separated from
unincorporated dNTPs by chromatography through a Sephadex G50 
column. The f i r s t  peak was the probe and the second peak the 
unincorporated nucleotides.
(v i)  Hybridi sation
The myc probe was then ready to hybridise to the Northern b lo t  
of v ira l  RNAs on the Gene-screen f i l t e r .  The buffer used 
throughout th is  procedure consisted o f: 5 x SSC (750 mM sodium
chloride, 75 mM sodium c i t r a te  pH 7.0) 50 mM sodium phosphate, 
10% dextran, 5 x Denhardt's so lu tion , 0.1% SDS, 50% formamide 
(deionised) and 100 yg/ml denatured salmon sperm DNA. The Gene-
screen was pre-wetted in 1 x Gene-screen buffer then sealed in a
p las tic  bag in the above buffer and incubated at 42°C in a shaking 
water-bath overnight. The next day a corner of the bag was cut
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open and the probe (bo iled , cooled and d ilu ted  to 5 ng/ml in 
hybridisation b u ffer)  was added and the bag re-sealed (using a heat 
s e a le r ) .  This was incubated as before at 42°C overnight in a 
shaking water-bath. The f i l t e r  was then removed and washed at high 
stringency by incubating in 0.1 x SSC plus 0.5% SOS at 60°C fo r  2 x 
30 minutes (changing buffer between washes) then in 5 changes of  
0.1 x SSC for 1 minute/wash at room temperature. A fter the f i l t e r  
was dried on a sheet of Whatman 3 MM f i l t e r  paper at room
temperature i t  was ready for autoradiography.
( v i i )  Autoradiography
The f i l t e r  was taped onto a backing of cardboard and pieces of 
tape marked with radioactive ink were placed at several locations  
around the f i l t e r  as markers. Both f i l t e r  and backing sheet were 
then wrapped in c l in g - f i lm  to prevent contamination of the
in tensify ing  screen which was la id  on top (Dupont in tens ify ing  
screens). This was then placed in an X-ray f ilm  holder (in  a dark 
room) and covered with a sheet of Kodak XAR-5 X-ray f i lm .  The f i lm  
was exposed at -70°C for several days and developed in an automatic 
X-ray f i lm  processor.
The analysis of infected FEA c e l ls  for acquired myc sequences
( i ) The in fection  of FEA c e l ls  with recombinant viruses
Feline embryonic f ib rob las ts  were infected with viruses from 
tumours known to contain recombinant proviruses. Two sources of  
virus were used from T3 and T i l :  th a t  derived from the plasma of 
the cats and that present in the supernatant of c e l ls  cultured from 
the tumour. FL74 ce l l  supernatant was included as a control since 
i t  is  known not to release a recombinant virus but does release  
helper non-defective FeLV. Cell culture supernatant only was used 
from the F422 cell l in e  as plasma from th is  tumour is not ava ilab le
and plasma was used as the only source of virus from a case p r io r
to th is  study designated 847^3 since ce l ls  were not cultured from 
th is  lymphosarcoma. This experiment was designed to determine i f
the recombinant viruses associated with these tumours are 
in fectious i . e .  can be transmitted in v i t ro  via helper FeLV.
FEA ce lls  were infected by the same method used for in t e r ­
ference testing  previously described in th is  chapter. A fter  the 
FEA c e lls  had been routine ly  subcultured for 3 weeks to ensure
spread of the virus throughout the cu ltu re ,  they were grown to 1 x
lO^ ce l ls  and the DNA was isolated according to the protocol in
Chapter One (The iso la tion  of DNA from infected and uninfected 
FEA c e l l s ) .  Uninfected FEA c e lls  were used as control DNA in th is  
procedure and both th is  DNA and that from the infected FEA c e lls  
was digested with re s t r ic t io n  endonuclease and analysed for the 
presence of acquired myc DNA sequences.
( i i )  Restriction of DNAs
The DNAs were digested in s t e r i le  eppendorf I tubes with two 
re s tr ic t io n  enzymes, Kpnl and P s tI ,  both of which cut w ithin the 
v ira l  LTRs and in te rn a lly  w ithin the v irus . 20 yg of each DNA was 
digested with 0 .1  units of each re s tr ic t io n  enzyme by incubating  
the samples plus 0.1 units of enzyme at 37°C overnight then for a 
fu rther 2-4 hours in the presence of an additional 0.1 units of
enzyme. Following the second incubation a tes t  gel o f  0.8%‘agarose 
was run to check that the DNA had completely digested. Whole X 
DNA was used for the marker lanes but digested marker can also be 
used in th is  case as the marker lanes are only to ind icate  th a t  the 
gel has run properly. When digestion was complete the DNAs were 
precip ita ted  by adding 3/50volumes 5M NaCl and 2 volumes of ethanol 
(ETOH) and incubated at -70°C for 1 hour. When the DNAs had
precip ita ted  they were spun down for 5 minutes in an Eppindorf
cen tr ifuge, then the ETOH was decanted and the DNAs were dried in a 
ly o p h i l is e r  for 10 minutes. A fter drying, 40 yl of 1 x TE b u ffe r  
(10 mM Tris HC1 pH 7.9 and 1 mM EDTA) per tube was added to
resuspend the DNAs and th is  was incubated a t 37°C for 10-15 minutes 
to ensure that the DNAs had resuspended completely before e le c t ro -  
phoresi s.
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( i i i ) Electrophoresis of restricted DNAs
The to ta l 40 yl of res tr ic ted  DNAs were loaded onto agarose 
horizontal gels with 10 yl of tracking dye. For Kpn-1 re s tr ic te d  
DNAs a 0.7% agarose gel was used and for P s t- I  re s tr ic te d  DNAs a 
0.8% agarose gel was used, made up in 1 x TEA buffer (40 mM 
Tris base, 2 mM EDTA, 20 mM NaCl and 20 mM sodium aceta te , pH 8.15)  
which was also the buffer used for electrophoresis.The marker lanes 
were radio!abelled Hind I I I  res tr ic ted  X  DNA at 5,000 cpm/lane in 
an excess of cold Hind I I I  X digest. The gels were run overnight 
at less than 20V then processed in the following manner. The gels 
were stained fo r 30 minutes with ethidium bromide which in t e r ­
calates with the DNA and hence enables v isu a lisa t io n  of the 
res tr ic ted  DNA under an u l t r a v o i le t  l ig h t  source. This provides an 
ind ication  of whether the gels have run properly and allows 
accurate trimming of the gels for Southern b lo t t in g .
The gels were then prepared for b lo tt in g  by denaturing fo r  30 
minutes in a denaturing buffer (1.5M NaCl + 0.5MNa0H) then
neutra lis ing  for 30 minutes in a neutra lis ing  buffer (3MNaCl + 0.5M 
Tris base, pH 7 .0 ) .  The gels were rinsed in 3 changes of 1 x 
Gene-screen buffer for 30 minutes/wash and transferred  to  Gene- 
screen membrane by the process of Southern b lo tt in g  which is  
identica l to that of Northern b lo tt in g  described for the v ira l  
RNA. The processing of the blotted membrane, the nick t ra n s la t io n  
of the pCT4 3 ‘ myc probe, the probing of the b lo t and the auto­
radiography procedures again were identical to those previously  
described for v ira l  RNA analys is .
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RESULTS
FeLV subgroups associated with thymic lymphosarcoma
Table 5 shows the results  obtained by interference testing  of 
Fea c e l ls  infected by virus derived from the plasma and ce ll  
culture  supernatants from the fe l in e  T -ce ll  tumours. Ten of these 
12 cats had an additional subgroup other than A (9 had B, 1 had C) 
associated with e ith e r  the tumour ce lls  or c irc u la t in g  in the 
plasma. T4 and T12 cell culture virus subgroup was not determined 
as in the case of T4, since the ce lls  died immediately in culture  
and did not release s u f f ic ie n t  virus for FEA in fe c t io n .  In the 
case of T12 ce ll cu ltu re , the virus infected FEA c e l ls  died before 
the subgroup could be determined by in terference te s t in g .  The 
oncogene status of these tumours (which was determined by Dr. J. 
N eil)  is also shown and these results w il l  be discussed in the 
following section.
The analysis of v ira l  genomic RNA for myc sequences
Figure 25 shows a Northern b lot of v ira l  RNA from the ce l l  
l ines T3, F422 and FL74 probed with FeLV-myc and indicates that  
recombinant myc/FeLV viruses are released by the ce l l  l ines  F422 
and T3. FL74, shown in the middle lane, has no recombinant
myc/FeLV provirus and was therefore not expected to release  
anything but helper FeLV. The genome size of the two defective  
recombinant viruses is d i f fe r e n t .  T3 is  5 kilobase pa irs , smaller 
than helper FeLV genome size which is  8 .5  kilobase pa irs .  F422 
defective recombinant genome is 9 kilobase pairs long, m arginally  
la rger than helper FeLV genome length but not too large to be 
packaged into v ir io n s . Helper FeLV can be visualised in these 
blots by probing with a U3 exogenous virus probe (Casey e t a l . ,  
1981) which hybridised with an 8 .5  kilobase band of a l l  three  
viruses (data not shown).
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The analysis of infected FEA c e lls  for acquired myc sequences
Figure 26 shows a tes t  gel of virus infected FEA DNAs and 
indicates that the DNAs have been completely digested by both Kpn-I 
and P s t - I .  The two flanking lanes in each set of wells was whole 
DNA marker. The res tr ic ted  genomes of the FEA c e l ls  appear as 
smears down the lanes in between the marker lanes and are FEA c e l ls  
infected with virus as denoted in the legends. Control DNA was
isolated from uninfected FEA c e l ls .  The DNA was visualised by
staining with ethidium bromide (EtBr) and photographed using an 
u l t r a v io le t  l ig h t  source.
The agarose gel electrophoresis of the res tr ic ted  DNAs to be
* used in the Southern b lo tt in g  technique is shown in F ig . 27. The
marker lanes here are H in d - I I I  X  res tr ic ted  DNA and the DNA was 
visualised in the same way as before (Figure 26 ) .  This
demonstrated that the gel had run properly and could now be blotted
onto Gene-screen for probing with pCT4 3' myc.
Figure 28 demonstrates the in v i t ro  transmission of FeLV/myc
recombinant viruses. The recombinant myc is  present in FEA c e l ls
infected by virus in the supernatant of the F422 and T i l  tumour
ce lls  and in the plasma of the T3 c a t .  No additional recombinant 
myc hybridising band was seen in the control FEA DNA or in the FEA 
DNA infected by cell supernatant from the FL74 or T3 c e l l  l ines  or 
the plasma from the T i l  or 84793 cats. These results  w i l l  be 
discussed at length in the next section.
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DISCUSSION
Epidemiological evidence suggests tha t an additional subgroup 
other than A, usually B, is more often associated with cats with 
lymphosarcoma than with th e ir  healthy viraemic counterparts 
( J a r r e t t ,  1980). The results of the in terference tes ts  (Table 5) 
to  determine which subgroups of FeLV were associated with these 
T-cell tumours support th is  observation as subgroup B (and in the 
case of T3, subgroup C) is  present in 83% of the lymphosarcomas 
studied.
The association of the subgroup B virus with disease in these 
cats is of p a rt ic u la r  in te re s t  with respect to the s tr ik in g  analogy 
between the highly 1eukaemogenic mink ce ll focus forming (MCF) 
viruses of mice (Famulari, 1983) and FeLV-B. Recent evidence shows 
that considerable homology exists between certa in  regions of the 
env gene of FeLV-B (b io lo g ic a l ly  cloned from the Gardner-Arnstein 
FeLV is o la te )  and the env gene of MCF virus (Elder and M ullins ,  
1983). MCF viruses arise by recombination of an ecotropic parental 
virus with endogenous murine leukaemia virus sequences present in 
the murine genome (Chattopadhyay et a l . ,  .1982) and possess an 
extended host range over the parental v irus . FeLV-B has a s im ila r  
expanded host range, and l ik e  MCF viruses forms an in te r ­
ference group d is t in c t  from the ecotropic subgroup A viruses 
( J a r r e t t ,1980; Rein, 1982).
In th is  respect the observations of Onions et a l . (pers.comm.) 
that the onset of myeloid leukaemia in cats infected with the 
FeLV-AB/GM-1 virus correlates temporally with the appearance of 
subgroup B virus in the plasma is in tr igu ing  and is undoubtedly 
important in the progression of leukaemia in those cats . S im ila r ly  
the frequent presence of subgroup B viruses in the present tumour 
series is suggestive that these viruses may have a role to play in 
the development o f th is  disease although, since these cats were 
f i r s t  encountered when lymphosarcoma had already developed, nothing 
is known of the temporal appearance of the subgroups p rio r to the 
onset of neoplasia. The high frequency with which subgroup B
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viruses are associated with these tumours may ind icate  tha t the 
subgroup B envelope gp70 may have a mitogenic e f fe c t  on the ce l ls  
causing an early  p ro ! ife ra t io n  due to autostimulation s im ila r  to 
that proposed by McGrath and Weissman (1979) in the murine system 
(see General In trod uction ).  A lte rn a t iv e ly  the subgroup B viruses  
may be involved in recombination events with the c e l lu la r  myc 
proto-oncogene, although some tumours had no detectable myc 
a lte ra t io n  and had associated subgroup B virus (Table 5 ) .  
Subgroup B involvement in recombinational processes is not 
un like ly  since Russell and J a rre t t  (1978b) have proposed that  
FeLV-C may arise de novo in infected cats by recombining with 
endogenous sequences. This emerged from a study on FDCMA ( fe l in e  
oncornavirus-associated ce ll membrane antigen) which was f i r s t
(
described by Essex et a l . (1971a, 1971b) as an antigen or antigen 
complex expressed on the surface of FeLV-producing leukaemic ce lls  
of the FL74 ce ll l in e .  However, experiments by Russell and 
J a rre t t  (1978a) f i r s t  suggested a re la tionsh ip  between FeLV-C and 
FOCMA. These authors found neu tra lis ing  antibody to FeLV-C but 
not to FeLV-A in cats which were known to have antibody to FOCMA. 
More recen tly , Vedbrat et a l . (1983) have concluded that FOCMA is 
an FeLV-C envelope g lycoprotein . They found that when monoclonal 
antibodies to FOCMA were used in neu tra lisa tion  tests  they
neutralised FeLV-B and FeLV-C but not FeLV-A (J a r re t t  and Lutz, 
cited in Vedbrat et a l . ,  1983). These monoclonals therefore  bind 
to an epitope common to FeLV-B/Sarma and FeLV-C/Sarma. Such an 
antigen was described e a r l ie r  by adsorption experiments using 
serum from a cat inoculated with FL74 c e l ls  which neutralised  
FeLV-B/Sarma and FeLV-C/Sarma (Russell and J a r r e t t ,  1978b).
Russell and J a rre t t  (1978a) proposed tha t anti-FeLV-C
antibody may be evoked by an antigenic determinant which is  coded 
for by the endogenous FeLV-like genes which are present in cat 
c e lls  (Levin et a l . ,  1976; Okabe £]_., 1976) and which are 
expressed in cats during in fection  with FeLV-A. Indeed recent 
evidence from Mullins (pers.comm.) suggests tha t the endogenous 
FeLV genes are ac t ive ly  transcribed in both v irus-negative  and 
v iru s -p o s it ive  leukaemias. Russell and J a r re t t  (1978a) fu r th e r
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proposed that the orig in  of the ra re , in fectious FeLV-C might be a 
recombination between in fec ting  FeLV-A and these endogenous v ira l  
genes implying that each FeLV-C iso la te  may have arisen de novo in 
a FeLV infected cat (Russell and J a r r e t t ,  1978b). I t  may be that
both FeLV subgroups B and C arise by th is  recombination mechanism 
which would explain why subgroups B and C are never iso lated  in the 
f ie ld  in the absence of FeLV-A. Virus neu tra lisa tion  data also 
support th is  contention since only FeLV-A has been demonstrated to 
be an tig en ica l ly  monotypic while a great deal of antigenic  
d iv e rs ity  exists among FeLV-B and FeLV-C iso lates (Russell and 
J a r r e t t ,  1978b) which is understandable i f  these subgroups have 
been generated by recombination between in fec ting  FeLV-A viruses
and endogenous FeLV env sequences.
Recently i t  has been shown that DNA probes specific  for the 
envelope gene of FeLV-B detect s im ila r  sequences in FeLV-C and
endogenous v ira l genomes but not in FeLV-A (Warnock et a l . pers. 
comm.). This strongly supports the hypothesis tha t FeLV-B and 
FeLV-C arise by recombination. Since subgroup B viruses may
therefore evolve by recombinational events they may s im ila r ly  be 
involved in the myc recombinations detected in these T -ce ll  tumours 
since FeLV seems able to commonly recombine with c e l lu la r  proto­
oncogenes (Besmer et a l . ,  1983b). Two forms of myc a l te ra t io n  are 
seen in th is  series of n a tu ra lly  occurring T -cell lymphosarcomas; 
rearrangement of the c e l lu la r  proto-oncogene by in tegration  of the 
FeLV genome into the myc locus and recombination of FeLV with part 
of the myc locus generating recombinant myc/FeLVs. The thymic 
lymphosarcomas presented here fa r  more -frequently released 
recombinant myc/FeLV than was expected (25%) and a fu r th e r  25% 
involved rearrangements of the myc gene by adjacent integration, of  
FeLV. Three tumours in th is  series were derived experimentally:  
T5, T8 and Tin. Cats T8 and T10 were inoculated at b ir th  with the 
Rickard stra in  of FeLV which contains subgroups A and B. T5 was a 
cat experimentally inoculated at b ir th  with FeLV/Glasgow-1 which is  
a subgroup A v iru s . Rearrangement of the myc gene has occurred in 
T5 and T8 and also in a f ie ld  case cat T7.
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Rearrangements are possibly seen more frequently than 
recombinants in tumours induced by known highly pathogenic viruses 
l ik e  Rickard since these viruses have been selected fo r leukaemo- 
genicity  and may contain strong enhancers which can ac tiva te  or 
increase expression of myc simply by in tegrating  next to i t ,  
whereas non-selected viruses in natural conditions may require  
recombination with the myc gene to induce neoplasia. In te re s tin g ly  
T7, which was a f ie ld  case involving a rearrangement of myc, was 
integrated very close to the gene (within a few hundred base pairs)  
compared to T8 (several thousand base pairs d is t a l ) .  This may 
imply that the FeLV did not have a p a r t ic u la r ly  strong enhancer but 
activated myc by v ir tu e  of i t s  close proximity to the gene.
Another tumour of p a rt ic u la r  note is  T17. No FeLV antigen was 
detected in the plasma of th is  case and only very small quantit ies  
of infectious virus were isolated (1 focus on 1 5cm plate on one of 
three occasions te s te d ) .  However FeLV of subgroup A was isolated  
from cultured tumour c e l ls  and was found to contain recombinant 
myc/FeLV provirus integrated in the ce ll genome (J . Neil pers. 
comm.). The extremely low level of virus detectable in the plasma 
of th is  cat correlated with the presence of anti-FeLV-A and 
anti-FeLV-C neu tra lis ing  antibodies and therefore there may have 
been neutralised virus c irc u la t in g  in the plasma in immune 
complexes. A lte rn a t iv e ly ,  as in c a t t le  infected with bovine 
leukaemia v irus , the virus emerging into the plasma from the ce l ls  
may be incomplete i f  antibody modulates the v ira l  protein and 
in h ib its  v ira l  production (Gupta et a l . ,  1984). Transcription  
studies of primary tumour material should elucidate which of these 
mechanisms is correc t.
Whichever mechanism operates, the presence of detectable FeLV in  
the tumour ce l ls  of th is  cat but not free in the plasma, could 
explain the observations by Hardy et a l . (1980) th a t  v irus-negative  
lymphosarcomas are iso lated  more frequently from cats tha t have 
been exposed to FeLV than from cats that have never been exposed. 
Although i t  is  d i f f i c u l t  to determine exactly by what c r i te r io n  
these lymphosarcomas are considered to be v irus -negative , and
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indeed which category of lymphosarcoma is being referred to for a 
given set of results  (thymic or a lim entary), i t  may have been that  
the antigen-negative cats which developed thymic lymphosarcoma in 
Hardy's series did in fact contain FeLV proviruses.
I t  would then appear tha t there are two d is t in c t  classes of  
virus-negative thymic lymphosarcomas, probably generated by 
d is t in c t  mechanisms. One c lass, exemplified by T17, although 
plasma virus-negative is producing virus from the tumour c e l ls ,  and 
the other class is t ru ly  virus-negative determined by lack of both 
exogenous integrated provirus in the c e l lu la r  DNA, (determined by 
U3 probing; Casey et a l . ,  1QR1) and c ircu la tin g  free plasma v iru s .  
Three such true virus-negative thymic lymphosarcomas have been 
studied, including one in th is  present series (T6  = 88960) a l l  o f  
which have no detectable c ircu la tin g  plasma virus and no integrated  
exogenous provirus in the tumour c e l l  DNA (Neil et a l . ,  1984). 
Furthermore, no myc a lte ra t io n s  were detected in any of these three  
virus-negative thymic lymphosarcomas or in another three  
virus-negative alimentary lymphosarcomas although rearrangements 
may have occurred outside the domain analysed in the study. 
Further experiments are required to investigate the mechanisms of 
transformation in these cases.
The iso la tion  of recombinant viruses released from tumour ce l l  
cultures shown in Figure 25 provided proof that these recombinants 
were packaged and released from the tumour ce lls  with helper FeLV. 
Had they not been released from the c e l ls ,  the p o s s ib i l i ty  of  
horizontal spread of the recombinant myc/FeLVs in vivo would have 
to have been ruled out. Since the recombinant viruses were 
released from the tumour c e l ls  i t  was important to estab lish  i f  
these viruses were infectious j_n_ v i t r o . Figure 28 c le a r ly  
demonstrates that the recombinant viruses of T3, T il and F422 can 
gain entry to permissive ce l ls  (FEA) via helper FeLV and become 
integrated as provirus into the ce ll  genome. The viruses used for  
these infections were not t i t r a te d  and were, th ere fo re , plated onto 
the ce lls  at d i f fe re n t  concentrations. This was probably why the  
plasma helper FeLV of T3 (which subsequently turned out to be high
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t i t r e :  10? f fu /m l ) carried s u f f ic ie n t  FeLV/myc in to  the FEA c e lls  
to be detected in the genome, whereas the ce ll cu lture  supernatant 
did not ( i t  had very low helper t i t r e :  5 x 10^ f fu /m l ) .  S im ila r ly  
the plasma helper virus of T il and 84793 (a case p r io r  to th is  
series) may have been at too low a t i t r e  to in fe c t  the FEA c e lls  
with s u f f ic ie n t  recombinant to be detected. In p a r t ic u la r  84793 
was the tumour tissue from which the fe l in e  myc probe pCT4 3' was 
cloned and th is  had a very low copy number (3) of c lo n a lly  
integrated proviruses so re la t iv e ly  l i t t l e  recombinant v irus may 
have been c irc u la t in g  in the plasma of th is  c a t .  Both the control 
uninfected FEA DNA and the DNA from the FEA c e l ls  in fected with 
FL74 ce ll culture virus do not display an additional myc band as 
expected. No morphological transformation was detected in the FEA
ce lls  infected by these recombinant viruses but th is  may simply 
r e f le c t  tha t  FEA c e l ls  are not ta rget ce lls  fo r  transformation by 
these recombinant v iruses. Since these viruses were in fe c tio u s  in 
v i t ro  fu r th e r  experiments were required to determine t h e i r  
pathogenicity in vivo and these are the subject of the next 
chapter.
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TABLE 5
FeLV subgroups associated with thymic lymphosarcoma
Tumour Virus subgroup Oncogene status
Plasma Tumour
T3 AC A myc recombinant
T4 AB N/D -
T5 AB A myc rearrangement
T7 AB A myc rearrangement
T8 AB A myc rearrangement
T10 AB AB -
T i l AB AB myc recombinant
T12 A N/D -
T14 AB AB -
T15 AB A -
T16 A AB -
T17 -ve A myc recombinant
FIGURE 24.
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Figure 24 shows the method used to trans fe r  RNA or DNA from agarose 
gels onto membrane (Gene-screen) suitable for the hybrid­
isation  of radioactive probes.
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Figure 25 shows a northern b lo t  or  v i r a l  RNA from the c e l l  l i n e s  
T3, F422 and FL74 probed w i th  f e l i n e  v-myc (pCT4 3 ' ) .
FIGURE 26.
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Figure 26 demonstrates that the digestion o f  the DNAs w i th  
re s tr ic t io n  enzymes was complete.
The method is described in the te x t .
TCS * tissue cu lture  supernatant.
FIGURE 27 
Gel f o r  Southern b l o t  o f  ONAs
Figure 27 demonstrates tha t  the FEA ONAs digested w i th  P s t - I  had 
run p rope r ly  on the agarose gel and th a t  t h i s  gel was 
s u i t a b le  f o r  b l o t t i n g  onto gene-screen
FIGURE 28
In v i t r o  t ransmiss ion  o f  FeLV/myc recombinant v i ruses
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Figure 28 demonstrates the in  v i t r o  t ransmiss ion  o f  FeLV/myc 
recombinant v i ruses from F422 and T22 TCS and T3 plasma 
in to  FEAs.
TCS = t i s s u e  c u l t u r e  supernatant.
(Nei l  et  al . ,  1 984).
CHAPTER SIX
THE IN VIVO PATHOGENESIS OF FeLV/myc 
RECOMBINANT VIRUSES
INTRODUCTION
Avian and murine acutely transforming leukaemia viruses which 
carry a v ira l  one (v -onc) gene are known to rap id ly  produce a wide 
spectrum of disease in vivo (B ister 1984; Fischinger, 1984). ALVs 
do not contain a v -onc gene but in tegrate  near spec if ic  host 
proto-oncogenes and again produce a spectrum of disease in vivo but 
a f te r  a longer la te n t  period than that observed with the acute 
leukaemia viruses (Crittenden and Kung, 1984). In the ca t ,  some 
virus-induced thymic lymphosarcomas have recently been shown to  
involve the oncogene myc e ith e r  incorporated into the v ira l  genome 
in the form of an acutely transforming virus or by insert ion  of an 
FeLV genome adjacent to the myc locus (Neil et a l . ,  1984; Levy et 
a l . ,  1984 and Mullins et  ^ ^1_., 1984). The transforming properties  
of the recombinant FeLV/myc viruses F422 and T3, obtained from the 
tumour ce l l  l in e s ,  have been- studied both in vivo and in v i t r o . 
The in v i t r o  experiments, described in Chapter F ive, suggest that  
these recombinant viruses do not morphologically transform FEA 
ce lls  in culture unlike avian acute leukaemia viruses containing  
v-myc sequences. These l a t t e r  viruses read ily  transform avian 
f ib rob las ts  in v i t ro  and one s t ra in ,  MC29, has been shown in 
addition to transform fibrob las ts  of mammalian or ig in  (Ouade, 
1979). I t  may be that FEA c e l ls  are not ta rget c e l ls  fo r these 
recombinant fe l in e  viruses or a l te rn a t iv e ly  they may a l te r  a 
c e l lu la r  growth property such as anchorage dependence and permit 
ce lls  to grow in semi-solid agar. Experiments are in hand to t r y  
to determine which haemopoietic ce lls  are targets fo r these viruses  
in v i t ro  and th e ir  e f fe c t  on the growth properties of the c e l ls  
they in fe c t .
Since these viruses were o r ig in a l ly  isolated from thymic 
! lymphosarcomas, attempts have been made to in fe c t  cultured mature 
; T -ce lls  from the thymus of SPF cats with these viruses but the 
I in fection  of mature fe lin e  thymocytes with any fe l in e  leukaemia 
: virus has proven to be extremely d i f f i c u l t .  (Rojko et a l . ,  1980).  
In conjunction with these in v i t ro  studies, experiments were 
undertaken to investigate  the pathogenicity of the F422 and T3 
recombinant viruses in vivo.
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The results  of th is  work, with respect to the spectrum of disease 
induced by these viruses, the speed of development of disease and 
the c lo n a l ity  of the resu ltant tumours, is  the subject of the 
present chapter.
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MATERIALS AND METHODS
The work in th is  chapter was done in co llaboration  with Dr. 
D. Onions and Dr. J. N e il .  I am p a r t ic u la r ly  gratefu l to Dr. 
Onions for carrying out procedures requiring a Home Office  
Licence. I am also grateful to  Dr. S. Toth who determined the 
pathology of the disease produced by these viruses.
The in fec tion  of k ittens  with the FeLV/myc recombinant viruses
Virus was harvested from the ce ll l ines T3 and F422 two days 
a f te r  feeding and was c la r i f ie d  and concentrated by u l t r a f i l t r a t i o n  
using an Ami con hollow f ib re  concentrator (model CH4) as described 
in Chapter One. Virus was inoculated into newborn k ittens  at 5 x 
105 ffu /m l in t ra p e r i to n e a l ly ; seven cats were inoculated with T3 
virus and three cats with F422 v irus . The two groups o f cats were 
housed separately and four tracer  cats which were not inoculated  
with virus were housed together with the infected cats in each 
group to attempt to detect horizontal transmission of the virus  
(F ig . 29). Blood samples were taken from a l l  cats every two weeks 
and were screened for abnormal haematology and plasma virus  
subgroup.
The establishment of ce l l  l ines from the thymic lymphosarcomas
Cats which developed c l in ic a l ly  detectable thymic lympho­
sarcoma were sacrif iced and the tumours removed and established in 
culture in an identica l manner to that described in Chapter Three 
(Preparation of ce ll  cultures from tumours). In b r ie f ,  c e l ls  were 
iso lated from the tumours in single ce ll suspensions by dic ing with 
scalpels and stomaching in RPMI 2% + Me. The c e l ls  were then 
washed, counted, and resuspended at 5 x lofyml in e i th e r  RPMI 20% + 
Me alone or in 50:50 medium (RPMI 20% + Me + LyCM). Cultures were 
maintained by subculturing twice weekly and dead c e l ls  were removed 
by centrifugation  through Ficoll-paque at 2 0 0 0  rpm for 10 minutes.
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The molecular analysis of tumour and ce ll l in e  DNA
( i ) The extraction  of DNA from tumour material and ce l l  l ines
Tumour material from cats with thymic lymphosarcoma was stored 
at -70°C un ti l  required. Cells from lines which were established  
from 5 o f 10  of these tumours were grown to a to ta l ce l l  number of 
1 x 1 n  ^ by routine feeding with RPMI 20% + Me. The c e l ls  were spun 
down and washed once in PBS then resuspended d ir e c t ly  into 4M 
guanidinium isothiocyanate buffer with a 1 0  ml agar p ip e t te .  The 
frozen tumour tissue material was thawed in the same buffer and 
diced with scalpels then stomached gently to break up the t iss u e .  
Both th is  s lurry  and the cell suspension were c la r i f i e d  by
centr ifugation  at 1 0 , 0 0 0  rpm' for 10  minutes to remove gross 
debris . The DNAs were then isolated by centr ifugation  through a 
discontinuous CsCl gradient (2 ml o f 51% CsCl on top o f 2 ml 56% 
CsCl) at 35,000 rpm for 20 hours a f te r  which time the DNA had 
banded at the in te rface  of the two CsCl solutions. The bands were 
c a re fu l ly  removed using a wide bore p ipette  and dialysed b r ie f ly  
against 1 x TE buffer at 4°C to remove any residual CsCl.
Proteinase K (Boehringer) was added at a concentration of 50 yg/ml
DNA in 1 x TE containing 0.5% SOS and the DNAs incubated overnight
at 37°C. Phenol, equ ilib ra ted  to pH 8 .0  in 1 x TE buffer was used 
to extract the DNAs by adding in equal volume to the DNA and mixing 
gently end over end at room temperature for 10 minutes. The top 
aqueous phase was then removed to a fresh tube and extracted once 
more with phenol then twice with chloroform (49 parts chloroform :l  
part isoamyl alcohol) and dialysed against 1 x TE at 4°C with two 
to three changes of b u ffe r .  The DNA was next treated with RNase at 
a concentration of 20 yg/ml overnight at 37°C and extracted with  
phenol and chloroform exactly as before. F in a l ly  the samples were 
dialysed extensively against buffer at 4°C prior to r e s t r ic t io n .
( i i ) The re s tr ic t io n  analysis of the isolated DNAs
The DNAs were digested in s t e r i le  Eppindorf tubes with two 
re s tr ic t io n  enzymes, EcoRl, and Kpn-1. EcoRl cuts the T3 provirus
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both in te rn a l ly  and in the flanking sequences which generates
unique proviral fragments. However, there is  no EcoRl s i te  within  
the recombinant F422 provirus. EcoRl therefore  cuts outside the 
virus in the flanking sequences of F422 generating large unique 
fragments which makes counting of individual bands on the blots  
more d i f f i c u l t .  This w il l  be discussed fu rth e r  in the results  
section. 20 pg of each DNA was res tr ic ted  with 0.1 units of each 
re s t r ic t io n  enzyme following the protocol described in Chapter Five 
(Restric tion  o f DNAs). The protocol fo r Southern b lo tt in g  the DNA, 
nick tran s la tio n  of the pCT4 3' myc probe, hybrid isation of the
probe to the blots and autoradiography of the blots were again 
identica l to those described in Chapter Five.
The determination of virus subgroups associated with the infected  
cats
Blood samples were taken from a l l  the cats every week for four 
weeks then approximately every two weeks until the f ina l sample and
at death. The subgroup of virus present in the plasma was
determined by the standard interference te s t  (described in Chapter 
F ive ) .  Supernatant from the tumour ce ll  lines was also tested in 
the same manner to determine the subgroup of virus being released 
from the ce l ls  in cu ltu re .
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RESULTS
The spectrum of disease induced by the recombinant viruses
All the cats infected with the T3 and F422 viruses were
destroyed in extremis. Of the seven cats inoculated with T3
recombinant v irus , f iv e  (T3C4 , T3C5 , T3Cg, T3Cy and T3C^) developed 
thymic lymphosarcoma 81-Q8 days post-in fection  as shown in Table 
6 . Pathological examination revealed tha t in addition to the
tumour three of these cats (T3 C4 , T3Cg and T3Cg) had sinus
h is tiocyto s is  and T3C4 , T3Cg and T3Cg had erythroid hypoplasia.
T -cell depletion was marked in T3 C5 and T3C^. The other two of  
these seven cats (T3C^ and T3C2 ) died *103 and 71 days a f te r
in fec tion  respective ly; T3C  ^ had erythroid hypoplasia and T3 C2 had 
haematopoietic dysplasia, both showed marked T -ce ll  depletion as 
shown in Table 7. Of the four tracer  cats housed with the
infected cats, only one (T3C^) became pers is ten tly  viraemic from 
147 days post-in fection  onward but a l l  four became la te n t ly  
infected with FeLV subgroup AB as shown in Table 8 . Of the three
cats infected with F422 recombinant virus two (F422/1 and F422/3)
developed thymic lymphosarcoma 123 and 112 days pos t- in fec tion  
respective ly . The pathology of the other cat (F422/2) revealed  
lymphoblastic leukaemia with marked T -ce ll depletion 71 days
post-in fection  and a l l  the tracer  cats are , to date (134 days post 
in fe c t io n )  plasma virus-negative although whether or not these cats 
are la te n t ly  infected in the bone marrow remains to be determined.
The establishment of ce ll  l ines  from the thymic lymphosarcomas
Of the f iv e  cats inoculated with T3 virus tha t  developed 
tumours, four ce ll l ines were established in tissue cu ltu re  from
the tumours of T3 C4 , T3C5 , T3 C7 anc* ^3Cg. The tumour from cat T3C6
was very small and too l i t t l e  material was ava ilab le  to establish  
i t  in cu ltu re .  All four ce ll l ines grew immediately in RPM1 20% + 
Me alone and were dependent on mercaptoethanol for th e i r  continued 
p ro l ife ra t io n  in cu ltu re . Of the two cats inoculated with F422 
virus that developed tumours, one established into a ce l l  l in e  in
90
v i t ro  in RPM1 20% + Me alone but not so read ily  as the c e l ls  from 
the tumours of the T3 infected cats . These ce l ls  were cultured in 
v itro  in s u f f ic ie n t  quantit ies  for DNA iso la tio n  and analysis .
The molecular analysis of tumour and ce ll l in e  DNA
Figure 30 shows Southern blots of T3 and F422 tumour DNA
res tr ic ted  with Kpn-1 and probed with fe l in e  v-myc pCT4 3 1. Kpn-1 
cuts the provirus in te rn a l ly  and therefore  generates a unique 
defective proviral band containing the acquired myc sequences. The 
results  show that the T3 tumours, (A, B, C and D) contain defective  
proviruses which are representative of those in the orig ina l  
tumour. In add ition , however, T3A and T3B are c le a r ly  harbouring 
defective proviruses which have undergone fu rthe r  deletion (small 
bands under major bands on b lo t ) .  S im ila r ly ,  the F422 tumours A 
and B and resultant ce ll  l in e ,  (B), contain defective proviruses 
which are representative of those of the orig ina l tumour.
Figure 31 shows Southern blots of the same DNAs res tr ic ted
with EcoRl and probed again with fe l in e  v-myc pCT4 3 ‘ . EcoRl cuts 
within the T3 provirus and also in the flanking c e l lu la r  sequences 
enabling the determination of the number of integrated defective  
proviruses. EcoRl, however, has no re s tr ic t io n  s i te  w ithin the
F422 defective provirus and is therefore cutting in the flanking
c e l lu la r  sequences only. This generates very large fragments which 
are d i f f i c u l t  to count. Therefore these DNAs w il l  be re s tr ic te d  
with another enzyme which cuts within the provirus (Hind I I I )  to
c la r i f y  the number of integrated defective proviruses in the F422 
induced tumours and resultant ce ll  l in e .
Figure 32 shows Southern blots of T3-induced tumour and
homologous derived cell l in e  derived DNA. The DNAs were re s tr ic te d  
with EcoRl as before and probed with v-myc pCT4 3 ‘ . From a
comparison of the position and number of bands generated by th is  
enzyme digest in the tumour and ce ll  l in e  DNAs i t  is  c lear  th a t  the 
ce ll l ines which were established in culture are representative
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of the tumours from which they orig ina ted . The EcoRl digest shows 
that the copy number of integrated defective proviruses and th e i r  
pattern of in tegration  is s im ila r  in the tumours and homologous 
cel 1 l in e s . , •
The virus subgroups associated with the infected cats
The results  of the interference tests to determine the 
subgroup of virus found in the T3 infected cats are shown in 
Table 9. Blood samples assayed (23-32 days) p r io r  to death 
! revealed that a l l  of the cats had only subgroup A FeLV c ircu la tin g
in the plasma with the exception of T3C£ which had subgroup AC 
plasma virus detected 10 days before death. Four of the six plasma 
| samples which were assayed at death contained FeLV with an
additional subgroup other than A and three of these subgroups were 
identica l to those released by the homologous ce l ls  that were 
cultured. (T3C4, T3C5 and T3C7).
The interference data on the F422 virus infected cats is  
incomplete but Table 10 shows the virus subgroup c irc u la t in g  in the 
plasma of the cats 35 days p o s t- in fec tio n . Determination both of 
plasma virus subgroup at death and the subgroup of the virus  
released from the tumour c e l ls  of these cats has proven d i f f i c u l t  
to assay since the virus appears to have a cytopathic e f fe c t  on the 
FEA c e lls  as i t  spreads through the cu ltu re . This w i l l  be 
discussed in the next section.
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DISCUSSION
The ra p id ity  with which the T3 and F422 recombinant viruses 
induce tumours in newborn cats (81-98 days post-in fec tion  and 
71-123 days pos t- in fec tion  respective ly) is typical of acutely  
transforming leukaemia viruses of other species which rap id ly
produce disease on inoculation into susceptible animals (B is te r ,  
1984). In p a r t ic u la r ,  in the fe l in e  system, the Rickard s tra in  of 
FeLV was shown to rap id ly  produce malignant lymphosarcoma of mixed 
histiocytic -lym phocytic  ce ll type on inoculation into  newborn 
k ittens  (30-139 days pos t- in fec tion ) (Rickard et a l . ,  1969). In 
the same experiment a few animals with longer la te n t  periods
between inoculation and death (around 160 days p o s t- in fec tio n )  
developed thymic lymphosarcomas. In te res ting ly  T3Cj and T3Cg cats 
showed lymph node enlargement as early  as 40 days p o s t- in fe c t io n .  
Examination of an excised poplitea l lymph node from cat T3Cg 
indicated abundant sinus h istiocytes and occasional giant ce lls  
reminiscent of the mixed h istiocytic-lym phocytic  lymphoma described 
by Rickard. However, these lesions regressed in both cats .
The s p e c if ic i ty  of disease produced by these recombinant 
viruses is not due to s p e c if ic i ty  conferred by the oncogene v-myc 
as myc is  associated with a spectrum of neoplasia in several 
species from avian to human. The myc oncogene is  not only
incorporated into defective retroviruses (Enrie tto  et a l . ,  1983) or 
altered by the in tegration  of re trov irus  into the c e l lu la r  locus 
(Hayward et a l . ,  1981) but i t  is  also involved in non-viral
mechanisms of tumourigenesis such as the chromosomal translocation  
seen in B u rk it t 's  lymphomas ( Croce et_ al_., 1983). Any s p e c if ic i ty  
of disease induced by these recombinant viruses is more probably 
due to tissue specific  enhancer sequences in the v ira l  LTR 
(suggested by Anderson and Scolnick, 1983) s im ila r  to those 
described for immunoglobulin genes (Boss, 1983). The v ira l  LTRs 
contain promoter and enhancer sequences for RNA tran scr ip tio n  
(Temin, 1982) and may therefore increase the level of c e l lu la r  myc 
mRNA i f  myc sequences are incorporated into the v ira l  genome or are 
adjacent to the v ira l  genome.
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Both T3 and F422 ce l l  lines release recombinant and helper 
FeLV with subgroup A envelopes. The orig ina l T3 cat however had 
both subgroups A and C FeLV c ircu la ting  in the plasma as well as 
recombinant v irus . The results of the in terference tests  shown in 
Tables 9 and 10 demonstrate that although these cats were 
inoculated with subgroup A virus only, additional subgroups are 
frequently generated in v iv o . I t  is of p a r t ic u la r  in te re s t  that  
a l l  of the T3 infected cats that had AC subgroup plasma virus 
developed erythroid hypoplasia with the exception of T3C2 which 
did , however, display haematological dysplasia. The plasma virus  
subgroup of T3C6 remains to be determined but th is  cat also showed 
erythroid hypoplasia and the association of subgroup C virus with 
th is  condition is well documented (J a r re t t  et a l . ,  1984).
Furthermore, in the present series of cats there may be some 
suggestion of a temporal association between the appearance of 
these additional subgroups in the plasma and the onset of disease, 
s im ilar  to that observed by Onions et a l . (pers. comm.) in the GM-1 
in vivo experiments. I t  seems probable that the T3 and F422 "A" 
envelopes are in fact part ia l  recombinants between in fec ting  
subgroup A viruses and endogenous FeLV sequences, since additional 
plasma subgroups have never been generated when Glasgow-1 (subgroup 
A) FeLV has been inoculated into cats (0 . Ja rre t t  pers. comm.). I t  
may be tha t there is  genomic masking of a small subgroup C 
component present in these viruses but th is  is un like ly  since the 
virus is grown in FEA c e l ls  for a minimum of three weeks before 
subgroup determination by interference te s t in g .  This method of 
assay should eas ily  permit subgroup C detection and i t  therefore  
seems more l ik e ly  that these subgroup A viruses have some subgroup 
C envelope sequences present enabling them to read ily  recombine 
with other endogenous c e l lu la r  sequences. Recent evidence from 
Vedbrat et a l . (1983) using non-neutralis ing anti-FeLV-C monoclonal 
antibody against F422 c e l ls  supports th is  theory. The results  
suggest that F422 ce lls  display FeLV-C envelope determinants which 
react with th is  non-neutralis ing antibody and i t  would therefore  be 
in tr igu ing  to use th is  monoclonal against the T3 c e l l  l in e .  
Unfortunately, th is  antibody has not been ava ilab le  and 
immunofluorescence tests carried out in co llaboration  with Prof.
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0. J a r r e t t ,  using neutra lis ing  FeLV-C monoclonal antibodies  
(supplied by H. Lutz and C. Grant) against both the T3 and F422
ce ll l ines  have been negative. Further characterisation  of these
ce ll  l ines  is  currently  in progress using a wide range of
monoclonal antibodies.
The Southern b lot shown in Figure 31 c le a r ly  demonstrates tha t  
these induced thymic lymphosarcomas are clonal (or at most 
o ligoclonal)  in o r ig in ,  l ik e  those induced in the avian system 
(Hayward, 1981). Even although the bands on the b lot of the F422 
tumour and ce ll l in e  DNAs are la rge , i t  is obvious tha t  a unique
set of fragments has been generated. This indicates th a t  the 
tumour has arisen from a single c e l l ,  or at most a very few c e l ls ,  
otherwise there would have bee-n proviral in tegrations at a great 
many s ites  in the DNA which would have generated a smear on the 
southern b lo t .  Considering the speed with which these tumours 
developed and the potent oncogenic nature of the viruses used to 
induce them, i t  had seemed l ik e ly  that several ce l ls  may have been 
transformed at the same time and polyclonal tumours, s im ila r  to 
those induced by FeSV (Resmer, 1984) would not have been 
surpris ing. The c lo n a l ity  of these tumours suggests tha t  a second 
transformation step a f te r  the in fection  o f  myc is necessary for  
tumour development or tha t selection fo r a rap id ly  d iv id ing  
transformed clone occurs.
The p o s s ib i l i ty  that an a ltered requirement for or s e n s it iv i ty  
to a growth factor could play a role at th is  stage is curren tly  
under inves tiga t ion . The s im i la r i ty  between the re s tr ic te d  tumour 
and the ce ll l in e  DNAs (F ig .  32) show that the cultured c e l ls  are 
representative of the tumour ce ll population although there may be 
some additional rearrangment in some of the other ce ll l ines  which 
have s t i l l  to be checked. This often occurs when c e l ls  are 
passaged in v i t r o . The T3 tumour ce l ls  in p a r t ic u la r  were read ily  
established in v i t ro  in the absence of growth fa c to r .  Only one 
f ie ld  case, T17, was established in cu lture  in th is  fashion and 
th is  too releases both recombinant and helper FeLV. I t  would 
therefore  appear tha t the presence of recombinant virus or the
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passage of these viruses in vivo is  generating transformed ce lls  
with l i t t l e  or no growth r e s t r ic t io n .  Whether or not the presence 
of the myc oncogene is related to the loss of growth factor control 
of d iv is ion of these ce l ls  remains to be established.
The successful transmission of these recombinant FeLV/myc 
viruses in vivo has c le a r ly  demonstrated th e ir  acutely transforming 
potential in nature. Horizontal transmission of these viruses has 
yet to be demonstrated but one of the T3 uninfected tra ce r  cats 
(T3C ^) has now become pers is ten tly  viraemic and virus has been 
iso lated from the plasma of th is  cat and w il l  be analysed for the 
presence of acquired myc sequences. Bone marrow cultures have been 
established from a l l  the la te n t ly  infected tra ce r  cats and virus  
induced from these c e l ls  has, .been plated.onto FEA c e l ls  to produce 
a s u f f ic ie n t  quantity fo r  analysis for acquired myc sequences. The 
DNA of the infected FEAs has been analysed in a s im ila r  manner as 
before but no newly acquired myc sequences have been detected 
(Onions, pers.comm.). The absence of acquired myc sequences is ,  
however, inconclusive as th is  may simply r e f le c t  the amount of 
recombinant virus present; i f  the t i t r e  was too low not enough myc 
would have been present to allow detection by the probe. I t  w il l  
be in te re s t in g ’ to determine i f  horizontal transmission of the 
FeLV/myc virus occurs in vivo or i f  each of these viruses is  
generated de novo in each cat by recombination between in fec ting  
FeLV and c e l lu la r  sequences.
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TABLE 6.
T U M O U R S  P R O D U C E D  BY T 3  F eLV -znyc
CASE
T 3 C 4
PATHOLOGY
Thymic lym phosarcom a  
Sinus histiocytosis  
Erythroid hypoplasia
T IM E
AFTER
INFECTIO N
days
81
T 3 C 5 Thym ic lym phosarcom a  
Erythroid hypoplasia  
T -ce ll depletion
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T 3 C 6  Thymic lym phosarcom a 91
Erythroid hypoplasia  
Sinus histiocytosis
T 3 C 7  Thym ic lyphosarcom a 91
T 3C 8 Thym ic lym phosarcom a  
T -c e ll depletion  
Sinus histiocytosis
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TABLE 7.
CASE
T 3C 1
T 3 C 2
D IS E A S E  P R O D U C E D  BY T 3  Fe LV-myc
PATHOLOGY T IM E  AFTER INFECTIO N
Erythroid hypoplasia 103 days
T-cell depletion
Haematopoietic dysplasia 71 days
T-cell depletion
TABLE 8.
INFECTION OF TRACER CATS IN FeLV T3 EXPERIMENT
CASE VIRAEMIA LATENCY (DaysI 
69 -7 4  115-118
T3C3 At 28 days only AB AB
T3C9 Not detected AB AB
T3C10 Not detected AB AB
T3C11 At 147 days onward AB AB
TABLE 9
Subgroups at death 
Case Plasma Tumour c e l ls
T3C1 AC
T3C2 AC
T3C4 AC AC
T3C5 ABC ABC
T3C6 - N/D A
T3C7 A A
T3C8 . A ABC
ND = not done.
TARLE 10
Subgroups 35 days post in fection
Case PIasma
F422/1 A
F422/2 AB
F422/3 AB
FIGURE 29.
FeLV-myc PATHOGENESIS EXPERIMENT
T3
T3 Cell line 
FeLV-A/myc
Amicon
ultrafiltration
 Thymic lymphosarcoma 
Viraemia : FeLV-AC 
Tumour : FeLV-A
F422 Cell line 
FeLV-A/ myc
i
Amicon
ultrafiltration
5 X10 f.f.u. i/p into newborn 5x10 f.f.u. i/p into newborn
m  A
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3 infected
_
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Figure 30 shows DNAs isolated from the T3 and F422 tumours. The 
DNAs have been 're s tr ic te d  with Kpn-1 which cuts the 
virus in te rn a l ly
M
A, B, C,
(B)
CON
= Hind I I I  X DNA marker.
D = T3 and F422 induced tumour DNAs.
= cell line DNA derived from the F422 
induced tumour B.
= control DNA.
FIGURE 30
The demonstra t ion t h a t  the prov iruses  o f  the T3 and F422 tumours
are re p re s e n ta t iv e  o f  those in the o r i g i n a l  c e l l  l i n e s
P r o b e : 
v - myc 3' 
(exon 3)
T3 TUMOURS F422 TUMOURS
M T3 A B C D M F422 A B (B) CON
Digests Kpn l
Figure 31 shows DNAs isolated from the T3 and F422 induced
tumours. The DNAs have been res tr ic ted  with EcoRl 
which has a re s tr ic t io n  s ite  within the T3 provirus and 
also in c e l lu la r  flanking sequences. The F422 
provirus, however, does not contain a re s tr ic t io n  s ite  
for EcoRl therefore th is  enzyme is cutting these DNAs 
in c e l lu la r  flanking sequences only.
M = Hind I I I  X DNA marker.
A, B, C, D = T3 and F422 induced tumour DNAs.
(B) = c e l l  l in e  DNA derived from the F422
induced tumour B.
CON = control DNA.
FIGURE 31
Clonal o r i g i n  o f  tumours demonstrated by 
EcoRl r e s t r i c t i o n  ana lys is
T3 TUMOURS F422 TUMOURS
M T3 A B C D M F422 A B (B) CON
23.1 -
9 .4-  
6.7 -
4 . 4 -
2.3
2.0
0.6 -
EcoRl
Figure 32 shows a comparison of the integrat ion pattern of the
proviruses of tumour and representative cel l  l in e  
DNAs. The T3 DNAs were restr ic ted  with EcoRl which 
cuts both within the virus and in the f lanking  
sequences.
M = Hind I I I  X  DNA marker.
A, B = two of the T3 induced tumour DNAs.
(A),  (B) = the corresponding cell  l in e  DNAs.
FIGURE 32
The comparison o f  the r e s t r i c t i o n  maps o f  
tumour and rep resen ta t ive  c e l l  l i n e  DNAs.
GENERAL DISCUSSION
c
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This study was concerned with two principal aspects of the 
pathogenesis of T-cell  neoplasia in the cat ;  f i r s t ,  the 
invest igat ion of the ro le ,  i f  any, of IL -2  in the p ro ! i fe ra t io n  of  
neoplastic T-cel l  s in v i t ro  and secondly, the determination of the 
properties of the FeLVs associated with these tumours.
A prerequisite for  th is  work was a source of fe l in e  IL-2  which 
could support the long-term culture of normal activated T -c e l ls .  
The production of lymphocyte conditioned medium from SPF cats has 
answered th is  requirement and has enabled both the long-term growth 
of normal T -ce l ls  and the establishment of neoplastic T -ce l l  l in e s .
The investigation into the requirement of T -ce l ls  for an 
exogenous source of IL-2 in v i t ro  has been very rewarding. These 
studies have revealed that  although normal T -ce l ls  are absolutely  
dependent on an exogenous source of  IL-2  for growth in v i t r o , 
neoplastic T-cel ls  isolated from FeLV posit ive thymic 
lymphosarcomas, f a l l  into one of two categories with respect to 
th is  requirement (Figure 33).
Of nine tumours (3 f i e l d  cases , .4 T3 v i rus - in fec ted  cats and 2 
F422 v i rus- in fected cats) from which a recombinant FeLV/myc virus 
has been iso la ted ,  seven have established in cul ture  independent of 
an exogenous source of IL -2 .  (One of the other two, T i l ,  requires 
an exogenous source of IL-2 fo r  growth in v i t r o ) .  S t r ik in g ly ,  of 
nine other tumours which did not harbour an FeLV/myc recombinant 
v irus ,  none established in culture independent of an exogenous 
source of IL -2  but three grew i f  IL -2  was added to the medium.
Our recent observations (Stewart et a l . ,  submitted) suggest 
that the level o f  myc RNA in the tumour c e l ls  which harbour 
FeLV/myc recombinant virus is increased approximately 100-fold over 
that  in normal activated T -c e l ls .
In the l ig h t  of recent studies on the re la t ionship  of  
oncogenes to growth factors and growth factor  receptors (reviewed 
by He!din and Westermark, 1984) and from the results presented here
i t  is possible to speculate on the possible re lat ionship  between 
myc and the growth factor  independence of the neoplastic fe l in e  
T-cel ls  in th is  series .
Since myc is  a nuclear DNA binding protein i t  may have a 
regulatory function in the induction or de-repression of  
t ranscr ip t ion  of a regulatory protein involved in cel l  d iv is ion .  
I t  has been reported that  c-myc is an inducible gene and that  the 
expression of c-myc mRNA is increased 10 to 40- fo ld  within 1-3 
hours a f te r  cell  st imulation with a mitogen such as Con-A (Kel ly  et  
a l . ,  1 983).  In addit ion ,  th is  induction not only occurs in the 
presence of cyclohexamide demonstrating that no new protein species 
is required, but in the presence of both Con-A and cyclohexamide, 
superinduction of the gene is observed, suggesting that  a l a b i le  
protein may regulate c -myc levels  in these c e l ls .
I t  has also been well documented that  although the increased 
expression of c-myc "primes" the cell  to div ide,  the binding of  
IL-2 to the cell  membrane is essential  for the cel l  to proceed from 
the la te  G1 phase of cel l  division into S phase (Klaus and 
Hawrylowicz, 1984).  The product of the c-myc gene would therefore  
appear to provide a l ink  between the mitogenic signal (s) to the 
cel l  instructing i t  to divide and the competent c e l l ,  ready to 
undergo d iv is ion .  The most obvious hypothesis which could emerge 
from these observations is that  the myc proto-oncogene e i th e r  
d i re c t ly  or in d i r e c t ly  (via a secondary i n t r a c e l lu la r  message) 
controls the expression of the growth factor  receptor.  In the case 
of T -c e l ls ,  th is  would be the IL-2 receptor and recent evidence 
from Tsudo et a l . (1982; 1983) that  the IL-2  receptor on human ATL 
ce l ls  is not down-regulated by the monoclonal antibody (ant i -Tac)  
which modulates the IL-2 receptor (Tac-ag) on normal activated  
T-cel ls  suggests that the regulation of the IL-2  receptor may be 
d i f fe r e n t  between normal and malignant T -ce l ls .
One can envisage that  the const i tut ive  expression of the IL-2  
receptor on IL-2  dependent malignant T-cel ls  could d i r e c t ly  lead to
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the uncontrolled p r o l i fe ra t io n  of these c e l l s .  On the other hand, 
the const i tu t ive  expression of the receptor on so-called IL-2  
independent T -ce l ls  is not such an obvious advantage..
The crucial  fact to be determined in th is  case is the 
de f in i t io n  of " IL -2  independent" T-cel l  growth. Whether or not 
malignant T -cel ls  are t r u ly  independent of an exogenous source of 
IL -2  for growth or whether they are r e a l ly  hyper-responsive to low 
levels present in foetal c a l f  serum has not been s a t is fa c to r i l y  
established, even in the experiments presented in th is  work. 
I t  w i l l  be important to study the growth of the T3 cel l  l in e  in a 
complete Iscoves medium which is free of FCS. I f  these ce l ls  
continue to grow in th is  medium i t  can be concluded that  they are 
t r u ly  independent of exogenous IL -2  for p ro l i f e ra t io n  in v i t r o . I t  
has been the assumption in many experiments (my own included) tha t  
the ce l ls  do not respond to IL -2  in the FCS but one must be wary of  
th is  assumption since i t  was believed that  in the murine system 
BF1J-E ce l ls  infected with Friend MuLV could d i f f e r e n t i a t e  in the 
absence of erythropoiet in when in fact the ce l ls  were responding to 
low levels of th is  factor  in the foetal  c a l f  serum in the cul ture  
medium (Hankins, 1983).
A const i tu t ive  expression of IL-2 receptor could, in theory,  
confer a hyper-responsive state on a c e l l .  However, adsorption 
data (presented in Chapter Four) suggests that  the neoplastic  
T-cel ls  studied in th is  series do not display an excess of  
available  receptors. I t  may be that  the IL-2 receptors on these 
cel ls  are a ltered in such a way that  they behave as i f  IL -2  were 
bound in the absence of the factor  or a l te rn a t iv e ly  the receptors 
may be binding an endogenous factor  produced by the c e l l s .  I f  
these ce l ls  are producing and responding to t h e i r  own growth 
fac to r ,  i t  is not produced in detectable levels  free in the 
supernatant of the c e l l s .  However, the dexamethasone inh ib i t io n  
and rescue experiments (also presented in Chapter Four) strongly  
suggest that  the IL-2  independent T-cel l  l ines T3 and T17 are 
producing and responding to IL -2  or a closely related fa c to r .  This 
would not disagree with a receptor-orientated hypothesis which
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would postulate that  the enhanced expression of myc results  in the 
const i tut ive  expression of  IL -2  receptors on these c e l l s .  Indeed, 
although a l l  sub-classes of T-cel ls  have been shown to be capable 
of producing IL -2 ,  helper T -cel ls  are the major source of th is  
factor  (Robb, 19R4) and i t  would be of interest  to determine i f  the 
T i l  neoplastic T -ce l ls  were of  the same subset as the T3 and T17 
"IL-2 independent" c e l l s .  The hypothesis, on th is  basis,  would be 
that  enhanced levels  o f  myc results in the const i tu t ive  expression 
of receptors on a l l  T -cel l  subsets but that when th is  occurs in a 
T-cell  of the helper subset which is capable of producing IL -2 ,  
then these cel ls  would be capable of uncontrolled p r o l i f e r a t io n .
The results in Chapter Six demonstrate that  the tumours 
produced by the T3 and F422 FeLV/myc recombinant viruses are 
clonal ,  or at most ol igoclonal in o r ig in .  I t  therefore follows 
that  i f  these viruses integrate  into multiple target  ce l ls  on 
infect ion then a secondary event, such as the act iva t ion  of a 
second oncogene, must occur to achieve the ful ly -transformed c e l l .  
A lte rna t ive ly ,  the selection for a rapidly growing clone may occur 
i f ,  for example, a sub-population of the infected ce l ls  are capable 
of continuously dividing by auto-stimulation
Clearly the most immediate questions to be answered now are:  
( i )  are neoplastic T-cel l  l ines such as T3 and T17 t r u l y  IL -2  
independent in v i t ro? ( i i )  what is the level of IL -2  mRNA in these 
cells? ( i i i )  do these ce l ls  const i tu t ive ly  express a receptor for  
IL-2? and ( iv )  i f  so, does th is  expression corre late  with enhanced 
myc expression in the cells? .
Several experiments have been designed to answer these 
questions. As mentioned previously,  the T3 cel l  l in e  w i l l  be grown 
in a complete Iscoves medium without FCS to examine the p o s s ib i l i t y  
that  the ce l ls  are hyper-responsive to low levels of IL-2 in foetal  
c a l f  serum. I f  these cel ls  are t r u ly  IL-2 independent they w i l l  be 
probed with a human IL-2  cDNA clone (provided by Dr. R. Gallo) to 
determine the in t r a c e l lu la r  level of IL -2  mRNA. I f  the cross-  
hybridi sation between the human and fe l in e  IL-2  is  poor, then the
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human IL-2 w i l l  be used as a detection system for the cloning of
the fe l in e  IL-2  gene. I t  is also hoped to have the human IL-2
receptor cDNA clone made available  to us in the near future and
simi lar  experiments are planned to determine i f  the IL-2
independent neoplastic T -ce l ls  which harbour a recombinant virus  
con st i tu t ive ly  express the IL-2  receptor.  Ul t imate ly ,  i t  is hoped 
to introduce combinations of the myc gene and the IL-2 gene into 
normal ce l ls  via re t ro v ira l  packaging deletion mutants, and observe 
the outcome of in fe c t ion .  The results of these experiments should 
e i th er  prove or disprove the hypothesis that  the enhanced 
expression of the myc gene leads to the const i tu t ive  expression of 
IL-2 receptors on neoplastic T -ce l ls .
I f  the normal product of c -myc is essential  to the regulation  
of normal cel l  d iv is ion at the level of control of growth factor  
receptor expression then one can envisage a model whereby the 
aberrant expression of myc could lead to the transformation of a 
wide spectrum of target  ce l ls  of d i f fe re n t  histogenetic or igins  
(Graf and Beug, 1978).
In th is  respect the study of the e f fec t  of increased myc and 
11-2 expression on T-cel ls  should help to elucidate the mechanism 
of transformation of FeLV/myc posit ive thymic lymphosarcomas of the 
cat .
102
FIGURE 33.
The correlat ion between the presence of  recombinant virus  
and independence from exogenous IL -2 .
Class I  -  Thymic lymphosarcomas harbouring FeLV/myc recombinant 
v irus .
7/9 grew independently of exogenous IL-2
1 /9  grew in the presence of exogenous IL-2
Class 2 -  Thymic lymphosarcomas harbouring helper FeLV only.
0/9 grew independently of exogenous IL-2
3/9 grew in the presence of exogenous IL-2
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